ID,PMID,YEAR,Sequence,MAP,Name,C-ter MOD,N-ter MOD,Linear/Cyclic,Stereo-Chemistry,Modified,Length,Fuction,Activity,RBCs Source,Origin,Experimental structure,Non-Hemolytic
1025,18081258,2008,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},Katala B1,Free,Free,Cyclic,L,None,29,Anti-HIV,HD50 =11.7μM,Human,Cyclotides (Chinese herb from the Violaceae family Viola yedoensis),NA,NA
1027,18081258,2008,GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN,GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN{cyc:N-C},Cycloviolacin Y1,Free,Free,Cyclic,L,None,33,Anti-HIV,Poor hemolytic,Human,Cyclotides (Chinese herb from the Violaceae family Viola yedoensis),NA,NA
1028,18081258,2008,GVPCGESCVFIPCITGVIGCSCSSNVCYLN,GVPCGESCVFIPCITGVIGCSCSSNVCYLN{cyc:N-C},Cycloviolacin Y4,Free,Free,Cyclic,L,None,30,Anti-HIV,HD50 =9.3μM,Human,Cyclotides (Chinese herb from the Violaceae family Viola yedoensis),NA,NA
1029,18081258,2008,GIPCAESCVWIPCTVTALVGCSCSDKVCYN,GIPCAESCVWIPCTVTALVGCSCSDKVCYN{cyc:N-C},Cycloviolacin Y5,Free,Free,Cyclic,L,None,30,Anti-HIV,HD50 = 8.7μM,Human,Cyclotides (Chinese herb from the Violaceae family Viola yedoensis),NA,NA
1076,17114219,2007,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Hemolytic,100% hemolysis at 2μM,Rat,"Melittin (venom of the european honey bee, Apis mellifera)",Random coil and α Helical,NA
1100,17307975,2007,alK-lK-lK-lK,{nnr:alK}-{nnr:l}K-{nnr:l}K-{nnr:l}K,OAK 1,Free,Free,Linear,Mix,"a = amino, l = lauric acid, alK = aminolauryl-lysine",4,Antiplasmodial,24.6± 1.2% hemolysis at 100 μM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA
1101,17307975,2007,lK-lK-lK-lK,{nnr:l}K-{nnr:l}K-{nnr:l}K-{nnr:l}K,OAK 2,Free,Free,Linear,Mix,"l = lauric acid, alK = aminolauryl-lysine",4,Antiplasmodial,26.1±4.5% hemolysis at 100 μM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA
1102,17307975,2007,K-lK-lK-lK,K-{nnr:l}K-{nnr:l}K-{nnr:l}K,OAK 3,Free,Free,Linear,Mix,"l = lauric acid, alK = aminolauryl-lysine",4,Antiplasmodial,2.3±1.5% hemolysis at 100 μM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA
1103,17307975,2007,alK-lK-lK,{nnr:a}{nnr:l}K-{nnr:l}K-{nnr:l}K,OAK 4,Free,Free,Linear,Mix,"a = amino, l = lauric acid",3,Antiplasmodial,3.4±0.8% hemolysis at 100 μM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA
1104,17307975,2007,lK-lK-lK,{nnr:l}K-{nnr:l}K-{nnr:l}K,OAK 5,Free,Free,Linear,Mix,"l = lauric acid, alK = aminolauryl-lysine",3,Antiplasmodial,13.3±4.3% hemolysis at 100 μM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA
1105,17307975,2007,K-lK-lK,K-{nnr:l}K-{nnr:l}K,OAK 6,Free,Free,Linear,Mix,"l = lauric acid, alK = aminolauryl-lysine",3,Antiplasmodial,<0.1% hemolysis at 100 μM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA
1106,17307975,2007,alK-lK,{nnr:alK}-{nnr:l}K,OAK 7,Free,Free,Linear,Mix,"a = amino, l = lauric acid, alK = aminolauryl-lysine",2,Antiplasmodial,0.14±0.3% hemolysis at 100 μM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA
1107,17307975,2007,lK-lK,{nnr:l}K-{nnr:l}K,OAK 8,Free,Free,Linear,Mix,l = lauric acid,2,Antiplasmodial,4.9±1.7% hemolysis at 100 μM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA
1108,17307975,2007,K-lK,K-{nnr:l}K,OAK 9,Free,Free,Linear,Mix,l = lauric acid,2,Antiplasmodial,<0.1% hemolysis at 100 μM,Human,Oligoacyllysine analog (Synthetic peptide),NA,NA
1280,18695936,2009,GRILSFIKGLAEHL,GRILSFIKGLAEHL{ct:Amid},Eumenine mastoparan-OD,Amidation,Free,Linear,L,None,14,Hemolytic,>40% hemolysis at 50μM,Sheep,"Venom of a Vespid solitary wasp, Orancistrocerus drewseni drewseni",α-helix,NA
1281,18695936,2009,ILGIITSLLKSL,ILGIITSLLKSL{ct:Amid},Orancis-Protonectin,Amidation,Free,Linear,L,None,12,Hemolytic,~80% hemolysis at 50μM,Sheep,"Venom of a Vespid solitary wasp, Orancistrocerus drewseni drewseni",α-helix,NA
1282,18695936,2009,INLKALAALAKKIL,INLKALAALAKKIL{ct:Amid},Mastoparan,Amidation,Free,Linear,L,None,14,Hemolytic,<10% hemolysis at 50μM,Sheep,"Black-bellied hornet  (Vespa basalis,  Vespinae) venom",α-helix,NA
1516,20564013,2010,GTPCGESCVYIPCISGVIGCSCTDKVCYLN,GTPCGESCVYIPCISGVIGCSCTDKVCYLN{cyc:N-C},Kalata B5,Free,Free,Cyclic,L,None,30,Pesticidal,HD50 =27.4±1.2μM,Human,Cyclotides (Oldenlandia affinis),typical bracelet cyclotide fold,NA
1531,20728940,2010,NPVLVKDATGSTQFGPVQALGAQYSMWKLK,NPVLVKDATGSTQFGPVQALGAQYSMWKLK,CP2,Free,Free,Linear,L,None,30,Inhibitor of  complement pathway,100% hemolysis at 0.77mM,Sheep,Coat protein derivative (human astrovirus type 1),NA,NA
1532,20728940,2010,PAICQRATATLGTVGSNTSGTTEIEACILL,PAICQRATATLGTVGSNTSGTTEIEACILL,CP1,Free,Free,Linear,L,None,30,Inhibitor of  complement pathway,100% hemolysis at 0.77mM,Sheep,Coat protein derivative (human astrovirus type 1),NA,NA
1533,20728940,2010,PAIAQRATATLGTVGSNTSGTTEIEACILL,PAIAQRATATLGTVGSNTSGTTEIEACILL,C04A,Free,Free,Linear,L,None,30,Inhibitor of  complement pathway,100% hemolysis at 0.77mM,Sheep,Coat protein derivative (human astrovirus type 1),NA,NA
1534,20728940,2010,PAICQRATATLGTVGSNTSGTTEIEAAILL,PAICQRATATLGTVGSNTSGTTEIEAAILL,C27A,Free,Free,Linear,L,None,30,Inhibitor of  complement pathway,90% hemolysis at 0.77mM,Sheep,Coat protein derivative (human astrovirus type 1),NA,NA
1535,20728940,2010,PAICQRATATLGTVGSNTSGTTAIEACILL,PAICQRATATLGTVGSNTSGTTAIEACILL,E23A,Free,Free,Linear,L,None,30,Inhibitor of  complement pathway,80% hemolysis at 0.77mM,Sheep,Coat protein derivative (human astrovirus type 1),Helix+Sheet+Loop,NA
1536,20728940,2010,PAICQRATATLGTVGSNTSGTTEIAACILL,PAICQRATATLGTVGSNTSGTTEIAACILL,E25A,Free,Free,Linear,L,None,30,Inhibitor of  complement pathway,95% hemolysis at 0.77mM,Sheep,Coat protein derivative (human astrovirus type 1),NA,NA
1537,20728940,2010,PAICQRAEIEACILL,PAICQRAEIEACILL,Δ8-22,Free,Free,Linear,L,None,15,Inhibitor of  complement pathway,100% hemolysis at 0.77mM,Sheep,Coat protein derivative (human astrovirus type 1),NA,NA
1578,14769216,2004,FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRNLVPRTES,FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRNLVPRTES,FALL-39,Free,Free,Linear,L,None,39,Antibiotic,>25% hemolysis at 200g/l,Human,Cathelicidin (Homo sapiens bone marrow),α-helical,NA
1579,14769216,2004,FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRNLVPRTES,FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRNLVPRTES,FALL-39,Free,Free,Linear,L,None,39,Antibiotic,>30% hemolysis at 400g/l,Human,Cathelicidin (Homo sapiens bone marrow),α-helical,NA
1580,14769216,2004,FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRKLVPRTES,FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRKLVPRTES,FALL-39-lys32,Free,Free,Linear,L,None,39,Antibiotic,30% hemolysis at 200g/l,Human,Cathelicidin (Homo sapiens bone marrow),α-helical,NA
1581,14769216,2004,FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRKLVPRTES,FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRKLVPRTES,FALL-39-lys32,Free,Free,Linear,L,None,39,Antibiotic,40% hemolysis at 400g/l,Human,Cathelicidin (Homo sapiens bone marrow),α-helical,NA
1582,14769216,2004,FALLGDFFRKSKEKIGKEFKRIVKRIKDFFRNLVPRTES,FALLGDFFRKSKEKIGKEFKRIVKRIKDFFRNLVPRTES,FALL-39-lys24,Free,Free,Linear,L,None,39,Antibiotic,>30% hemolysis at 200g/l,Human,Cathelicidin (Homo sapiens bone marrow),α-helical,NA
1583,14769216,2004,FALLGDFFRKSKEKIGKEFKRIVKRIKDFFRNLVPRTES,FALLGDFFRKSKEKIGKEFKRIVKRIKDFFRNLVPRTES,FALL-39-lys24,Free,Free,Linear,L,None,39,Antibiotic,>35% hemolysis at 400g/l,Human,Cathelicidin (Homo sapiens bone marrow),α-helical,NA
1595,15052574,2004,I/LNWLKLGKAIIDAI/L,I/LNWLKLGKAIIDAI/L{ct:Amid},Agelaia-MP,Amidation,Free,Linear,L,None,14,Inflammatory,75% hemolysis at 1 x10-6 M,Rat,Mastoparan (venom of the wasp Agelaia pallipes pallipes),NA,NA
1596,15150833,2004,INWLKLGKMVIDAL,INWLKLGKMVIDAL{ct:Amid},13a,Amidation,Free,Linear,L,None,14,Inflammatory,100% hemolysis at 6.2x10-5 M,Rat,Mastoparan (venom of the social wasp Polybia paulista),NA,NA
1597,15150833,2004,IDWLKLGKMVMDVL,IDWLKLGKMVMDVL{ct:Amid},13b,Amidation,Free,Linear,L,None,14,Inflammatory,100% hemolysis at 6.2x10-5 M,Rat,Mastoparan (venom of the social wasp Polybia paulista),NA,NA
1598,15225564,2004,ILGTILGLLKGL,ILGTILGLLKGL{ct:Amid},Protonectin,Amidation,Free,Linear,L,None,12,Chemotactic,>40% hemolysis at 10-4 M,Rat,Mastoparan (venom of the neotropical social wasp Agelaia pallipes pallipes),NA,NA
1599,15225564,2004,INWLKLGKAIIDAL,INWLKLGKAIIDAL{ct:Amid},Agelaia-MP,Amidation,Free,Linear,L,None,14,Mast cell degranulating toxin,~90% hemolysis  at 10-4 M,Rat,Mastoparan (venom of the neotropical social wasp Agelaia pallipes pallipes),NA,NA
1613,15328050,2004,FWGALAKGALKLIPSLFSSFSKKD,FWGALAKGALKLIPSLFSSFSKKD,Pin2,Free,Free,Linear,L,None,24,Hemolytic,~60% hemolysis at 25µM,Pig,Pandinin 2 (Pandinus imperator),α-helical,NA
1614,15328050,2004,FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ,FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ,Oxki1,Free,Free,Linear,L,None,48,Hemolytic,~100% hemolysis at 25µM,Pig,Oxyopinin (Oxyopes kitabensis),α-helical,NA
1619,15581688,2005,INWKKMAAATALKMI,INWKKMAAATALKMI{ct:Amid},MP,Amidation,Free,Linear,L,None,15,Hemolytic,40% hemolysis at 10µM,Rat,Venom of the Neotropical social wasp Protopolybia exigua (Saussure),α-helical,NA
1620,15581688,2005,INWLKLGKKVSAIL,INWLKLGKKVSAIL{ct:Amid},MPI,Amidation,Free,Linear,L,None,14,Hemolytic,40% hemolysis at 10µM,Rat,Venom of the Neotropical social wasp Protopolybia indica (Saussure),α-helical,NA
1621,15616319,2005,QRSVSNAATRVCRTGRSRWRDVCRNFMRR,QRSVSNAATRVCRTGRSRWRDVCRNFMRR,G8,Free,Free,Linear,L,None,29,Antibiotic,>80% hemolysis 100µM,Rabbit,Granulysin-Derived Peptides,α-helical,NA
1622,15616319,2005,QRSVSNAATRVCRTGRSRW,QRSVSNAATRVCRTGRSRW,G13,Free,Free,Linear,L,None,19,Antibiotic,20% hemolysis 100µM,Rabbit,Granulysin-Derived Peptides,α-helical,NA
1623,15616319,2005,GRSRWRDVCRNFMRR,GRSRWRDVCRNFMRR,G14,Free,Free,Linear,L,None,15,Antibiotic,40% hemolysis 100µM,Rabbit,Granulysin-Derived Peptides,α-helical,NA
1624,15616319,2005,GQSQWRDVCRNFMRR,GQSQWRDVCRNFMRR,G15,Free,Free,Linear,L,None,15,Antibiotic,~40% hemolysis 100µM,Rabbit,Granulysin-Derived Peptides,α-helical,NA
1625,15616319,2005,GRSRWRDVCRNFMRRYQSRVIQGLV,GRSRWRDVCRNFMRRYQSRVIQGLV,G20,Free,Free,Linear,L,None,25,Antibiotic,>80% hemolysis 100µM,Rabbit,Granulysin-Derived Peptides,α-helical,NA
1626,15629533,2005,MAQDIISTIGDLVKWIIDTVNKFTKK,MAQDIISTIGDLVKWIIDTVNKFTKK{nt:Formylation},Peptide f-26,Free,Formylation,Linear,L,None,26,Antibiotic,~90% hemolysis at 30µM,Guinea-pig,Analog of delta-lysin from staphylococcus aureus (synthetic peptide),α-helical,NA
1627,15629533,2005,MAQDIISTIGDLVKWIIDTVNKFTKK,MAQDIISTIGDLVKWIIDTVNKFTKK,Peptide n-26,Free,Free,Linear,L,None,26,Hemolytic,~95% hemolysis at 30µM,Guinea-pig,Analog of delta-lysin from staphylococcus aureus (synthetic peptide),α-helical,NA
1628,15629533,2005,AQDIISTIGDLVKWIIDTVNKFTKK,AQDIISTIGDLVKWIIDTVNKFTKK,Peptide n-25,Free,Free,Linear,L,None,25,Hemolytic,>75% hemolysis at 30µM,Guinea-pig,Analog of delta-lysin from staphylococcus aureus (synthetic peptide),α-helical,NA
1629,15629533,2005,IISTIGDLVKWIIDTVNKFTKK,IISTIGDLVKWIIDTVNKFTKK,Peptide n-22,Free,Free,Linear,L,None,22,Hemolytic,100% hemolysis at 5µM,Guinea-pig,Analog of delta-lysin from staphylococcus aureus (synthetic peptide),α-helical,NA
1630,15629533,2005,STIGDLVKWIIDTVNKFTKK,STIGDLVKWIIDTVNKFTKK,Peptide n-20,Free,Free,Linear,L,None,20,Hemolytic,~100% hemolysis at 20µM,Guinea-pig,Analog of delta-lysin from staphylococcus aureus (synthetic peptide),α-helical,NA
1631,15629533,2005,IGDLVKWIIDTVNKFTKK,IGDLVKWIIDTVNKFTKK,Peptide n-18,Free,Free,Linear,L,None,18,Hemolytic,<50% hemolysis at 30µM,Guinea-pig,Analog of delta-lysin from staphylococcus aureus (synthetic peptide),α-helical,NA
1632,15629533,2005,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide n-16,Free,Free,Linear,L,None,16,Hemolytic,<25% hemolysis at 30µM,Guinea-pig,Analog of delta-lysin from staphylococcus aureus (synthetic peptide),α-helical,NA
1639,15822124,2005,FRKLFRVYSNFLRGKLKL,FRKLFRVYSNFLRGKLKL{nt:Acet}{ct:Amid},P1buy,Amidation,Acetylation,Linear,L,None,18,Hemolytic,62% hemolysis at 10µM,Rat,"Protein Data Bank (PDB, 1buy)",α-helical,NA
1640,15822124,2005,WYSEMKRNVQRLERAIEE,WYSEMKRNVQRLERAIEE{nt:Acet}{ct:Amid},P1c3c,Amidation,Acetylation,Linear,L,None,18,Hemolytic,18% hemolysis at 10µM,Rat,"Protein Data Bank (PDB, 1c3c)",α-helical,NA
1641,15822124,2005,RDAKELVELFFEEIRRAL,RDAKELVELFFEEIRRAL{nt:Acet}{ct:Amid},P1ihf,Amidation,Acetylation,Linear,L,None,18,Hemolytic,46% hemolysis at 10µM,Rat,"Protein Data Bank (PDB, 1ihf)",α-helical,NA
1642,15822124,2005,KQLIRFLKRLDRNLWGLA,KQLIRFLKRLDRNLWGLA{nt:Acet}{ct:Amid},P1ill,Amidation,Acetylation,Linear,L,None,18,Hemolytic,48% hemolysis at 10µM,Rat,"Protein Data Bank (PDB, 1ill)",α-helical,NA
1668,16460023,2006,VSAVAKVAMKKGAALLKKMGVKISPLK,VSAVAKVAMKKGAALLKKMGVKISPLK,P1,Free,Free,Linear,L,None,27,Hemolytic,50% hemolysis at >900µM,Human,Peptides derived from Trialysin protein found in the saliva of Triatoma infestans,NA,NA
1669,16460023,2006,KQLKKVSAVAKVAMKKGAALLKKMGVK,KQLKKVSAVAKVAMKKGAALLKKMGVK,P2,Free,Free,Linear,L,None,27,Hemolytic,50% hemolysis at 450µM,Human,Peptides derived from Trialysin protein found in the saliva of Triatoma infestans,NA,NA
1670,16460023,2006,VGKVLKQLKKVSAVAKVAMKKGAALLK,VGKVLKQLKKVSAVAKVAMKKGAALLK,P3,Free,Free,Linear,L,None,27,Hemolytic,50% hemolysis at >900µM,Human,Peptides derived from Trialysin protein found in the saliva of Triatoma infestans,NA,NA
1671,16460023,2006,KFGKIVGKVLKQLKKVSAVAKVAMKKG,KFGKIVGKVLKQLKKVSAVAKVAMKKG,P4,Free,Free,Linear,L,None,27,Hemolytic,50% hemolysis at 274µM,Human,Peptides derived from Trialysin protein found in the saliva of Triatoma infestans,NA,NA
1672,16460023,2006,GKVLDKFGKIVGKVLKQLKKVSAVAKV,GKVLDKFGKIVGKVLKQLKKVSAVAKV,P5,Free,Free,Linear,L,None,27,Hemolytic,50% hemolysis at 117µM,Human,Peptides derived from Trialysin protein found in the saliva of Triatoma infestans,NA,NA
1673,16460023,2006,FKIKPGKVLDKFGKIVGKVLKQLKKVSAVAKV,FKIKPGKVLDKFGKIVGKVLKQLKKVSAVAKV,P6,Free,Free,Linear,L,None,32,Hemolytic,50% hemolysis at 90µM,Human,Peptides derived from Trialysin protein found in the saliva of Triatoma infestans,NA,NA
1674,16460023,2006,FKIKPGKVLDKFGKIVGKVLKQLKKVS,FKIKPGKVLDKFGKIVGKVLKQLKKVS,P7,Free,Free,Linear,L,None,27,Hemolytic,50% hemolysis at 296µM,Human,Peptides derived from Trialysin protein found in the saliva of Triatoma infestans,NA,NA
1675,16460028,2006,GASLSFKILKTVLEALGNV,GASLSFKILKTVLEALGNV,EqTII11-29,Free,Free,Linear,L,None,19,Hemolytic,10% hemolysis at 25µM,Human,Actinoporin from sea anaemone Actinia equina L,NA,NA
1684,16730857,2006,KFKLKQ,KFKLKQ{cyc:N-C},BPC6L,Free,Free,Cyclic,L,None,6,Hemolytic,11±4.6% hemolysis at 360µM,Human,Synthetic peptide,NA,NA
1687,16730857,2006,KLKfKLKQ,KLKF{d}KLKQ{cyc:N-C},BPC8D,Free,Free,Cyclic,Mix,None,8,Hemolytic,37±5.2% hemolysis at 360µM,Human,Synthetic peptide,NA,NA
1688,16730857,2006,KLKLKfKLKQ,KLKLKF{d}KLKQ{cyc:N-C},BPC10D,Free,Free,Cyclic,Mix,None,10,Hemolytic,42± 6.8% hemolysis at 360µM,Human,Synthetic peptide,NA,NA
1689,16730857,2006,KLKLKLKQ,KLKLKLKQ{cyc:N-C},BPC8S1,Free,Free,Cyclic,L,None,8,Hemolytic,1±0.1% hemolysis at 360µM,Human,Synthetic peptide,NA,NA
1690,16730857,2006,LKLKLKLQ,LKLKLKLQ{cyc:N-C},BPC8S3,Free,Free,Cyclic,L,None,8,Hemolytic,5±0.1% hemolysis at 360µM,Human,Synthetic peptide,NA,NA
1692,16848415,2006,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,M0,Free,Free,Linear,L,None,26,Hemolytic,HL50 = 1.5 μM at pH 7.4,Mouse,Analog of Melittin,NA,NA
1693,16848415,2006,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,M0,Free,Free,Linear,L,None,26,Hemolytic,HL50 = 6 μM at pH 4.5,Mouse,Analog of Melittin,NA,NA
1694,16848415,2006,CIGAVLKVLTTGLPALISWIKRKRQQC,CIGAVLKVLTTGLPALISWIKRKRQQC,M1,Free,Free,Linear,L,None,27,Hemolytic,HL50 = 3.0 at pH 7.4,Mouse,Analog of Melittin,NA,NA
1695,16848415,2006,CIGAVLKVLTTGLPALISWIKRKRQQC,CIGAVLKVLTTGLPALISWIKRKRQQC,M1,Free,Free,Linear,L,None,27,Hemolytic,HL50 = 1 μM at pH 4.5,Mouse,Analog of Melittin,NA,NA
1696,16848415,2006,CKKIGAVLKVLTTGLPALISWIKRKRQQKKC,CKKIGAVLKVLTTGLPALISWIKRKRQQKKC,M6,Free,Free,Linear,L,None,30,Hemolytic,HL50 = 2.5 μM at pH 7.4,Mouse,Analog of Melittin,NA,NA
1728,17142988,2006,INWLKLGKKILGAI,INWLKLGKKILGAI{ct:Amid},Pm-R1,Amidation,Free,Linear,L,None,14,Hemolytic,24 % of hemolysis at 50mM,Sheep,Kinins derivative (Polistes rothneyi iwatai),NA,NA
1729,17142988,2006,LNFKALAALAKKIL,LNFKALAALAKKIL{ct:Amid},Pm-R2,Amidation,Free,Linear,L,None,14,Hemolytic,23 % of hemolysis at 50mM,Sheep,Kinins derivative (Polistes rothneyi iwatai),NA,NA
1730,17142988,2006,IAWLKLGKGILGAL,IAWLKLGKGILGAL{ct:Amid},Pm-R3,Amidation,Free,Linear,L,None,14,Hemolytic,36 % of hemolysis at 50mM,Sheep,Kinins derivative (Polistes rothneyi iwatai),NA,NA
1731,17142988,2006,ILGTILGLLKGL,ILGTILGLLKGL{ct:Amid},Polistes-protonectin,Amidation,Free,Linear,L,None,12,Hemolytic,97 % of hemolysis at 50mM,Sheep,Kinins derivative (Polistes rothneyi iwatai),NA,NA
1732,17142988,2006,IALKALAALAKKIL,IALKALAALAKKIL{ct:Amid},Mastparan,Amidation,Free,Linear,L,None,14,Hemolytic,18 % of hemolysis at 50mM,Sheep,Mastoparans family,NA,NA
1737,17547385,2007,GKGLTicOicGRTicOicGFTicOicGRTicOicGFTicOicGRTicOicGKR,GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GKR{ct:Amid},Peptide-2,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",29,Antibiotic,100% hemolysis at100µM,Mouse,Synthetic peptide,NA,NA
1738,17547385,2007,GKGLTicOicGRTicOicGFTicOicGRTicOicGFTicOicGRTicOicGKR,GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GKR{ct:Amid},Peptide-2,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",29,Antibiotic,100% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1739,17547385,2007,GKGLTicOicGLTicOicGKTicOicGLTicOicGKTicOicGLTicOicGLR,GKGL{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GLR{ct:Amid},Peptide-3,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",29,Antibiotic,100% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1740,17547385,2007,GKGLTicOicGLTicOicGKTicOicGLTicOicGKTicOicGLTicOicGLR,GKGL{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GLR{ct:Amid},Peptide-3,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",29,Antibiotic,100% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1741,17547385,2007,GKGLTicOicGKTicOicGLTicOicGKTicOicGLTicOicGKTicOicGKR,GKGL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GKR{ct:Amid},Peptide-4,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",29,Antibiotic,100% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1742,17547385,2007,GKGLTicOicGKTicOicGLTicOicGKTicOicGLTicOicGKTicOicGKR,GKGL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GKR{ct:Amid},Peptide-4,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",29,Antibiotic,100% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1743,17547385,2007,GKGLTicOicFKTicOicKFTicOicFKTicOicKFTicOicFKTicOicFKR,GKGL{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}FKR{ct:Amid},Peptide-5,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",29,Antibiotic,100% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1744,17547385,2007,GKGLTicOicFKTicOicKFTicOicFKTicOicKFTicOicFKTicOicFKR,GKGL{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}KF{nnr:Tic}{nnr:Oic}FK{nnr:Tic}{nnr:Oic}FKR{ct:Amid},Peptide-5,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",29,Antibiotic,100% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1745,17547385,2007,GKGLTicOicGRTicOicGFTicOicGRTicOicGFTicOicELMNS,GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid},Peptide-6,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",27,Antibiotic,70% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1746,17547385,2007,GKGLTicOicGRTicOicGFTicOicGRTicOicGFTicOicELMNS,GKGL{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GR{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid},Peptide-6,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",27,Antibiotic,70% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1747,17547385,2007,ELMNSTicOicGLTicOicGKTicOicGLTicOicGKTicOicELMNS,ELMNS{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid},Peptide-7,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",28,Antibiotic,3% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1748,17547385,2007,ELMNSTicOicGLTicOicGKTicOicGLTicOicGKTicOicELMNS,ELMNS{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid},Peptide-7,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",28,Antibiotic,3% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1749,17547385,2007,ELMNSTicOicGKLGKTicOicELMS,ELMNS{nnr:Tic}{nnr:Oic}GKLGK{nnr:Tic}{nnr:Oic}ELMS{ct:Amid},Peptide-8,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",18,Antibiotic,23% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1750,17547385,2007,ELMNSTicOicGKLGKTicOicELMS,ELMNS{nnr:Tic}{nnr:Oic}GKLGK{nnr:Tic}{nnr:Oic}ELMS{ct:Amid},Peptide-8,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",18,Antibiotic,23% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1751,17547385,2007,ELSTicOicGKGTicOicLKES,ELS{nnr:Tic}{nnr:Oic}GKG{nnr:Tic}{nnr:Oic}LKES{ct:Amid},Peptide-9,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",14,Antibiotic,23% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1752,17547385,2007,ELSTicOicGKGTicOicLKES,ELS{nnr:Tic}{nnr:Oic}GKG{nnr:Tic}{nnr:Oic}LKES{ct:Amid},Peptide-9,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",14,Antibiotic,23% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1753,17547385,2007,GKGLTicOicβAlaKTicOicβAlaFTicOicβAlaKTicOicβAlaFTicOicELMNS,GKGL{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid},Peptide-20,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine",27,Antibiotic,55% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1754,17547385,2007,GKGLTicOicβAlaKTicOicβAlaFTicOicβAlaKTicOicβAlaFTicOicELMNS,GKGL{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid},Peptide-20,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine",27,Antibiotic,55% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1755,17547385,2007,EGKGLGβAlaβAlaKTicOicβAlaFTicOicβAlaETicOicβAlaFTicOicELMNS,EGKGLG{nnr:βAla}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}E{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid},Peptide-21,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine",28,Antibiotic,27% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1756,17547385,2007,EGKGLGβAlaβAlaKTicOicβAlaFTicOicβAlaETicOicβAlaFTicOicELMNS,EGKGLG{nnr:βAla}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}E{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}ELMNS{ct:Amid},Peptide-21,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine",28,Antibiotic,27% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1757,17547385,2007,KLTicOicKTicOicFTicOicKTicOicFTicOicKTicOicKR,KL{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}KR{ct:Amid},Peptide-22,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",21,Antibiotic,63% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1758,17547385,2007,KLTicOicKTicOicFTicOicKTicOicFTicOicKTicOicKR,KL{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}KR{ct:Amid},Peptide-22,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",21,Antibiotic,63% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1759,17547385,2007,GFTicOicGKTicOicGFTicOicGKTicKKKK,GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-23,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",19,Antibiotic,14% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1760,17547385,2007,GFTicOicGKTicOicGFTicOicGKTicKKKK,GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-23,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",19,Antibiotic,14% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1761,17547385,2007,GFTicOicGKTicOicGFTicOicGKTicKKKK,GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid},Peptide-26,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",19,Antibiotic,33.4% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1762,17547385,2007,GFTicOicGKTicOicGFTicOicGKTicKKKK,GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid},Peptide-26,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",19,Antibiotic,14.3% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1763,17547385,2007,KLTicOicGKTicOicGFTicOicGKTicKKKK,KL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid},Peptide-27,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",19,Antibiotic,43.6% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1764,17547385,2007,KLTicOicGKTicOicGFTicOicGKTicKKKK,KL{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKK{ct:Amid},Peptide-27,Amidation,Free,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",19,Antibiotic,24.9% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1765,17547385,2007,FTicOicKTicOicFTicOicKTicKKKK,F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-28,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",15,Antibiotic,86.8% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1766,17547385,2007,FTicOicKTicOicFTicOicKTicKKKK,F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-28,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",15,Antibiotic,50% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1767,17547385,2007,GABAFTicOicGABAKTicOicGABAFTicOicGABAKTicKKKK,{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-29,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid",19,Antibiotic,10.8% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1768,17547385,2007,GABAFTicOicGABAKTicOicGABAFTicOicGABAKTicKKKK,{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-29,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid",19,Antibiotic,1% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1769,17547385,2007,GTicOicKTicOicGTicOicKTicKKKK,G{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}G{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-30,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",15,Antibiotic,26.7% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1770,17547385,2007,GTicOicKTicOicGTicOicKTicKKKK,G{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}G{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-30,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",15,Antibiotic,9.2% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1771,17547385,2007,GFOicGKOicGFOicGKKKKK,GF{nnr:Oic}GK{nnr:Oic}GF{nnr:Oic}GKKKKK{nt:Acet}{ct:Amid},Peptide-31,Amidation,Acetylation,Linear,L,Oic = octahydroindolecarboxylic acid,15,Antibiotic,5.9% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1772,17547385,2007,GFOicGKOicGFOicGKKKKK,GF{nnr:Oic}GK{nnr:Oic}GF{nnr:Oic}GKKKKK{nt:Acet}{ct:Amid},Peptide-31,Amidation,Acetylation,Linear,L,Oic = octahydroindolecarboxylic acid,15,Antibiotic,3.2% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1773,17547385,2007,GFTicGKTicGFTicGKTicKKKK,GF{nnr:Tic}GK{nnr:Tic}GF{nnr:Tic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-32,Amidation,Acetylation,Linear,L,Tic = tetrahydroisoquinolinecarboxylic acid,16,Antibiotic,6% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1774,17547385,2007,GFTicGKTicGFTicGKTicKKKK,GF{nnr:Tic}GK{nnr:Tic}GF{nnr:Tic}GK{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-32,Amidation,Acetylation,Linear,L,Tic = tetrahydroisoquinolinecarboxylic acid,16,Antibiotic,4.9% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1775,17547385,2007,GFTicGGKTicGGFTicGGKTicKKKK,GF{nnr:Tic}GGK{nnr:Tic}GGF{nnr:Tic}GGK{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-33,Amidation,Acetylation,Linear,L,Tic = tetrahydroisoquinolinecarboxylic acid,19,Antibiotic,5.70% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1776,17547385,2007,GFTicGGKTicGGFTicGGKTicKKKK,GF{nnr:Tic}GGK{nnr:Tic}GGF{nnr:Tic}GGK{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-33,Amidation,Acetylation,Linear,L,Tic = tetrahydroisoquinolinecarboxylic acid,19,Antibiotic,3.80% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1777,17547385,2007,GFG-Oic-GKG-Oic-GFG-Oic-GKGKKKK,GFG-{nnr:Oic}-GKG-{nnr:Oic}-GFG-{nnr:Oic}-GKGKKKK{nt:Acet}{ct:Amid},Peptide-34,Amidation,Acetylation,Linear,L,Oic = octahydroindolecarboxylic acid,19,Antibiotic,3.30% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1778,17547385,2007,GFGOicGKGOicGFGOicGKGKKKK,GFG{nnr:Oic}GKG{nnr:Oic}GFG{nnr:Oic}GKGKKKK{nt:Acet}{ct:Amid},Peptide-34,Amidation,Acetylation,Linear,L,Oic = octahydroindolecarboxylic acid,19,Antibiotic,3.3% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1779,17547385,2007,GFFOicGKFOicGFFOicGKFKKKK,GFF{nnr:Oic}GKF{nnr:Oic}GFF{nnr:Oic}GKFKKKK{nt:Acet}{ct:Amid},Peptide-35,Amidation,Acetylation,Linear,L,Oic = octahydroindolecarboxylic acid,19,Antibiotic,27.30% hemolysis  at 100µM,Mouse,Synthetic peptide,NA,NA
1780,17547385,2007,GFFOicGKFOicGFFOicGKFKKKK,GFF{nnr:Oic}GKF{nnr:Oic}GFF{nnr:Oic}GKFKKKK{nt:Acet}{ct:Amid},Peptide-35,Amidation,Acetylation,Linear,L,Oic = octahydroindolecarboxylic acid,19,Antibiotic,8.9% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1781,17547385,2007,βAlaFTicOicβAlaKTicOicβAlaFTicOicβAlaKTicKKKK,{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-36,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine",19,Antibiotic,24.4% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1782,17547385,2007,βAlaFTicOicβAlaKTicOicβAlaFTicOicβAlaKTicKKKK,{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}{nnr:Oic}{nnr:βAla}F{nnr:Tic}{nnr:Oic}{nnr:βAla}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-36,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, βAla = β-alanine{nnr:Bala} – β-Alanine",19,Antibiotic,7.4% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1783,17547385,2007,AhxFTicOicAhxKTicOicAhxFTicOicAhxKTicKKKK,{nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}{nnr:Oic}{nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-37,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, Ahx = 6-aminohexanoic acid",19,Antibiotic,44.7% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1784,17547385,2007,AhxFTicOicAhxKTicOicAhxFTicOicAhxKTicKKKK,{nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}{nnr:Oic}{nnr:Ahx}F{nnr:Tic}{nnr:Oic}{nnr:Ahx}K{nnr:Tic}KKKK{nt:Acet}{ct:Amid},Peptide-37,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, Ahx = 6-aminohexanoic acid",19,Antibiotic,26.6% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1785,17547385,2007,FTicOicKTicOicFTicOicKTicKKKKKK,F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKKKK{nt:Acet}{ct:Amid},Peptide-38,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",17,Antibiotic,41.3% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1786,17547385,2007,FTicOicKTicOicFTicOicKTicKKKKKK,F{nnr:Tic}{nnr:Oic}K{nnr:Tic}{nnr:Oic}F{nnr:Tic}{nnr:Oic}K{nnr:Tic}KKKKKK{nt:Acet}{ct:Amid},Peptide-38,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",17,Antibiotic,33.5% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1787,17547385,2007,GFTicOicGKTicOicGFTicOicGKTicKKKKK,GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKKK{nt:Acet}{ct:Amid},Peptide-39,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",20,Antibiotic,24.9% hemolysis  at 100µM,Mouse,Synthetic peptide,NA,NA
1788,17547385,2007,GFTicOicGKTicOicGFTicOicGKTicKKKKK,GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}{nnr:Oic}GF{nnr:Tic}{nnr:Oic}GK{nnr:Tic}KKKKK{nt:Acet}{ct:Amid},Peptide-39,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid",20,Antibiotic,18.9% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1789,17547385,2007,GABAFTicOicGABAKTicOicGABAFTicOicGABAKTicKKKKK,{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKKK{nt:Acet}{ct:Amid},Peptide-40,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid",18,Antibiotic,29.7% hemolysis at 100µM,Mouse,Synthetic peptide,NA,NA
1790,17547385,2007,GABAFTicOicGABAKTicOicGABAFTicOicGABAKTicKKKKK,{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}{nnr:Oic}{nnr:GABA}F{nnr:Tic}{nnr:Oic}{nnr:GABA}K{nnr:Tic}KKKKK{nt:Acet}{ct:Amid},Peptide-40,Amidation,Acetylation,Linear,L,"Tic = tetrahydroisoquinolinecarboxylic acid, Oic = octahydroindolecarboxylic acid, GABA= γ-aminobutyric acid",18,Antibiotic,10.5% hemolysis at 25µM,Mouse,Synthetic peptide,NA,NA
1815,17826814,2007,SELAGTIIDGASLTFEVLDKVLGELGKVSRK,SELAGTIIDGASLTFEVLDKVLGELGKVSRK,St I 1–31,Free,Free,Linear,L,None,31,Hemolytic,"Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is above 0.002 min-1",Human,Sticholysin (Stichodactyla helianthus),NA,NA
1816,17826814,2007,ELAGTIIDGASLTFEVLDKVLGELGKVSRK,ELAGTIIDGASLTFEVLDKVLGELGKVSRK,St I 2–31,Free,Free,Linear,L,None,30,Hemolytic,"Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is less than 0.002 min-1",Human,Sticholysin (Stichodactyla helianthus),NA,NA
1817,17826814,2007,SLTFEVLDKVLGELGKVSRK,SLTFEVLDKVLGELGKVSRK,St I 12–31,Free,Free,Linear,L,None,20,Hemolytic,"Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is  ~0.004 min-1",Human,Sticholysin (Stichodactyla helianthus),NA,NA
1818,17826814,2007,ALAGTIIAGASLTFQVLDKVLEELGKVSRK,ALAGTIIAGASLTFQVLDKVLEELGKVSRK,St II 1–30,Free,Free,Linear,L,None,30,Hemolytic,"Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is  above 0.010 min-1",Human,Sticholysin (Stichodactyla helianthus),NA,NA
1819,17826814,2007,SLTFQVLDKVLEELGKVSRK,SLTFQVLDKVLEELGKVSRK,St II 11–30,Free,Free,Linear,L,None,20,Hemolytic,"Hemolytic activity expresssed as the initial rate (∆A/∆t, min- 1) i.e. at above 100 µM activity is  ~0.002 min-1",Human,Sticholysin (Stichodactyla helianthus),NA,NA
1820,17927208,2007,FHPSLWVLIPQYIQLIRKILKSG,FHPSLWVLIPQYIQLIRKILKSG,Conolysin-Mt,Free,Free,Linear,L,None,23,Hemolytic,40% hemolysis at 1 µM,Human,Conolysin-Mt (Conus mustelinus),NA,NA
1821,17927208,2007,FHPSLWVLIPQYIQLIRKILKSG,FHPSLWVLIPQYIQLIRKILKSG,Conolysin-Mt,Free,Free,Linear,L,None,23,Hemolytic,90% hemolysis at 10 µM,Human,Conolysin-Mt (Conus mustelinus),NA,NA
1829,17980935,2007,KKLFKKILKFL,KKLFKKILKFL{ct:Amid},BP76,Amidation,Free,Linear,L,None,11,Hemolytic,3±1% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1830,17980935,2007,KKLFKKILKVL,KKLFKKILKVL{nt:Benzoylation}{ct:Amid},BP31,Amidation,Benzoylation,Linear,L,None,11,Hemolytic,34±9.2% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1831,17980935,2007,KKLFKKILKWL,KKLFKKILKWL{ct:Amid},BP52,Amidation,Free,Linear,L,None,11,Hemolytic,51±4.8% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1832,17980935,2007,FKLFKKILKFL,FKLFKKILKFL{ct:Amid},BP66,Amidation,Free,Linear,L,None,11,Hemolytic,9±2.2% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1833,17980935,2007,KKLFKKILKFL,KKLFKKILKFL{nt:Acet}{ct:Amid},BP77,Amidation,Acetylation,Linear,L,None,11,Hemolytic,6±0.6% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1834,17980935,2007,KKLFKKILKFL,KKLFKKILKFL{nt:Tosylation}{ct:Amid},BP78,Amidation,Tosylation,Linear,L,None,11,Hemolytic,40±4.0% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1835,17980935,2007,LKLFKKILKFL,LKLFKKILKFL{ct:Amid},BP81,Amidation,Free,Linear,L,None,11,Hemolytic,10±1.3% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1836,17980935,2007,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Hemolytic,3±0.1% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1837,17980935,2007,KKLFKKILKYL,KKLFKKILKYL{nt:Tosylation}{ct:Amid},BP102,Amidation,Tosylation,Linear,L,None,11,Hemolytic,40±3.5% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1838,17980935,2007,KKLFKKILKYL,KKLFKKILKYL{nt:Benzoylation}{ct:Amid},BP103,Amidation,Benzoylation,Linear,L,None,11,Hemolytic,42±4.7% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1839,17980935,2007,LKLFKKILKYL,LKLFKKILKYL{ct:Amid},BP105,Amidation,Free,Linear,L,None,11,Hemolytic,14±1.6% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1840,17980935,2007,YKLFKKILKKL,YKLFKKILKKL{nt:Tosylation}{ct:Amid},BP121,Amidation,Tosylation,Linear,L,None,11,Hemolytic,22±1.3% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1841,17980935,2007,KKLFKKILKKL,KKLFKKILKKL{nt:Tosylation}{ct:Amid},BP125,Amidation,Tosylation,Linear,L,None,11,Hemolytic,2±0.7% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1842,17980935,2007,KKLFKKILKKL,KKLFKKILKKL{nt:Benzoylation}{ct:Amid},BP126,Amidation,Benzoylation,Linear,L,None,11,Hemolytic,2±0.4% hemolysis at 50µM,Human,Synthetic peptide,NA,NA
1843,17980935,2007,KKLFKKILKFL,KKLFKKILKFL{ct:Amid},BP76,Amidation,Free,Linear,L,None,11,Hemolytic,34±2.1% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1844,17980935,2007,KKLFKKILKVL,KKLFKKILKVL{nt:Benzoylation}{ct:Amid},BP31,Amidation,Benzoylation,Linear,L,None,11,Hemolytic,71±2.3% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1845,17980935,2007,KKLFKKILKWL,KKLFKKILKWL{ct:Amid},BP52,Amidation,Free,Linear,L,None,11,Hemolytic,84±6.5% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1846,17980935,2007,FKLFKKILKFL,FKLFKKILKFL{ct:Amid},BP66,Amidation,Free,Linear,L,None,11,Hemolytic,63±5.9% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1847,17980935,2007,KKLFKKILKFL,KKLFKKILKFL{nt:Acet}{ct:Amid},BP77,Amidation,Acetylation,Linear,L,None,11,Hemolytic,40±3.8% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1848,17980935,2007,KKLFKKILKFL,KKLFKKILKFL{nt:Tosylation}{ct:Amid},BP78,Amidation,Tosylation,Linear,L,None,11,Hemolytic,85±7.4% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1849,17980935,2007,LKLFKKILKFL,LKLFKKILKFL{ct:Amid},BP81,Amidation,Free,Linear,L,None,11,Hemolytic,65±1.5% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1850,17980935,2007,KKLFKKILKYL,KKLFKKILKYL{ct:Amid},BP100,Amidation,Free,Linear,L,None,11,Hemolytic,22±2.8% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1851,17980935,2007,KKLFKKILKYL,KKLFKKILKYL{nt:Tosylation}{ct:Amid},BP102,Amidation,Tosylation,Linear,L,None,11,Hemolytic,79±6.5% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1852,17980935,2007,KKLFKKILKYL,KKLFKKILKYL{nt:Benzoylation}{ct:Amid},BP103,Amidation,Benzoylation,Linear,L,None,11,Hemolytic,83±13.5% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1853,17980935,2007,LKLFKKILKYL,LKLFKKILKYL{ct:Amid},BP105,Amidation,Free,Linear,L,None,11,Hemolytic,91±6.2% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1854,17980935,2007,YKLFKKILKKL,YKLFKKILKKL{nt:Tosylation}{ct:Amid},BP121,Amidation,Tosylation,Linear,L,None,11,Hemolytic,81±3.7% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1855,17980935,2007,KKLFKKILKKL,KKLFKKILKKL{ct:Amid},BP125,Amidation,Free,Linear,L,None,11,Hemolytic,8±1.6% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1856,17980935,2007,KKLFKKILKKL,KKLFKKILKKL{ct:Amid},BP126,Amidation,Free,Linear,L,None,11,Hemolytic,14±2.9% hemolysis at 100µM,Human,Synthetic peptide,NA,NA
1857,17981364,2007,SLLSLINKLIT,SLLSLINKLIT,Decoralin,Free,Free,Linear,L,None,11,Hemolytic,50-60% hemolysis at 10-3 M,Mouse,Decoralin (Oreumenes decoratus),NA,NA
1858,17981364,2007,SLLSLINKLIT,SLLSLINKLIT{ct:Amid},Decoralin-NH2,Amidation,Free,Linear,L,None,11,Hemolytic,100% hemolysis at 10-3 M,Mouse,Decoralin analog (Oreumenes decoratus),NA,NA
1859,17981364,2007,SLLSLINKLIT,SLLSLINKLIT{ct:Amid},Decoralin-NH2,Amidation,Free,Linear,L,None,11,Hemolytic,EC50 = 80 µM,Human,Decoralin analog (Oreumenes decoratus),NA,NA
1867,15052574,2004,I/LLGTILGLLKGI/L,I/LLGTILGLLKGI/L{ct:Amid},Agelaia-CP,Amidation,Free,Linear,L,None,15,Inflammatory,0% hemolysis at 1x10-5 M (non-hemolytic),Rat,Mastoparan (Agelaia pallipes pallipes),NA,Non-hemolytic
1872,15196144,2004,DSHEKRHHGYKRKFHEKHHSHRGY,DSHEKRHHGYKRKFHEKHHSHRGY,Histatin-5,Free,Free,Linear,L,None,24,Fungicidal,0% hemolysis at 100µM (non-hemolytic),Human,Histatin,NA,Non-hemolytic
1873,15196144,2004,FKCRRWQWRMKKLG,FKCRRWQWRMKKLG,LFB(17–30),Free,Free,Linear,L,None,14,Fungicidal,0% hemolysis at 100µM (non-hemolytic),Human,Human lactoferrin,NA,Non-hemolytic
1874,15196144,2004,KRLFKKLLFSLRKY,KRLFKKLLFSLRKY,Dhvar 4,Free,Free,Linear,L,None,14,Fungicidal,0% hemolysis at 100µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic
1875,15196144,2004,KRLFRRWQWRMKKY,KRLFRRWQWRMKKY,JH8194,Free,Free,Linear,L,None,14,Fungicidal,0% hemolysis at 100µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic
1876,15196144,2004,KRLFRRLLFSMKKY,KRLFRRLLFSMKKY,JH8195,Free,Free,Linear,L,None,14,Fungicidal,0% hemolysis at 100µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic
1877,15196144,2004,FKCKKVVISLRRY,FKCKKVVISLRRY,JH8944,Free,Free,Linear,L,None,13,Fungicidal,0% hemolysis at 100µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic
1881,15304333,2004,ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV,ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV,Psalmopeotoxin I (PcFK1),Free,Free,Linear,L,None,33,Antimalarial,0%hemolysis at 100µM (non-hemolytic),Human,Venom of the tarantula Psalmopoeus cambridgei,NA,Non-hemolytic
1882,15304333,2004,ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV,ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV,Psalmopeotoxin I (PcFK1),Free,Free,Linear,L,None,28,Antimalarial,No hemolysis at 10µM (non-hemolytic),Human,Venom of the tarantula Psalmopoeus cambridgei,NA,Non-hemolytic
1883,15581688,2005,INWKAIIEAAKQAL,INWKAIIEAAKQAL{ct:Amid},MP II,Amidation,Free,Linear,L,None,14,Hemolytic,No hemolysis at 10µM (non-hemolytic),Rat,Mastoparan (Parapolybia indica),NA,Non-hemolytic
1884,15581688,2005,INWLKLGKAVIDAL,INWLKLGKAVIDAL{ct:Amid},MP III,Amidation,Free,Linear,L,None,14,Hemolytic,No hemolysis at 10µM (non-hemolytic),Rat,Mastoparan (Parapolybia indica),NA,Non-hemolytic
1890,15822124,2005,NRLARHFRDIAGRVNQRL,NRLARHFRDIAGRVNQRL{nt:Acet}{ct:Amid},P1c9k,Amidation,Acetylation,Linear,L,None,18,Hemolytic,Non-hemolytic,Rat,Protein Data Bank (PDB),NA,Non-hemolytic
1891,15822124,2005,LKDVEEAQQKIINIIRRL,LKDVEEAQQKIINIIRRL{nt:Acet}{ct:Amid},P1qc7,Amidation,Acetylation,Linear,L,None,18,Hemolytic,Non-hemolytic,Rat,Protein Data Bank (PDB),NA,Non-hemolytic
1967,11242518,2001,AVGIGALFLGFLGAAGSTMGARS,AVGIGALFLGFLGAAGSTMGARS{ct:Amid},FP-1,Amidation,Free,Linear,L,None,23,Hemolytic,50% hemolysis at 40 µM,Human,Synthetic peptides derived from the gp41 domain,NA,NA
1968,11242518,2001,AVGIGALFLGFLGAAGSTMGARS,AVGIGALFLGFLGAAGSTMGARS{ct:Amid},FP-1,Amidation,Free,Linear,L,None,23,Hemolytic,90% hemolysis at 100 µM,Human,Synthetic peptides derived from the gp41 domain,NA,NA
1969,11242518,2001,AAGLAMLFLGILSAAGSTMGARA,AAGLAMLFLGILSAAGSTMGARA{ct:Amid},FP-IVAU,Amidation,Free,Linear,L,None,23,Hemolytic,50-55% hemolysis at 40 µM,Human,Synthetic peptides derived from the gp41 domain,NA,NA
1970,11242518,2001,AAGLAMLFLGILSAAGSTMGARA,AAGLAMLFLGILSAAGSTMGARA{ct:Amid},FP-IVAU,Amidation,Free,Linear,L,None,23,Hemolytic,55-60% hemolysis at 80 µM,Human,Synthetic peptides derived from the gp41 domain,NA,NA
1971,11242518,2001,NNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQ,NNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQ{ct:Amid},DP-107,Amidation,Free,Linear,L,None,38,Hemolytic,20-30% hemolysis at40 µM,Human,Synthetic peptides derived from the gp41 domain,NA,NA
1972,11242518,2001,NNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQ,NNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQ{ct:Amid},DP-107,Amidation,Free,Linear,L,None,38,Hemolytic,20-30% hemolysis at 40 µM,Human,Synthetic peptides derived from the gp41 domain,NA,NA
1973,11478963,2001,LKLKSIVSWAKKVL,LKLKSIVSWAKKVL{ct:Amid},MP-B,Amidation,Free,Linear,L,None,14,Hypotensive,80-85% hemolysis at 15 µM,Guinea-pig,MP-B (Vespa basalis),NA,NA
1974,11478963,2001,LKLKSIVSWAKKVL,LKLKSIVSWAKKVL{ct:Amid},MP-B,Amidation,Free,Linear,L,None,14,Hypotensive,81-85% hemolysis at 15 µM,Guinea-pig,MP-B (Vespa basalis),NA,NA
1975,11478963,2001,lklksivswakkvl,L{d}K{d}L{d}K{d}S{d}I{d}V{d}S{d}W{d}A{d}K{d}K{d}V{d}L{d}{ct:Amid},D-MP-B,Amidation,Free,Linear,D,None,14,Hypotensive,82-85% hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA
1976,11478963,2001,lklksivswakkvl,L{d}K{d}L{d}K{d}S{d}I{d}V{d}S{d}W{d}A{d}K{d}K{d}V{d}L{d}{ct:Amid},D-MP-B,Amidation,Free,Linear,D,None,14,Hypotensive,83-85% hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA
1977,11478963,2001,LkLKSIVSWAKKVL,LK{d}LKSIVSWAKKVL{ct:Amid},[D-Lys2]-MP-B,Amidation,Free,Linear,Mix,None,14,Hypotensive,84-85% hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA
1978,11478963,2001,LkLKSIVSWAKKVL,LK{d}LKSIVSWAKKVL{ct:Amid},[D-Lys2]-MP-B,Amidation,Free,Linear,Mix,None,14,Hypotensive,85-85% hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA
1979,11478963,2001,LKLkSIVSWAKKVL,LKLK{d}SIVSWAKKVL{ct:Amid},[D-Lys4]-MP-B,Amidation,Free,Linear,Mix,None,14,Hypotensive,86-85% hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA
1980,11478963,2001,LKLkSIVSWAKKVL,LKLK{d}SIVSWAKKVL{ct:Amid},[D-Lys4]-MP-B,Amidation,Free,Linear,Mix,None,14,Hypotensive,87-85% hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA
1981,11478963,2001,LKLKSIVSWAkkVL,LKLKSIVSWAK{d}K{d}VL{ct:Amid},"[D-Lys11,12]-MP-B",Amidation,Free,Linear,Mix,None,14,Hypotensive,88-85% hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA
1982,11478963,2001,LKLKSIVSWAkkVL,LKLKSIVSWAK{d}K{d}VL{ct:Amid},"[D-Lys11,12]-MP-B",Amidation,Free,Linear,Mix,None,14,Hypotensive,89-85% hemolysis at 15 µM,Guinea-pig,Synthetic peptide,NA,NA
1987,11532323,2001,WEAKLAKALAKALAKHLAKALAKALKACEA,WEAKLAKALAKALAKHLAKALAKALKACEA,PEG-KALA,Free,Free,Linear,L,None,30,Hemolytic,50-60% hemolysis at 10 µg/ml,Human,Synthetic peptide,NA,NA
1988,11532323,2001,WEAKLAKALAKALAKHLAKALAKALKACEA,WEAKLAKALAKALAKHLAKALAKALKACEA,PEG-KALA,Free,Free,Linear,L,None,30,Hemolytic,90-95% hemolysis at 100 µg/ml,Human,Synthetic peptide,NA,NA
2000,21924309,2011,LKLKSIVSWAKKVL,LKLKSIVSWAKKVL{ct:Amid},MP-B,Amidation,Free,Linear,L,None,14,Antioxidant,Non-hemolytic,Human,MP-B (Vespa basalis),NA,Non-hemolytic
2001,21924309,2011,LKWKSIVSWAKKVL,LKWKSIVSWAKKVL{ct:Amid},MP-B-1,Amidation,Free,Linear,L,None,14,Antioxidant,Non-hemolytic,Human,MP-B analog (Vespa basalis),NA,Non-hemolytic
2002,21924309,2011,LKLKNIVSWAKKVL,LKLKNIVSWAKKVL{ct:Amid},MP-B-2,Amidation,Free,Linear,L,None,14,Antioxidant,Non-hemolytic,Human,MP-B analog (Vespa basalis),NA,Non-hemolytic
2003,21924309,2011,LKLKSIVSYAKKVL,LKLKSIVSYAKKVL{ct:Amid},MP-B-3,Amidation,Free,Linear,L,None,14,Antioxidant,Non-hemolytic,Human,MP-B analog (Vespa basalis),NA,Non-hemolytic
2484,10747913,2000,CGETCVGGTCNTPGCTCSWPVCTRNGLPV,CGETCVGGTCNTPGCTCSWPVCTRNGLPV{cyc:N-C},Kalata B1,Free,Free,Cyclic,L,None,29,Anti-HIV,50% hemolytic at 50μM,Human,Macrocyclic peptides,NA,NA
2532,10821683,2000,CKLLLKWLLKLLKC,CKLLLKWLLKLLKC{cyc:N-C},Cyclic-K4L7W,Free,Free,Cyclic,L,None,14,Cytolytic,50% hemolytic at 50μM,Human,Synthetic peptide,NA,NA
2533,10821683,2000,CH3-S-CKLLLKWLLKLLKC-S-CH3,CH3-S-CKLLLKWLLKLLKC-S-CH3,Linear-K4L7W,Free,Free,Linear,L,None,14,Cytolytic,100% hemolytic at 5μM,Human,Synthetic peptide,NA,NA
2534,10821683,2000,cklllkwllkllkc,C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{cyc:N-C},"cyclic-[D]-L3,4,8,10-K4L7W",Free,Free,Cyclic,D,None,14,Cytolytic,90% hemolytic at 50μM,Human,Synthetic peptide,NA,NA
2535,10821683,2000,CH3-S-cklllkwllkllkc-S-CH3,C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{nt:CH3-S-}{ct:-S-CH3},"linear-[D]-L3,4,8,10-K4L7W",Free,Free,Linear,D,None,14,Cytolytic,5% hemolytic at 50μM,Human,Synthetic peptide,NA,NA
2541,18501981,2008,GVIIDTLKGAAKTVAAELLRKAHCKLTNSC,GVIIDTLKGAAKTVAAELLRKAHCKLTNSC{ct:Amid},Brevinin-2GUb,Amidation,Free,Linear,L,None,30,Cytolytic,LC50 = 700μM,Human,Insulin-releasing peptide (Hylarana guntheri),NA,NA
2775,19960443,2010,pslvslvVqLvΔ-But-allothr-I-Hse-dab-K,P{d}S{d}L{d}V{d}S{d}L{d}V{d}VQ{d}LV{d}{nnr:Δ-But}-A{d}L{d}L{d}O{d}T{d}H{d}R{d}-I-{nnr:Hse}-{nnr:dab}-K{nt:β-hydroxyoctanoyl-Δ-But},Tolaasin,Free,β-hydroxyoctanoyl-Δ-But,Linear,Mix,"Δ-But = 2,3-dehydro-2-aminobutyric acid, Hse = L-homoserine, dab = D-2,4-diaminobutyric acid",18,Hemolytic,100% hemolysis at 0.53 μg/mL,Rat,Tolaasin (Pseudomonas tolaasii),NA,NA
2907,21343499,2011,kwklfkkipkflhlakkf,K{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid},HDP D-P18,Amidation,Free,Linear,D,None,18,Antimcrobial and Hemolytic,~94% hemolytic at 500μM,Human,Host defense peptides analog (Rana temporaria),NA,NA
2908,21343499,2011,kwklfkkipkflhlakkf,K{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{ct:Amid},HDP D-P18,Amidation,Free,Linear,D,None,18,Antimcrobial and Hemolytic,~10% hemolytic at 50μM,Human,Host defense peptides analog (Rana temporaria),NA,NA
2909,21343499,2011,EEEEAAAkwklfkkipkflhlakkf,EEEEAAAK{d}W{d}K{d}L{d}F{d}K{d}K{d}I{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{nt:Acet}{ct:Amid},Ac-E4-A3–D-P18,Amidation,Acetylation,Linear,Mix,None,24,Antimcrobial and Hemolytic,~3.5% hemolytic upto 500μM,Human,Host defense peptides analog (Rana temporaria),NA,NA
2945,21801309,2011,SWLRDIWDWICEVLSDFK,SWLRDIWDWICEVLSDFK,C5A,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC= 3.46μM,Human,C5A derived from the membrane anchor domain of the N-terminal region of NS5A protein,NA,NA
2946,21801309,2011,SWLRDLWDWICEVLSDFK,SWLRDLWDWICEVLSDFK,I6L,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC = 13.84μM,Human,C5A derivatives (HCV),NA,NA
2947,21801309,2011,SWLRDIWDWLCEVLSDFK,SWLRDIWDWLCEVLSDFK,I10L,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC =6.92μM,Human,C5A derivatives (HCV),NA,NA
2948,21801309,2011,SWLRDIWDWICELLSDFK,SWLRDIWDWICELLSDFK,V13L,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC = 3.44μM,Human,C5A derivatives (HCV),NA,NA
2949,21801309,2011,SWLRDLWDWLCEVLSDFK,SWLRDLWDWLCEVLSDFK,I6L/I10L,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC = 6.92μM,Human,C5A derivatives (HCV),NA,NA
2950,21801309,2011,SWLRDLWDWICELLSDFK,SWLRDLWDWICELLSDFK,I6L/V13L,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC = 53.75μM,Human,C5A derivatives (HCV),NA,NA
2951,21801309,2011,SWLRDIWDWLCELLSDFK,SWLRDIWDWLCELLSDFK,I10L/V13L,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC = 3.44μM,Human,C5A derivatives (HCV),NA,NA
2952,21801309,2011,SWLRDLWDWLCELLSDFK,SWLRDLWDWLCELLSDFK,I6L/I10L/V13L,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC = 107.50μM,Human,C5A derivatives (HCV),NA,NA
2953,21801309,2011,SWLRDIWDWLCEVLSDFK,SWLRDIWDWLCEVLSDFK,I10L,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC = 6.92μM,Human,C5A derivatives (HCV),NA,NA
2954,21801309,2011,SWLRDIWDWVCEVLSDFK,SWLRDIWDWVCEVLSDFK,I10V,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC =13.93μM,Human,C5A derivatives (HCV),NA,NA
2955,21801309,2011,SWLRDIWDWACEVLSDFK,SWLRDIWDWACEVLSDFK,I10A,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC = 14.10μM,Human,C5A derivatives (HCV),NA,NA
2956,21801309,2011,SWLRDIWDWGCEVLSDFK,SWLRDIWDWGCEVLSDFK,I10G,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC = 28.38μM,Human,C5A derivatives (HCV),NA,NA
2957,21801309,2011,SWLRDIWDWSCEVLSDFK,SWLRDIWDWSCEVLSDFK,I10S,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC =28.00μM,Human,C5A derivatives (HCV),NA,NA
2958,21801309,2011,SWLRDIWDWECEVLSDFK,SWLRDIWDWECEVLSDFK,I10E,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC =217.91μM,Human,C5A derivatives (HCV),NA,NA
2959,21801309,2011,SWLRDIWDWKCEVLSDFK,SWLRDIWDWKCEVLSDFK,I10K,Free,Free,Linear,L,None,18,Anti-HCV/HIV,MHC =214.81μM,Human,C5A derivatives (HCV),NA,NA
3002,21576247,2011,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},kB1,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,41.2 ±1.5% hemolytic at 25μM,Human,Kalata B1 (Oldenlandia affinis),NA,NA
3003,21576247,2011,GLPKCGETCVGGTCNTPGCTCSWPVCTRN,GLPKCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},V4K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,2.9±0.5% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3004,21576247,2011,GLPVCGDTCVGGTCNTPGCTCSWPVCTRN,GLPVCGDTCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},E7D,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,3.8±0.4% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3005,21576247,2011,GLPVCGEKCVGGTCNTPGCTCSWPVCTRN,GLPVCGEKCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},T8K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,3.4±0.7% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3006,21576247,2011,GLPVCGETCKGGTCNTPGCTCSWPVCTRN,GLPVCGETCKGGTCNTPGCTCSWPVCTRN{cyc:N-C},V10K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,0±1.7% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,Non-hemolytic
3007,21576247,2011,GLPVCGETCVGGTCKTPGCTCSWPVCTRN,GLPVCGETCVGGTCKTPGCTCSWPVCTRN{cyc:N-C},N15K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,2.1±0.4% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3008,21576247,2011,GLPVCGETCVGGTCNKPGCTCSWPVCTRN,GLPVCGETCVGGTCNKPGCTCSWPVCTRN{cyc:N-C},T16K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,4.3±0.1% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3009,21576247,2011,GLPVCGETCVGGTCNTPGCKCSWPVCTRN,GLPVCGETCVGGTCNTPGCKCSWPVCTRN{cyc:N-C},T20K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,51.3±1.6% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3010,21576247,2011,GLPVCGETCVGGTCNTPGCTCSWPKCTRN,GLPVCGETCVGGTCNTPGCTCSWPKCTRN{cyc:N-C},V25K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,1.1±1.0% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3011,21576247,2011,GLPVCGETCVGGTCNTPGCTCSWPVCTRK,GLPVCGETCVGGTCNTPGCTCSWPVCTRK{cyc:N-C},N29K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,54.5±0.9% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3012,21576247,2011,GLPVCGETCVGGTCNTPGCTCSKPVCTRN,GLPVCGETCVGGTCNTPGCTCSKPVCTRN{cyc:N-C},W23K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,2.4±0.7% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3013,21576247,2011,GLPVCGETCVGGTCNTPGCNCSWPVCTRK,GLPVCGETCVGGTCNTPGCNCSWPVCTRK{cyc:N-C},T20N29K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,64.4±2.2% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3014,21576247,2011,GLPVCGETCVGGTCNTPGCTCSWPVCTKN,GLPVCGETCVGGTCNTPGCTCSWPVCTKN{cyc:N-C},R28K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,12.0±1.8% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3015,21576247,2011,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,acyclic,Free,Free,Linear,L,None,29,Hemolytic and Anti-HIV,2.8±0.3% hemolytic at 25μM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA
3246,23262358,2013,DLLGTLGNLPLPFI,DLLGTLGNLPLPFI{ct:Amid},frenatin 2D,Amidation,Free,Linear,L,None,14,Immunomodulatory,No hemolysis upto 500μM,Human,Derived from skin secretions of Discoglossus sardus (Alytidae),NA,Non-hemolytic
3258,23415044,2013,FLGFLKNLF,FLGFLKNLF,WT,Free,Free,Linear,L,None,9,Antiviral,HC50 =137.9μg/ml,Human,Synthetic peptide (Ctry2459),α-helical,NA
3259,23415044,2013,FLGFLHHLF,FLGFLHHLF,H2,Free,Free,Linear,L,None,9,Antiviral,HC50 =203.3μg/ml,Human,Synthetic peptide (Ctry2459),α-helical,NA
3260,23415044,2013,FLHFLHHLF,FLHFLHHLF,H3,Free,Free,Linear,L,None,9,Antiviral,HC50 =416.4μg/ml,Human,Synthetic peptide (Ctry2459),α-helical,NA
3261,23523532,2013,GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME,GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME{ct:Amid},Cu 1a,Amidation,Free,Linear,L,None,35,Cytolytic,EC50 =7.8μM,Human,Derived from venom of Cupiennius salei,α-helical,NA
3262,23523532,2013,GAGALAKFLAKKVAKTVAKQAAKQGAKYVVNKQME,GAGALAKFLAKKVAKTVAKQAAKQGAKYVVNKQME{ct:Amid},A-Cu 1a,Amidation,Free,Linear,L,None,35,Cytolytic,EC50 >40μM,Human,Cu 1a analog,α-helical,NA
3263,23523532,2013,GKGALKKFLAKKVAKTVAKQAAKQGAKYVVNKQME,GKGALKKFLAKKVAKTVAKQAAKQGAKYVVNKQME{ct:Amid},K-Cu 1a,Amidation,Free,Linear,L,None,35,Cytolytic,EC50 >40μM,Human,Cu 1a analog,α-helical,NA
3264,23523532,2013,GFGTILKALAKIAGKVVKKLATKPGATYMLKENLK,GFGTILKALAKIAGKVVKKLATKPGATYMLKENLK{ct:Amid},Cu 2a,Amidation,Free,Linear,L,None,35,Cytolytic,EC50 =2.6μM,Human,Derived from venom of Cupiennius salei,α-helical,NA
3291,6325405,1984,KFTIVFPHNQKGNWKNVPSNYHYCP,KFTIVFPHNQKGNWKNVPSNYHYCP,VSV G,Free,Free,Linear,L,None,25,Hemolysin,400μg of peptide can totally lyse 7x108 erythrocytes in 10 min at pH 5.0,Sheep,Synthetic peptide (Vesicular Stomatitis Virus),NA,NA
3292,6325405,1984,CKTRTSTNTDHLWIAKSKARLSET,CKTRTSTNTDHLWIAKSKARLSET,Synthetic peptide-1,Free,Free,Linear,L,None,24,Not mentioned,0% hemolysis upto 500μg/ml (non hemolytic),Sheep,Synthetic peptide,NA,Non-hemolytic
3293,6325405,1984,PKDLKETLQEKKP,PKDLKETLQEKKP,Synthetic peptide-2,Free,Free,Linear,L,None,13,Not mentioned,0% hemolysis upto 500μg/ml (non hemolytic),Sheep,Synthetic peptide,NA,Non-hemolytic
3294,8027544,1994,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Cytolytic,100% hemolysis at 120μM,Mouse,Melttin (Honey bee venom),NA,NA
3295,8027544,1994,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Acet}{ct:Amid},Ac-Melittin,Amidation,Acetylation,Linear,L,None,26,Cytolytic,100% hemolysis at 120μM compared with melittin,Mouse,Melttin analog (Honey bee venom),NA,NA
3296,8027544,1994,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Lac=p-amidophenyl-β-D-lactopyranoside},Melittin-Lac,Lac=p-amidophenyl-β-D-lactopyranoside,Free,Linear,L,None,26,Cytolytic,120% hemolysis at 120μM compared with melittin,Mouse,Melttin analog (Honey bee venom),NA,NA
3297,8027544,1994,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{nt:Lac=p-amidophenyl-β-D-lactopyranoside and Suc=Succinyl}{ct:Amid},LacSuc-Melittin,Amidation,Lac=p-amidophenyl-β-D-lactopyranoside and Suc=Succinyl,Linear,L,None,26,Cytolytic,43% hemolysis at 120μM compared with melittin,Mouse,Melttin analog (Honey bee venom),NA,NA
3298,8027544,1994,KRKRQQGIGAVLKVLTTGLPALISWI,KRKRQQGIGAVLKVLTTGLPALISWI{ct:Amid},Melittin-(21-26) (1-20),Amidation,Free,Linear,L,None,26,Cytolytic,20% hemolysis at 120μM compared with melittin,Mouse,Melttin analog (Honey bee venom),NA,NA
3299,8027544,1994,KRKRQQGIGAVLKVLTTGLPALISWI,KRKRQQGIGAVLKVLTTGLPALISWI{nt:Acet}{ct:Amid},Ac-Melttin-(21-26) (1-20),Amidation,Acetylation,Linear,L,None,26,Cytolytic,20% hemolysis at 120μM compared with melittin,Mouse,Melttin analog (Honey bee venom),NA,NA
3300,8027544,1994,QQRKRKGIGAVLKVLTTGLPALISWI,QQRKRKGIGAVLKVLTTGLPALISWI{ct:Amid},Melttin-(26-21) (1-20),Amidation,Free,Linear,L,None,26,Cytolytic,15% hemolysis at 120μM compared with melittin,Mouse,Melttin analog (Honey bee venom),NA,NA
3301,8027544,1994,QQRKRKGIGAVLKVLTTGLPALISWI,QQRKRKGIGAVLKVLTTGLPALISWI{nt:Acet},Ac-Melittin-(26-21) (1-20),Free,Acetylation,Linear,L,None,26,Cytolytic,15% hemolysis at 120μM compared with melittin,Mouse,Melttin analog (Honey bee venom),NA,NA
3313,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,None,26,Cytolytic,82% hemolysis at 25μg,Human,δ-toxin (Staphylococcus aurezis),NA,NA
3314,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,None,26,Cytolytic,100% hemolysis at 75μg,Human,δ-toxin (Staphylococcus aurezis),NA,NA
3315,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,None,26,Cytolytic,73% hemolysis at 25μg,Horse,δ-toxin (Staphylococcus aurezis),NA,NA
3316,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,None,26,Cytolytic,85% hemolysis at 75μg,Horse,δ-toxin (Staphylococcus aurezis),NA,NA
3317,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,None,26,Cytolytic,92% hemolysis at 25μg,Guinea-pig,δ-toxin (Staphylococcus aurezis),NA,NA
3318,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,None,26,Cytolytic,100% hemolysis at 75μg,Guinea-pig,δ-toxin (Staphylococcus aurezis),NA,NA
3319,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,None,26,Cytolytic,87% hemolysis at 25μg,Rabbit,δ-toxin (Staphylococcus aurezis),NA,NA
3320,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,None,26,Cytolytic,100% hemolysis at 75μg,Rabbit,δ-toxin (Staphylococcus aurezis),NA,NA
3321,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,None,26,Cytolytic,38% hemolysis at 25μg,Sheep,δ-toxin (Staphylococcus aurezis),NA,NA
3322,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-A,Free,Formylation,Linear,L,None,26,Cytolytic,80% hemolysis at 75μg,Sheep,δ-toxin (Staphylococcus aurezis),NA,NA
3323,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,None,26,Cytolytic,47% hemolysis at 25μg,Human,δ-toxin derivative (Synthetic peptide),NA,NA
3324,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,None,26,Cytolytic,55% hemolysis at 75μg,Human,δ-toxin derivative (Synthetic peptide),NA,NA
3325,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,None,26,Cytolytic,34% hemolysis at 25μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA
3326,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,None,26,Cytolytic,43% hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA
3327,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,None,26,Cytolytic,32% hemolysis at 25μg,Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,NA
3328,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,None,26,Cytolytic,55% hemolysis at 75μg,Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,NA
3329,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,None,26,Cytolytic,20% hemolysis at 25μg,Rabbit,δ-toxin derivative (Synthetic peptide),NA,NA
3330,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,None,26,Cytolytic,22% hemolysis at 75μg,Rabbit,δ-toxin derivative (Synthetic peptide),NA,NA
3331,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK{nt:Formylation},Peptide-B,Free,Formylation,Linear,L,None,26,Cytolytic,2% hemolysis at 75μg,Sheep,δ-toxin derivative (Synthetic peptide),NA,NA
3332,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK,Peptide-C,Free,Free,Linear,L,None,26,Cytolytic,60% hemolysis at 75μg,Human,δ-toxin derivative (Synthetic peptide),NA,NA
3333,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK,Peptide-C,Free,Free,Linear,L,None,26,Cytolytic,50% hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA
3334,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK,Peptide-C,Free,Free,Linear,L,None,26,Cytolytic,58% hemolysis at 75μg,Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,NA
3335,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK,Peptide-C,Free,Free,Linear,L,None,26,Cytolytic,25% hemolysis at 75μg,Rabbit,δ-toxin derivative (Synthetic peptide),NA,NA
3336,2474443,1989,MAQDIISTIGDLVKWIIDTVNKFPKK,MAQDIISTIGDLVKWIIDTVNKFPKK,Peptide-C,Free,Free,Linear,L,None,26,Cytolytic,8% hemolysis at 75μg,Sheep,δ-toxin derivative (Synthetic peptide),NA,NA
3337,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,0% hemolysis at 75μg,Human,δ-toxin derivative (Synthetic peptide),NA,NA
3338,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,12% hemolysis at 250μg,Human,δ-toxin derivative (Synthetic peptide),NA,NA
3339,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,18% hemolysis at 500μg,Human,δ-toxin derivative (Synthetic peptide),NA,NA
3340,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,0% hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA
3341,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,20% hemolysis at 250μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA
3342,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,19% hemolysis at 500μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA
3343,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,0% hemolysis at 75μg,Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,NA
3344,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,23% hemolysis at 250μg,Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,NA
3345,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,51% hemolysis at 500μg,Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,NA
3346,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,0% hemolysis at 250μg,Rabbit,δ-toxin derivative (Synthetic peptide),NA,NA
3347,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,14% hemolysis at 500μg,Rabbit,δ-toxin derivative (Synthetic peptide),NA,NA
3348,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,0% hemolysis at 250μg,Sheep,δ-toxin derivative (Synthetic peptide),NA,NA
3349,2474443,1989,DLVKWIIDTVNKFTKK,DLVKWIIDTVNKFTKK,Peptide-D,Free,Free,Linear,L,None,16,Cytolytic,17% hemolysis at 500μg,Sheep,δ-toxin derivative (Synthetic peptide),NA,NA
3350,2474443,1989,MAQDIISTIGD,MAQDIISTIGD{nt:Formylation},Peptide-E,Free,Formylation,Linear,L,None,11,Cytolytic,0% hemolysis at 1000μg (non hemolytic),Human,δ-toxin derivative (Synthetic peptide),NA,Non-hemolytic
3351,2474443,1989,MAQDIISTIGD,MAQDIISTIGD{nt:Formylation},Peptide-E,Free,Formylation,Linear,L,None,11,Cytolytic,0% hemolysis at 1000μg (non hemolytic),Horse,δ-toxin derivative (Synthetic peptide),NA,Non-hemolytic
3352,2474443,1989,MAQDIISTIGD,MAQDIISTIGD{nt:Formylation},Peptide-E,Free,Formylation,Linear,L,None,11,Cytolytic,0% hemolysis at 1000μg (non hemolytic),Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,Non-hemolytic
3353,2474443,1989,MAQDIISTIGD,MAQDIISTIGD{nt:Formylation},Peptide-E,Free,Formylation,Linear,L,None,11,Cytolytic,0% hemolysis at 1000μg (non hemolytic),Rabbit,δ-toxin derivative (Synthetic peptide),NA,Non-hemolytic
3354,2474443,1989,MAQDIISTIGD,MAQDIISTIGD{nt:Formylation},Peptide-E,Free,Formylation,Linear,L,None,11,Cytolytic,0% hemolysis at 1000μg (non hemolytic),Sheep,δ-toxin derivative (Synthetic peptide),NA,Non-hemolytic
3355,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation},Peptide-F,Free,Formylation,Linear,L,None,26,Cytolytic,4% hemolysis at 75μg,Human,δ-toxin derivative (Synthetic peptide),NA,NA
3356,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation},Peptide-F,Free,Formylation,Linear,L,None,26,Cytolytic,12% hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA
3357,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation},Peptide-F,Free,Formylation,Linear,L,None,26,Cytolytic,36% hemolysis at 75μg,Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,NA
3358,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation},Peptide-F,Free,Formylation,Linear,L,None,26,Cytolytic,0% hemolysis at 75μg (non hemolytic),Rabbit,δ-toxin derivative (Synthetic peptide),NA,Non-hemolytic
3359,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK{nt:Formylation},Peptide-F,Free,Formylation,Linear,L,None,26,Cytolytic,0% hemolysis at 75μg (non hemolytic),Sheep,δ-toxin derivative (Synthetic peptide),NA,Non-hemolytic
3360,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK,Peptide-G,Free,Free,Linear,L,None,26,Cytolytic,13% hemolysis at 75μg,Human,δ-toxin derivative (Synthetic peptide),NA,NA
3361,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK,Peptide-G,Free,Free,Linear,L,None,26,Cytolytic,31% hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA
3362,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK,Peptide-G,Free,Free,Linear,L,None,26,Cytolytic,34% hemolysis at 75μg,Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,NA
3363,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK,Peptide-G,Free,Free,Linear,L,None,26,Cytolytic,35% hemolysis at 75μg,Rabbit,δ-toxin derivative (Synthetic peptide),NA,NA
3364,2474443,1989,MLQDLLSSLGDLLKSWLDTLNKFTKK,MLQDLLSSLGDLLKSWLDTLNKFTKK,Peptide-G,Free,Free,Linear,L,None,26,Cytolytic,13% hemolysis at 75μg,Sheep,δ-toxin derivative (Synthetic peptide),NA,NA
3365,2474443,1989,MLQDWLSSLGDLLKSLLDTVNKFTKK,MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc},Peptide-H,Free,Fmoc,Linear,L,None,26,Cytolytic,59% hemolysis at 75μg,Human,δ-toxin derivative (Synthetic peptide),NA,NA
3366,2474443,1989,MLQDWLSSLGDLLKSLLDTVNKFTKK,MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc},Peptide-H,Free,Fmoc,Linear,L,None,26,Cytolytic,25% hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA
3367,2474443,1989,MLQDWLSSLGDLLKSLLDTVNKFTKK,MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc},Peptide-H,Free,Fmoc,Linear,L,None,26,Cytolytic,91% hemolysis at 75μg,Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,NA
3368,2474443,1989,MLQDWLSSLGDLLKSLLDTVNKFTKK,MLQDWLSSLGDLLKSLLDTVNKFTKK{nt:Fmoc},Peptide-H,Free,Fmoc,Linear,L,None,26,Cytolytic,43% hemolysis at 75μg,Sheep,δ-toxin derivative (Synthetic peptide),NA,NA
3369,2474443,1989,MLQDWLSSLGDLLKSLLDTVNKFTKK,MLQDWLSSLGDLLKSLLDTVNKFTKK,Peptide-I,Free,Free,Linear,L,None,26,Cytolytic,40% hemolysis at 75μg,Human,δ-toxin derivative (Synthetic peptide),NA,NA
3370,2474443,1989,MLQDWLSSLGDLLKSLLDTVNKFTKK,MLQDWLSSLGDLLKSLLDTVNKFTKK,Peptide-I,Free,Free,Linear,L,None,26,Cytolytic,11% hemolysis at 75μg,Horse,δ-toxin derivative (Synthetic peptide),NA,NA
3371,2474443,1989,MLQDWLSSLGDLLKSLLDTVNKFTKK,MLQDWLSSLGDLLKSLLDTVNKFTKK,Peptide-I,Free,Free,Linear,L,None,26,Cytolytic,66% hemolysis at 75μg,Guinea-pig,δ-toxin derivative (Synthetic peptide),NA,NA
3372,2474443,1989,MLQDWLSSLGDLLKSLLDTVNKFTKK,MLQDWLSSLGDLLKSLLDTVNKFTKK,Peptide-I,Free,Free,Linear,L,None,26,Cytolytic,24% hemolysis at 75μg,Sheep,δ-toxin derivative (Synthetic peptide),NA,NA
3497,8896194,1996,LKLKSIVSWAKKVL,LKLKSIVSWAKKVL{ct:Amid},MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,>95% hemolysis at 30μM,Guinea-pig,Mastoparan B (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3498,8896194,1996,LKLKSIVSWAKKVL,LKLKSIVSWAKKVL{ct:Amid},MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,80% hemolysis at 20μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3499,8896194,1996,LNLKSIVSWAKKVL,LNLKSIVSWAKKVL{ct:Amid},[Asn2]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,~5% hemolysis at 30μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3500,8896194,1996,LNLKSIVSWAKKVL,LNLKSIVSWAKKVL{ct:Amid},[Asn2]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,~4% hemolysis at 20μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3501,8896194,1996,LKLNSIVSWAKKVL,LKLNSIVSWAKKVL{ct:Amid},[Asn4]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,>95% hemolysis at 30μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3502,8896194,1996,LKLNSIVSWAKKVL,LKLNSIVSWAKKVL{ct:Amid},[Asn4]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,>75% hemolysis at 20μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3503,8896194,1996,LKLLSIVSWAKKVL,LKLLSIVSWAKKVL{ct:Amid},[Leu4]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,~80% hemolysis at 30μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3504,8896194,1996,LKLLSIVSWAKKVL,LKLLSIVSWAKKVL{ct:Amid},[Leu4]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,>75% hemolysis at 20μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3505,8896194,1996,LNLNSIVSWAKKVL,LNLNSIVSWAKKVL{ct:Amid},"[Asn2,4]-MP-B",Amidation,Free,Linear,L,None,14,Edema inducer,~5% hemolysis at 30μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3506,8896194,1996,LNLNSIVSWAKKVL,LNLNSIVSWAKKVL{ct:Amid},"[Asn2,4]-MP-B",Amidation,Free,Linear,L,None,14,Edema inducer,~3% hemolysis at 20μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3507,8896194,1996,LKLKSIVSFAKKVL,LKLKSIVSFAKKVL{ct:Amid},[Phe9]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,~5% hemolysis at 30μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3508,8896194,1996,LKLKSIVSFAKKVL,LKLKSIVSFAKKVL{ct:Amid},[Phe9]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,~3% hemolysis at 20μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3509,8896194,1996,LKLKSIVSYAKKVL,LKLKSIVSYAKKVL{ct:Amid},[Tyr9]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,~4% hemolysis at 30μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3510,8896194,1996,LKLKSIVSYAKKVL,LKLKSIVSYAKKVL{ct:Amid},[Tyr9]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,~2% hemolysis at 20μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3511,8896194,1996,LKLKSIVSWALKVL,LKLKSIVSWALKVL{ct:Amid},[Leu11]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,>80% hemolysis at 30μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3512,8896194,1996,LKLKSIVSWALKVL,LKLKSIVSWALKVL{ct:Amid},[Leu11]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,>70% hemolysis at 20μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3513,8896194,1996,LKLKSIVSWAKLVL,LKLKSIVSWAKLVL{ct:Amid},[Leu12]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,~70% hemolysis at 30μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3514,8896194,1996,LKLKSIVSWAKLVL,LKLKSIVSWAKLVL{ct:Amid},[Leu12]-MP-B,Amidation,Free,Linear,L,None,14,Edema inducer,>55% hemolysis at 20μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3515,8896194,1996,LKLKSIVSWALLVL,LKLKSIVSWALLVL{ct:Amid},"[Leu11,12]-MP-B",Amidation,Free,Linear,L,None,14,Edema inducer,~80% hemolysis at 30μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3516,8896194,1996,LKLKSIVSWALLVL,LKLKSIVSWALLVL{ct:Amid},"[Leu11,12]-MP-B",Amidation,Free,Linear,L,None,14,Edema inducer,~55% hemolysis at 20μM,Guinea-pig,Mastoparan B analog (from the venom of  black-bellied hornet Vespa basalis),NA,NA
3517,9026036,1997,CIGAVLKVLTTGLPALISWIKRKRQQ,CIGAVLKVLTTGLPALISWIKRKRQQ,Dioleoylmelittin,Free,Free,Linear,L,None,26,Membrane disturbing,~20% hemolysis at 1μM,Dog,Synthetic peptide,NA,NA
3518,9026036,1997,CIGAVLKVLTTGLPALISWIKRKRQQ,CIGAVLKVLTTGLPALISWIKRKRQQ,Dioleoylmelittin,Free,Free,Linear,L,None,26,Membrane disturbing,100% hemolysis at 10μM,Dog,Synthetic peptide,NA,NA
3567,15304333,2004,ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV,ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV{ct:Amid},PcFK1,Amidation,Free,Linear,L,None,33,Antiplasmodial,No hemolysis at 10μM (non hemolytic),Human,Psalmopeotoxins (venom of the Trinidad chevron tarantula Psalmopoeus cambridgei),NA,Non-hemolytic
3568,15304333,2004,RCLPAGKTCVRGPMRVPCCGSCSQNKCT,RCLPAGKTCVRGPMRVPCCGSCSQNKCT,PcFK2,Free,Free,Linear,L,None,28,Antiplasmodial,No hemolysis at 10μM (non hemolytic),Human,Psalmopeotoxins (venom of the Trinidad chevron tarantula Psalmopoeus cambridgei),NA,Non-hemolytic
3576,18332165,2008,KILRGVCKKIMRTFLRRISKDILTGKK,KILRGVCKKIMRTFLRRISKDILTGKK{ct:Amid},NK-2,Amidation,Free,Linear,L,None,27,Antiplasmodial,No hemolysis upto 10μM (non hemolytic),Human,Synthetic shortened analog of the mammalian defense protein NK-lysin,NA,Non-hemolytic
3577,10600529,1999,RHARHD,RHARHD,Hannahpep,Free,Free,Linear,L,None,6,Plasma-anticlotting,No hemolysis (non hemolytic),Human,Indian King Cobra (Ophiophagus hannah) Venom,NA,Non-hemolytic
3578,10600529,1999,RHARHD,RHARHD,Hannahpep,Free,Free,Linear,L,None,6,Plasma-anticlotting,No hemolysis (non hemolytic),Goat,Indian King Cobra (Ophiophagus hannah) Venom,NA,Non-hemolytic
3579,10600529,1999,RHARHD,RHARHD,Hannahpep,Free,Free,Linear,L,None,6,Plasma-anticlotting,No hemolysis (non hemolytic),Mouse,Indian King Cobra (Ophiophagus hannah) Venom,NA,Non-hemolytic
3635,17927208,2007,FHPSLWVLIPQYIQLIRKILKSG,FHPSLWVLIPQYIQLIRKILKSG,Conolysin-Mt,Free,Free,Linear,L,None,23,Cytolytic,40% hemolysis at 1µM,Human,Derived from venom of Conus mustelinus,NA,NA
3636,17927208,2007,FHPSLWVLIPQYIQLIRKILKSG,FHPSLWVLIPQYIQLIRKILKSG,Conolysin-Mt,Free,Free,Linear,L,None,23,Cytolytic,~90% hemolysis at 10µM,Human,Derived from venom of Conus mustelinus,NA,NA
3637,17884127,2007,GLLDFVTGVGKDIFAQLIKQI,GLLDFVTGVGKDIFAQLIKQI{ct:Amid},Ocellatin 4,Amidation,Free,Linear,L,None,21,Cytolytic,HC50 =14.3 mM,Human,Derived from skin secretion of Leptodactylus ocellatus,NA,NA
3793,9108731,1996,GFFALIPKIISSPLFKTLLSAVGSALSSSGEQE,GFFALIPKIISSPLFKTLLSAVGSALSSSGEQE,PX1–33,Free,Free,Linear,L,None,33,Cytolytic,Conc. Required for hemolysis =1.75nmols,Human,Synthetic Peptide,NA,NA
3794,9108731,1996,GFFALIAKIISSPLFKTLLSAVGSALSSSGEQE,GFFALIAKIISSPLFKTLLSAVGSALSSSGEQE,PX1–33 (P7A),Free,Free,Linear,L,None,33,Cytolytic,Conc. Required for hemolysis =0.6nmols,Human,Synthetic Peptide,NA,NA
3795,9108731,1996,GFFALIPKIISSPLFKTLLSAVGSAL,GFFALIPKIISSPLFKTLLSAVGSAL,PX1–26,Free,Free,Linear,L,None,26,Cytolytic,Conc. Required for hemolysis =1.1nmols,Human,Synthetic Peptide,NA,NA
3796,9108731,1996,GFFALIPKIISSPLFKTL,GFFALIPKIISSPLFKTL{ct:Amid},PX1–18,Amidation,Free,Linear,L,None,18,Cytolytic,No hemolysis (Non hemolysis),Human,Synthetic Peptide,NA,Non-hemolytic
3797,9108731,1996,GFFALIAKIISSPLFKTL,GFFALIAKIISSPLFKTL{ct:Amid},PX1–18 (P7A),Amidation,Free,Linear,L,None,18,Cytolytic,Conc. Required for hemolysis =7.1nmols,Human,Synthetic Peptide,NA,NA
3808,9518597,1998,Aib-P-Aib-A-Aib-AQ-Aib-V-Aib-GL-Aib-PV-Aib-Aib-EQ,{nnr:Aib}-P-{nnr:Aib}-A-{nnr:Aib}-AQ-{nnr:Aib}-V-{nnr:Aib}-GL-{nnr:Aib}-PV-{nnr:Aib}-{nnr:Aib}-EQ{nt:Acet}{ct:Phenol},Alam-P14,Phenol,Acetylation,Linear,L,Aib = α- methylalanine,19,Cytolytic,EC50 =30μM,Human,Alamethicin,NA,NA
3825,9889358,1998,KLLLK,KLLLK{nt:Dansylation}{ct:Amid},DnsLK5NH2,Amidation,Dansylation,Linear,L,None,5,Cytotoxin,LD50 =90μM,Human,Synthetic Peptide,α-Helix,NA
3826,9889358,1998,KLLLKLLLK,KLLLKLLLK{nt:Dansylation},DnsLK9,Free,Dansylation,Linear,L,None,9,Cytotoxin,LD50 =4.5 μM,Human,Synthetic Peptide,α-Helix,NA
3827,9889358,1998,KLLLKLLLK,KLLLKLLLK{nt:Dansylation}{ct:Amid},DnsLK9,Amidation,Dansylation,Linear,L,None,9,Cytotoxin,LD50 =2.5 μM,Human,Synthetic Peptide,α-Helix,NA
3828,9889358,1998,KLLKLLLKLLKLLLKLLLKLLK,KLLKLLLKLLKLLLKLLLKLLK{nt:Dansylation},DnsLK22,Free,Dansylation,Linear,L,None,22,Cytotoxin,LD50 =0.3 μM,Human,Synthetic Peptide,α-Helix,NA
3829,9889358,1998,KLLKLLLKLLKLLLKLLLKLLK,KLLKLLLKLLKLLLKLLLKLLK{nt:Dansylation}{ct:Amid},DnsLK22,Amidation,Dansylation,Linear,L,None,22,Cytotoxin,LD50 =0.1 μM,Human,Synthetic Peptide,α-Helix,NA
3830,9889358,1998,KLLKLLLKLLLKLLK,KLLKLLLKLLLKLLK,LK15,Free,Free,Linear,L,None,15,Cytotoxin,LD50 =0.8 μM,Human,Synthetic Peptide,α-Helix,NA
3831,9889358,1998,KLLKLLLKLLLKLLK,KLLKLLLKLLLKLLK{nt:Dansylation},DnsLK15,Free,Dansylation,Linear,L,None,15,Cytotoxin,LD50 =0.3 μM,Human,Synthetic Peptide,α-Helix,NA
3832,9889358,1998,LKLLLLKLLKLKLWK,LKLLLLKLLKLKLWK,r-LK15,Free,Free,Linear,L,None,15,Cytotoxin,LD50 =5 μM,Human,Synthetic Peptide,α-Helix,NA
3889,11318033,2001,QlLVDlI,QL{d}LVDL{d}I{cyc:N-C},Lichenysin,Free,Free,Cyclic,Mix,None,7,Chelating agent,100% hemolysis at 15μM,Human,Bacillus licheniformis,NA,NA
3997,10600388,1999,CAESCVYIPCTVTALLGCSCSNRVCYNGIP,CAESCVYIPCTVTALLGCSCSNRVCYNGIP{cyc:N-C},Cycloviolacin O1,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
3998,10600388,1999,CGESCVWIPCISSAIGCSCKSKVCYRNGIP,CGESCVWIPCISSAIGCSCKSKVCYRNGIP{cyc:N-C},Cycloviolacin O2,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
3999,10600388,1999,CGESCVWIPCLTSAIGCSCKSKVCYRNGIP,CGESCVWIPCLTSAIGCSCKSKVCYRNGIP{cyc:N-C},Cycloviolacin O3,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4000,10600388,1999,CGESCVWIPCISSAIGCSCKNKVCYRNGIP,CGESCVWIPCISSAIGCSCKNKVCYRNGIP{cyc:N-C},Cycloviolacin O4,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4001,10600388,1999,CGESCVWIPCISSAVGCSCKNKVCYKNGTP,CGESCVWIPCISSAVGCSCKNKVCYKNGTP{cyc:N-C},Cycloviolacin O5,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4002,10600388,1999,CGESCVWIPCISAAVGCSCKSKVCYKNGTLP,CGESCVWIPCISAAVGCSCKSKVCYKNGTLP{cyc:N-C},Cycloviolacin O6,Free,Free,Cyclic,L,None,31,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4003,10600388,1999,CGESCVWIPCTITALAGCKCKSKVCYNSIP,CGESCVWIPCTITALAGCKCKSKVCYNSIP{cyc:N-C},Cycloviolacin O7,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4004,10600388,1999,CESCVWIPCISSVVGCSCKSKVCYKNGTLP,CESCVWIPCISSVVGCSCKSKVCYKNGTLP{cyc:N-C},Cycloviolacin O8,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4005,10600388,1999,CGESCVWIPCLTSAVGCSCKSKVCYRNGIP,CGESCVWIPCLTSAVGCSCKSKVCYRNGIP{cyc:N-C},Cycloviolacin O9,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4006,10600388,1999,CGESCVYIPCLTSAVGCSCKSKVCYRNGIP,CGESCVYIPCLTSAVGCSCKSKVCYRNGIP{cyc:N-C},Cycloviolacin O10,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4007,10600388,1999,CGESCVWIPCISAVVGCSCKSKVCYKNGTLP,CGESCVWIPCISAVVGCSCKSKVCYKNGTLP{cyc:N-C},Cycloviolacin O11,Free,Free,Cyclic,L,None,31,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4008,10600388,1999,CGESCVYIPCLTSAIGCSCKSKVCYRNGIP,CGESCVYIPCLTSAIGCSCKSKVCYRNGIP{cyc:N-C},Cycloviolacin H1,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4009,10600388,1999,CGESCVYIPCISGVIGCSCTDKVCYLNGTP,CGESCVYIPCISGVIGCSCTDKVCYLNGTP{cyc:N-C},Kalata B5,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4010,10600388,1999,CGESCVWIPCISAALGCSCKNKVCYRNGIP,CGESCVWIPCISAALGCSCKNKVCYRNGIP{cyc:N-C},Circulin A,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4011,10600388,1999,CGESCVFIPCISTLLGCSCKNKVCYRNGVIP,CGESCVFIPCISTLLGCSCKNKVCYRNGVIP{cyc:N-C},Circulin B,Free,Free,Cyclic,L,None,31,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4012,10600388,1999,CGESCVFIPCVTALLGCSCKSKVCYKNSIP,CGESCVFIPCVTALLGCSCKSKVCYKNSIP{cyc:N-C},Cyclopsychotride A,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4013,10600388,1999,VCGETCVGGTCNTPGCSCSRPVCTRNGLP,VCGETCVGGTCNTPGCSCSRPVCTRNGLP{cyc:N-C},Violapeptide I,Free,Free,Cyclic,L,None,29,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4014,10600388,1999,ICGETCVGGTCNTPGCSCSWPVCTRNGLP,ICGETCVGGTCNTPGCSCSWPVCTRNGLP{cyc:N-C},Cycloviolacin O12,Free,Free,Cyclic,L,None,29,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4015,10600388,1999,VCGETCFGGTCNTPGCSCTWPICTRDGLP,VCGETCFGGTCNTPGCSCTWPICTRDGLP{cyc:N-C},Kalata B2,Free,Free,Cyclic,L,None,29,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4016,10600388,1999,TCGETCFGGTCNTPGCTCDPWPICTDRGLP,TCGETCFGGTCNTPGCTCDPWPICTDRGLP{cyc:N-C},Kalata B3,Free,Free,Cyclic,L,None,30,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4017,10600388,1999,VCGETCVGGTCNTPGCTCSWPVCTRDGLP,VCGETCVGGTCNTPGCTCSWPVCTRDGLP{cyc:N-C},Kalata B4,Free,Free,Cyclic,L,None,29,Anti-HIV,50% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4018,10600388,1999,VCGETCEGGTCNTPGCSCSWPVCTRNGLP,VCGETCEGGTCNTPGCSCSWPVCTRNGLP{cyc:N-C},Kalata S,Free,Free,Cyclic,L,None,29,Anti-HIV,51% hemolysis at ~20μM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and  Oldenlandia afrnis)",NA,NA
4082,3125066,1988,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,Maganin 2,Free,Free,Linear,L,None,23,Antiparasitic,4% hemolysis at 50μg/ml,Human,Xenopus laevis,NA,NA
4083,3125066,1988,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,Maganin 2,Free,Free,Linear,L,None,23,Antiparasitic,3% hemolysis at 100μg/ml,Human,Xenopus laevis,NA,NA
4084,3125066,1988,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,Maganin 2,Free,Free,Linear,L,None,23,Antiparasitic,3% hemolysis at 200μg/ml,Human,Xenopus laevis,NA,NA
4085,3125066,1988,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,Maganin 2,Free,Free,Linear,L,None,23,Antiparasitic,4% hemolysis at 500μg/ml,Human,Xenopus laevis,NA,NA
4086,3125066,1988,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS,Maganin 2,Free,Free,Linear,L,None,23,Antiparasitic,6% hemolysis at 1000μg/ml,Human,Xenopus laevis,NA,NA
4087,3125066,1988,GWASKIGQTLGKIAKVGLKELIQPK,GWASKIGQTLGKIAKVGLKELIQPK,XPF,Free,Free,Linear,L,None,24,Antiparasitic,1% hemolysis at 50μg/ml,Human,Xenopus laevis,NA,NA
4088,3125066,1988,GWASKIGQTLGKIAKVGLKELIQPK,GWASKIGQTLGKIAKVGLKELIQPK,XPF,Free,Free,Linear,L,None,24,Antiparasitic,1% hemolysis at 100μg/ml,Human,Xenopus laevis,NA,NA
4089,3125066,1988,GWASKIGQTLGKIAKVGLKELIQPK,GWASKIGQTLGKIAKVGLKELIQPK,XPF,Free,Free,Linear,L,None,24,Antiparasitic,2% hemolysis at 200μg/ml,Human,Xenopus laevis,NA,NA
4090,3125066,1988,GWASKIGQTLGKIAKVGLKELIQPK,GWASKIGQTLGKIAKVGLKELIQPK,XPF,Free,Free,Linear,L,None,24,Antiparasitic,5% hemolysis at 500μg/ml,Human,Xenopus laevis,NA,NA
4091,3125066,1988,GWASKIGQTLGKIAKVGLKELIQPK,GWASKIGQTLGKIAKVGLKELIQPK,XPF,Free,Free,Linear,L,None,24,Antiparasitic,6% hemolysis at 1000μg/ml,Human,Xenopus laevis,NA,NA
4092,3125066,1988,GMASKAGAIAGKIAKVALKAL,GMASKAGAIAGKIAKVALKAL{ct:Amid},PGLa,Amidation,Free,Linear,L,None,21,Antiparasitic,4% hemolysis at 50μg/ml,Human,Xenopus laevis,NA,NA
4093,3125066,1988,GMASKAGAIAGKIAKVALKAL,GMASKAGAIAGKIAKVALKAL{ct:Amid},PGLa,Amidation,Free,Linear,L,None,21,Antiparasitic,3% hemolysis at 100μg/ml,Human,Xenopus laevis,NA,NA
4094,3125066,1988,GMASKAGAIAGKIAKVALKAL,GMASKAGAIAGKIAKVALKAL{ct:Amid},PGLa,Amidation,Free,Linear,L,None,21,Antiparasitic,4% hemolysis at 200μg/ml,Human,Xenopus laevis,NA,NA
4095,3125066,1988,GMASKAGAIAGKIAKVALKAL,GMASKAGAIAGKIAKVALKAL{ct:Amid},PGLa,Amidation,Free,Linear,L,None,21,Antiparasitic,5% hemolysis at 500μg/ml,Human,Xenopus laevis,NA,NA
4096,3125066,1988,GMASKAGAIAGKIAKVALKAL,GMASKAGAIAGKIAKVALKAL{ct:Amid},PGLa,Amidation,Free,Linear,L,None,21,Antiparasitic,7% hemolysis at 1000μg/ml,Human,Xenopus laevis,NA,NA
4098,11937508,2002,ALWKTLLKKVLKA,ALWKTLLKKVLKA{ct:Amid},K4-S4(1-13)NH2,Amidation,Free,Linear,L,None,13,Antiparasitic,3% hemolysis at 10μM,Human,Synthetic Peptide,NA,NA
4099,11937508,2002,ALWKTLLKKVLKA,ALWKTLLKKVLKA{nt:H2N-CH2-CO-P}{ct:Amid},Glycyl-P,Amidation,H2N-CH2-CO-P,Linear,L,None,13,Antiparasitic,2% hemolysis at 10μM,Human,Synthetic Peptide,NA,NA
4100,11937508,2002,ALWKTLLKKVLKA,ALWKTLLKKVLKA{nt:H2N-(CH2)3-CO-P}{ct:Amid},Aminobutyryl-P,Amidation,H2N-(CH2)3-CO-P,Linear,L,None,13,Antiparasitic,1% hemolysis at 10μM,Human,Synthetic Peptide,NA,NA
4101,11937508,2002,ALWKTLLKKVLKA,ALWKTLLKKVLKA{nt:H2N-(CH2)6-CO-P}{ct:Amid},Aminoheptanoyl-P,Amidation,H2N-(CH2)6-CO-P,Linear,L,None,13,Antiparasitic,1% hemolysis at 10μM,Human,Synthetic Peptide,NA,NA
4102,11937508,2002,ALWKTLLKKVLKA,ALWKTLLKKVLKA{nt:H2N-(CH2)11-CO-P}{ct:Amid},Aminolauroyl-P,Amidation,H2N-(CH2)11-CO-P,Linear,L,None,13,Antiparasitic,4% hemolysis at 10μM,Human,Synthetic Peptide,NA,NA
4103,11937508,2002,ALWKTLLKKVLKA,ALWKTLLKKVLKA{nt:H2N-C((CH2)4-NH2)H-CO-P}{ct:Amid},Lysyl-P,Amidation,H2N-C((CH2)4-NH2)H-CO-P,Linear,L,None,13,Antiparasitic,5% hemolysis at 10μM,Human,Synthetic Peptide,NA,NA
4104,12379643,2002,GLWSTIKQKGKEAAIAAAKAAGQAALGAL,GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid},DS 01,Amidation,Free,Linear,L,None,29,Antiparasitic,0.41% hemolysis at 4μg/ml,Human,Synthetic Peptide,NA,NA
4105,12379643,2002,GLWSTIKQKGKEAAIAAAKAAGQAALGAL,GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid},DS 01,Amidation,Free,Linear,L,None,29,Antiparasitic,0.54% hemolysis at 8μg/ml,Human,Synthetic Peptide,NA,NA
4106,12379643,2002,GLWSTIKQKGKEAAIAAAKAAGQAALGAL,GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid},DS 01,Amidation,Free,Linear,L,None,29,Antiparasitic,0.81% hemolysis at 16μg/ml,Human,Synthetic Peptide,NA,NA
4107,12379643,2002,GLWSTIKQKGKEAAIAAAKAAGQAALGAL,GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid},DS 01,Amidation,Free,Linear,L,None,29,Antiparasitic,1.08% hemolysis at 32μg/ml,Human,Synthetic Peptide,NA,NA
4108,12379643,2002,GLWSTIKQKGKEAAIAAAKAAGQAALGAL,GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid},DS 01,Amidation,Free,Linear,L,None,29,Antiparasitic,1.36% hemolysis at 64μg/ml,Human,Synthetic Peptide,NA,NA
4109,12379643,2002,GLWSTIKQKGKEAAIAAAKAAGQAALGAL,GLWSTIKQKGKEAAIAAAKAAGQAALGAL{ct:Amid},DS 01,Amidation,Free,Linear,L,None,29,Antiparasitic,2.17% hemolysis at 128μg/ml,Human,Synthetic Peptide,NA,NA
4110,15513914,2004,FLPLIGRVLSGIL,FLPLIGRVLSGIL{ct:Amid},Temporin A,Amidation,Free,Linear,L,None,13,Antiparasitic,LC50 >120μM,Human,Rana temporaria,NA,NA
4111,15513914,2004,LLPIVGNLLKSLL,LLPIVGNLLKSLL{ct:Amid},Temporin B,Amidation,Free,Linear,L,None,13,Antiparasitic,LC50 >120μM,Human,Rana temporaria,NA,NA
4121,18984589,2009,KKALLOHALHOLALLAOHLAHOLKKA,KKALL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid},HALO,Amidation,Free,Linear,L,O = L-Ornithine,26,Antiparasitic,HC50 =179.2μM,Human,Synthetic Peptide,NA,NA
4122,18984589,2009,ALALLOHALHOLALLAOHLAHOLALA,ALALL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LALA{ct:Amid},HALO-2,Amidation,Free,Linear,L,O = L-Ornithine,26,Antiparasitic,HC50 <5.6μM,Human,Synthetic Peptide,NA,NA
4123,18984589,2009,FFKKLOHALHOLALLAOHLAHOLKKA,FFKKL{nnr:O}HALH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid},HALO-F,Amidation,Free,Linear,L,O = L-Ornithine,26,Antiparasitic,HC50 <5.6μM,Human,Synthetic Peptide,NA,NA
4124,18984589,2009,KKALLOHPLHOLALLAOHLAHOLKKA,KKALL{nnr:O}HPLH{nnr:O}LALLA{nnr:O}HLAH{nnr:O}LKKA{ct:Amid},HALO-P8,Amidation,Free,Linear,L,O = L-Ornithine,26,Antiparasitic,HC50 =89.6μM,Human,Synthetic Peptide,NA,NA
4125,18984589,2009,akklohalhoallalohlahollakk,A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}A{d}H{d}{nnr:d-o}L{d}L{d}A{d}K{d}K{d}{ct:Amid},D-HALO-rev,Amidation,Free,Linear,D,o = D-Ornithine,26,Antiparasitic,HC50 =716.8μM,Human,Synthetic Peptide,NA,NA
4126,18984589,2009,akklohalhoallalohlpholkkff,A{d}K{d}K{d}L{d}{nnr:d-o}H{d}A{d}L{d}H{d}{nnr:d-o}A{d}L{d}L{d}A{d}L{d}{nnr:d-o}H{d}L{d}P{d}H{d}{nnr:d-o}L{d}K{d}K{d}F{d}F{d}{ct:Amid},D-HALO-P8F-rev,Amidation,Free,Linear,D,o = D-Ornithine,26,Antiparasitic,HC50 >65.2μM,Human,Synthetic Peptide,NA,NA
4135,10441158,1999,CGETCVGGTCNTPGCTCSWPVCTRNGLPV,CGETCVGGTCNTPGCTCSWPVCTRNGLPV{cyc:N-C},Kalata B1,Free,Free,Cyclic,L,None,29,Uterotonic,HD50 =50μM,Human,O. affinis,NA,NA
4136,10441158,1999,CGESCVFIPCISTLLGCSCKNKVCYRNGVIP,CGESCVFIPCISTLLGCSCKNKVCYRNGVIP{cyc:N-C},Circulin B,Free,Free,Cyclic,L,None,30,Uterotonic,HD50 =30μM,Human,O. affinis,NA,NA
4158,20564013,2010,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},Kalata B1,Free,Free,Cyclic,L,None,30,Pesticidal,HD50 = 20.0±1.1μM,Human,Cyclotides (Oldenlandia affinis),NA,NA
4159,20564013,2010,GLPVCGETCTLGTVYTQGCTCSWPICKRN,GLPVCGETCTLGTVYTQGCTCSWPICKRN{cyc:N-C},Kalata B7,Free,Free,Cyclic,L,None,30,Pesticidal,HD50 = 55.2±1.3μM,Human,Cyclotides (Oldenlandia affinis),NA,NA
4192,16460023,2006,FKIKASKVLDKFGKIVGKVLKQLKKVSAVAKV,FKIKASKVLDKFGKIVGKVLKQLKKVSAVAKV,P6_1,Free,Free,Linear,L,None,32,Hemolytic,LD50=12.6µM,Human,Peptides derived from Trialysin protein found in the saliva of Triatoma infestans,NA,NA
4193,16460023,2006,FSISASKVLDKFGKIVGKVLKQLKKVSAVAKV,FSISASKVLDKFGKIVGKVLKQLKKVSAVAKV,P6_2,Free,Free,Linear,L,None,32,Hemolytic,LD50=28.1µM,Human,Peptides derived from Trialysin protein found in the saliva of Triatoma infestans,NA,NA
4306,24041697,2013,GIVEQCCTSICSLYQLENYCN,GIVEQCCTSICSLYQLENYCN,Porcine Insulin,Free,Free,Linear,L,None,21,Amyloidogenicity,57.4 ± 4.6 % Hemolysis at 60 µM,Human,Insulin Derived From Pigs,α-Helix,NA
4307,24041697,2013,FVNQHLCGSHLVEALYLVCGERGFFYTPKA,FVNQHLCGSHLVEALYLVCGERGFFYTPKA,DOI,Free,Free,Linear,L,None,30,Amyloidogenicity,45.9 ± 3.4 % Hemolysis at 60 µM,Human,An Insulin Analog,α-Helix,NA
4404,23868208,2013,ALAGTIIAGASLTFQVLDKVLEELGKVSRK,ALAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid},StII1–30,Amidation,Free,Linear,L,None,30,Cytolytic,1.0±0.02 % Hemolysis at 40 µM,Human,Stichodactyla Helianthus,α-Helical,Non-hemolytic
4405,23868208,2013,AWAGTIIAGASLTFQVLDKVLEELGKVSRK,AWAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid},StII1–30L2W,Amidation,Free,Linear,L,None,30,Cytolytic,1.0±0.02 % Hemolysis at 40 µM,Human,Analogs Of Stii1–30,α-Helical,Non-hemolytic
4406,23868208,2013,ALAGTIIAGASWTFQVLDKVLEELGKVSRK,ALAGTIIAGASWTFQVLDKVLEELGKVSRK{ct:Amid},StII1–30L12W,Amidation,Free,Linear,L,None,30,Cytolytic,1.0±0.01 % Hemolysis at 40 µM,Human,Analogs Of Stii1–30,α-Helical,Non-hemolytic
4407,23868208,2013,ALAGTIIAGASLTFQVWDKVLEELGKVSRK,ALAGTIIAGASLTFQVWDKVLEELGKVSRK{ct:Amid},StII1–30L17W,Amidation,Free,Linear,L,None,30,Cytolytic,0.9 ±0.8 % Hemolysis at 40 µM,Human,Analogs Of Stii1–30,α-Helical,Non-hemolytic
4408,23868208,2013,ALAGTIIAGASLTFQVLDKVLEEWGKVSRK,ALAGTIIAGASLTFQVLDKVLEEWGKVSRK{ct:Amid},StII1–30L24W,Amidation,Free,Linear,L,None,30,Cytolytic,1.0±0.02 % Hemolysis at 40 µM,Human,Analogs Of Stii1–30,α-Helical,Non-hemolytic
4806,25054164,2014,LRPAILVRTK,LRPAILVRTK{ct:Amid},sauvatide,Amidation,Free,Linear,L,None,10,myotropic agent on rat,<8 % Hemolysis at 512 mg/L,Horse,Phyllomedusa Sauvagei Skin Secretion,NA,Low hemolytic
4867,24411680,2014,RKDVY,RKDVY{ct:Amid},TP-5,Amidation,Free,Linear,L,None,5,Anti-mycobacterial,50 % Hemolysis at >2000 mg/L,Rat,Synthetic Immunomodulatory Pentapeptide Of Thymopentin,α-Helix,Non-hemolytic
4868,24411680,2014,RRRRRR,RRRRRR{ct:Amid},RR-6,Amidation,Free,Linear,L,None,6,Anti-mycobacterial,50 % Hemolysis at >2000 mg/L,Rat,Synthetic Peptide,α-Helix,Non-hemolytic
4869,24411680,2014,RKDVYRRRRRR,RKDVYRRRRRR{ct:Amid},RR-11,Amidation,Free,Linear,L,None,11,Anti-mycobacterial,50 % Hemolysis at >2000 mg/L,Rat,Synthetic Modified Peptides Of Thymopentin,α-Helix,Non-hemolytic
4870,24411680,2014,RRRRRRRKDVY,RRRRRRRKDVY{ct:Amid},RY-11,Amidation,Free,Linear,L,None,11,Anti-mycobacterial,50 % Hemolysis at >2000 mg/L,Rat,Synthetic Modified Peptides Of Thymopentin,α-Helix,Non-hemolytic
5165,24965354,2014,WQWRMKKLG,WQWRMKKLG,LfcinB9,Free,Free,Linear,L,None,9,Anti-ovarian cancer,~7 % Hemolysis at 640 μg/ml,Sheep,Bovine Lactoferricin B,NA,Low hemolytic
5166,25025626,2014,KGD,KGD,vasotab TY,Free,Free,Linear,L,None,3,"Anti-thrombosis, vasodilator activity",0 % Hemolysis at 5 μg/ml,Human,Horsefly Of Tabanus Yao,NA,Non-hemolytic
5167,25025626,2014,KGD,KGD,vasotab TY,Free,Free,Linear,L,None,3,"Anti-thrombosis, vasodilator activity",0 % Hemolysis at 320 μg/ml,Human,Horsefly Of Tabanus Yao,NA,Non-hemolytic
5305,25056849,2015,FLGLLGSLL,FLGLLGSLL{ct:Amid},Feleucin-BO1,Amidation,Free,Linear,L,None,9,Antibaterial,100 % Hemolysis at 80 µM,Horse,"Synthetic,Skin Secretion Of Bombina Orientalis",Random coil,NA
5418,25869678,2015,MQFITDLIKKAVDFFKGLFGNK,MQFITDLIKKAVDFFKGLFGNK,WRK,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 2.78 µM,Human,Staphylococcus Warneri,α-Helix,NA
5419,25869678,2015,MQFITDLIGKAVDFFKGLFGNK,MQFITDLIGKAVDFFKGLFGNK,WRK_K9G,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at >20 µM,Human,Staphylococcus Warneri,α-Helix,NA
5420,25869678,2015,MQFITDLIKKAVDFFKGLFDNK,MQFITDLIKKAVDFFKGLFDNK,WRK_G20D,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 9.09 µM,Human,Staphylococcus Warneri,α-Helix,NA
5421,25869678,2015,MQFITDLIGKAVDFFKGLFDNK,MQFITDLIGKAVDFFKGLFDNK,WRK_K9G-G20D,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at >20 µM,Human,Staphylococcus Warneri,α-Helix,NA
5422,25869678,2015,MQFITDLIKKAVDVFKGLFGNK,MQFITDLIKKAVDVFKGLFGNK,WRK_F14V,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 12.5 µM,Human,Staphylococcus Warneri,α-Helix,NA
5423,25869678,2015,MQFITDLIKKAVDFIKGLFGNK,MQFITDLIKKAVDFIKGLFGNK,WRK_F15I,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 2.63 µM,Human,Staphylococcus Warneri,α-Helix,NA
5424,25869678,2015,MQFITDLIKKAVDVIKGLFGNK,MQFITDLIKKAVDVIKGLFGNK,WRK_F14V-F15I,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 8.33 µM,Human,Staphylococcus Warneri,α-Helix,NA
5425,25869678,2015,MQFITDLIKKAVDFFKGLVGNK,MQFITDLIKKAVDFFKGLVGNK,WRK_F19V,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 11.1 µM,Human,Staphylococcus Warneri,α-Helix,NA
5426,25869678,2015,MQTFQDILGKVIEVIKAIVDAK,MQTFQDILGKVIEVIKAIVDAK,rPSM,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 20 µM,Human,Staphylococcus Warneri,α-Helix,NA
5427,25869678,2015,MADVIAKIVEIVKGLIDQFTQK,MADVIAKIVEIVKGLIDQFTQK,PSM,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 7.14 µM,Human,Staphylococcus Epidermidis,α-Helix,NA
5428,25869678,2015,MAGVIAKIVEIVKGLIDQFTQK,MAGVIAKIVEIVKGLIDQFTQK,PSM_D3G,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 3.7 µM,Human,Staphylococcus Epidermidis,α-Helix,NA
5429,25869678,2015,MADVIAKIVEIVKKLIDQFTQK,MADVIAKIVEIVKKLIDQFTQK,PSM_G14K,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 9.88 µM,Human,Staphylococcus Epidermidis,α-Helix,NA
5430,25869678,2015,MAGVIAKIVEIVKKLIDQFTQK,MAGVIAKIVEIVKKLIDQFTQK,PSM_D3G-G14K,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 3.125 µM,Human,Staphylococcus Epidermidis,α-Helix,NA
5431,25869678,2015,MADVIAKFVEIVKGLIDQFTQK,MADVIAKFVEIVKGLIDQFTQK,PSM_I8F,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at >20 µM,Human,Staphylococcus Epidermidis,α-Helix,NA
5432,25869678,2015,MADVIAKIFEIVKGLIDQFTQK,MADVIAKIFEIVKGLIDQFTQK,PSM_V9F,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 4.76 µM,Human,Staphylococcus Epidermidis,α-Helix,NA
5433,25869678,2015,MADVIAKFFEIVKGLIDQFTQK,MADVIAKFFEIVKGLIDQFTQK,PSM_I8F-V9F,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at >20 µM,Human,Staphylococcus Epidermidis,α-Helix,NA
5434,25869678,2015,MADFIAKIVEIVKGLIDQFTQK,MADFIAKIVEIVKGLIDQFTQK,PSM_V4F,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 10 µM,Human,Staphylococcus Epidermidis,α-Helix,NA
5435,25869678,2015,MNGFILGKFFDVAKKILDTIFQK,MNGFILGKFFDVAKKILDTIFQK,rWRK,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 4 µM,Human,Staphylococcus Epidermidis,α-Helix,NA
5476,26134716,2015,SELAGTIIDGASLTFEVLDKVLGELGKVSRK,SELAGTIIDGASLTFEVLDKVLGELGKVSRK{ct:Amid},StI1-31,Amidation,Free,Linear,L,None,31,Hemolytic,50 % Hemolysis at 7.25 ± 0.01 nM,Human,Stichodactyla Helianthus,α-Helix,NA
5477,26134716,2015,ALAGTIIAGASLTFQVLDKVLEELGKVSRK,ALAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid},StII1-30,Amidation,Free,Linear,L,None,30,Hemolytic,50 % Hemolysis at 0.22 ± 0.002 nM,Human,Stichodactyla Helianthus,α-Helix,NA
5478,26134716,2015,SADVAGAVIDGASLSFDILKTVLEALGNVKRK,SADVAGAVIDGASLSFDILKTVLEALGNVKRK{ct:Amid},EqtII1-32,Amidation,Free,Linear,L,None,32,Hemolytic,50 % Hemolysis at 0.91 ± 0.01 nM,Human,Actinia Equina,α-Helix,NA
5479,26134716,2015,SADVAGAVIDGAGLGFDVLKTVLEALGNVKRK,SADVAGAVIDGAGLGFDVLKTVLEALGNVKRK{ct:Amid},FraC1-32,Amidation,Free,Linear,L,None,32,Hemolytic,50 % Hemolysis at 0.96 ± 0.06 nM,Human,Actinia Fragacea,α-Helix,NA
5673,26380930,2015,LLKKLLKK,LLKKLLKK{ct:Amid},LK,Amidation,Free,Linear,L,None,8,Anti-mycobacterial,50 % Hemolysis at >500 μg/ml,Rat,Synthetic Peptide,α-Helix,Low hemolytic
5674,26380930,2015,PLLKKLLKKP,PLLKKLLKKP{ct:Amid},PP,Amidation,Free,Linear,L,None,10,Anti-mycobacterial,50 % Hemolysis at >500 μg/ml,Rat,Synthetic Peptide,α-Helix,Low hemolytic
5675,26380930,2015,CLLKKLLKKC,CLLKKLLKKC{ct:Amid},CC,Amidation,Free,Linear,L,None,10,Anti-mycobacterial,50 % Hemolysis at >500 μg/ml,Rat,Synthetic Peptide,α-Helix,Low hemolytic
5676,26380930,2015,ILLKKLLKKI,ILLKKLLKKI{ct:Amid},II,Amidation,Free,Linear,L,None,10,Anti-mycobacterial,50 % Hemolysis at >500 μg/ml,Rat,Synthetic Peptide,α-Helix,Low hemolytic
5677,26380930,2015,MLLKKLLKKM,MLLKKLLKKM{ct:Amid},MM,Amidation,Free,Linear,L,None,10,Anti-mycobacterial,50 % Hemolysis at >500 μg/ml,Rat,Synthetic Peptide,α-Helix,Low hemolytic
5678,26380930,2015,WLLKKLLKKW,WLLKKLLKKW{ct:Amid},WW,Amidation,Free,Linear,L,None,10,Anti-mycobacterial,50 % Hemolysis at 363 μg/ml,Rat,Synthetic Peptide,α-Helix,Low hemolytic
5747,26196285,2015,IALILEPICCQERAA,IALILEPICCQERAA,PA,Free,Free,Linear,L,None,15,Hemolytic,50 % Hemolysis at 0.77 mM,Human,Peptide Inhibitors Of Complement C1 (Pic1),NA,NA
5748,26196285,2015,RALILEPICCQERAA,RALILEPICCQERAA,PA-I1R,Free,Free,Linear,L,None,15,Hemolytic,91.93 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5749,26196285,2015,IRLILEPICCQERAA,IRLILEPICCQERAA,PA-A2R,Free,Free,Linear,L,None,15,Hemolytic,87.28 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5750,26196285,2015,IARILEPICCQERAA,IARILEPICCQERAA,PA-L3R,Free,Free,Linear,L,None,15,Hemolytic,80.45 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5751,26196285,2015,IALRLEPICCQERAA,IALRLEPICCQERAA,PA-I4R,Free,Free,Linear,L,None,15,Hemolytic,43.71 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5752,26196285,2015,IALIREPICCQERAA,IALIREPICCQERAA,PA-L5R,Free,Free,Linear,L,None,15,Hemolytic,93.4 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5753,26196285,2015,IALILRPICCQERAA,IALILRPICCQERAA,PA-E6R,Free,Free,Linear,L,None,15,Hemolytic,87.59 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5754,26196285,2015,IALILERICCQERAA,IALILERICCQERAA,PA-P7R,Free,Free,Linear,L,None,15,Hemolytic,89.85 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5755,26196285,2015,IALILEPRCCQERAA,IALILEPRCCQERAA,PA-I8R,Free,Free,Linear,L,None,15,Hemolytic,62.32 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5756,26196285,2015,IALILEPIRCQERAA,IALILEPIRCQERAA,PA-C9R,Free,Free,Linear,L,None,15,Hemolytic,89.54 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5757,26196285,2015,IALILEPICRQERAA,IALILEPICRQERAA,PA-C10R,Free,Free,Linear,L,None,15,Hemolytic,89.8 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5758,26196285,2015,IALILEPICCRERAA,IALILEPICCRERAA,PA-Q11R,Free,Free,Linear,L,None,15,Hemolytic,90.87 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5759,26196285,2015,IALILEPICCQRRAA,IALILEPICCQRRAA,PA-E12R,Free,Free,Linear,L,None,15,Hemolytic,95.83 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5760,26196285,2015,IALILEPICCQERRA,IALILEPICCQERRA,PA-A14R,Free,Free,Linear,L,None,15,Hemolytic,88.65 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5761,26196285,2015,IALILEPICCQERAR,IALILEPICCQERAR,PA-A15R,Free,Free,Linear,L,None,15,Hemolytic,44.24 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5762,26196285,2015,EALILEPICCQERAA,EALILEPICCQERAA,PA-I1E,Free,Free,Linear,L,None,15,Hemolytic,89.27 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5763,26196285,2015,IELILEPICCQERAA,IELILEPICCQERAA,PA-A2E,Free,Free,Linear,L,None,15,Hemolytic,92.24 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5764,26196285,2015,IAEILEPICCQERAA,IAEILEPICCQERAA,PA-L3E,Free,Free,Linear,L,None,15,Hemolytic,100.27 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5765,26196285,2015,IALELEPICCQERAA,IALELEPICCQERAA,PA-I4E,Free,Free,Linear,L,None,15,Hemolytic,92.07 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5766,26196285,2015,IALIEEPICCQERAA,IALIEEPICCQERAA,PA-L5E,Free,Free,Linear,L,None,15,Hemolytic,94.33 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5767,26196285,2015,IALILEEICCQERAA,IALILEEICCQERAA,PA-P7E,Free,Free,Linear,L,None,15,Hemolytic,96.1 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5768,26196285,2015,IALILEPECCQERAA,IALILEPECCQERAA,PA-I8E,Free,Free,Linear,L,None,15,Hemolytic,95.74 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5769,26196285,2015,IALILEPIECQERAA,IALILEPIECQERAA,PA-C9E,Free,Free,Linear,L,None,15,Hemolytic,91.62 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5770,26196285,2015,IALILEPICEQERAA,IALILEPICEQERAA,PA-C10E,Free,Free,Linear,L,None,15,Hemolytic,95.21 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5771,26196285,2015,IALILEPICCEERAA,IALILEPICCEERAA,PA-Q11E,Free,Free,Linear,L,None,15,Hemolytic,65.6 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5772,26196285,2015,IALILEPICCQEEAA,IALILEPICCQEEAA,PA-R13E,Free,Free,Linear,L,None,15,Hemolytic,101.99 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5773,26196285,2015,IALILEPICCQEREA,IALILEPICCQEREA,PA-A14E,Free,Free,Linear,L,None,15,Hemolytic,98.09 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5774,26196285,2015,IALILEPICCQERAE,IALILEPICCQERAE,PA-A15E,Free,Free,Linear,L,None,15,Hemolytic,93.13 % Hemolysis at 0.77 mM,Human,Pa Derivatives,NA,NA
5775,26196285,2015,IALILEPICCQERAA,IALILEPICCQERAA{ct:dPEG24},PA-dPEG24,dPEG24,Free,Linear,L,None,15,Inhibits complement activation in vivo,2.99 % Hemolysis at 0.77 mM,Human,Pegylated Pa Peptides,NA,NA
5776,26196285,2015,IALILEPICCQERAA,IALILEPICCQERAA{ct:dPEG20},PA-dPEG20,dPEG20,Free,Linear,L,None,15,Hemolytic,11.41 % Hemolysis at 0.77 mM,Human,Pegylated Pa Peptides,NA,NA
5777,26196285,2015,IALILEPICCQERAA,IALILEPICCQERAA{ct:dPEG16},PA-dPEG16,dPEG16,Free,Linear,L,None,15,Hemolytic,12.04 % Hemolysis at 0.77 mM,Human,Pegylated Pa Peptides,NA,NA
5778,26196285,2015,IALILEPICCQERAA,IALILEPICCQERAA{ct:dPEG12},PA-dPEG12,dPEG12,Free,Linear,L,None,15,Hemolytic,11.41 % Hemolysis at 0.77 mM,Human,Pegylated Pa Peptides,NA,NA
5779,26196285,2015,IALILEPICCQERAA,IALILEPICCQERAA{ct:dPEG08},PA-dPEG08,dPEG08,Free,Linear,L,None,15,Hemolytic,34.66 % Hemolysis at 0.77 mM,Human,Pegylated Pa Peptides,NA,NA
5780,26196285,2015,IALILEPICCQERAA,IALILEPICCQERAA{ct:dPEG06},PA-dPEG06,dPEG06,Free,Linear,L,None,15,Hemolytic,44.82 % Hemolysis at 0.77 mM,Human,Pegylated Pa Peptides,NA,NA
5781,26196285,2015,IALILEPICCQERAA,IALILEPICCQERAA{ct:dPEG04},PA-dPEG04,dPEG04,Free,Linear,L,None,15,Hemolytic,12.36 % Hemolysis at 0.77 mM,Human,Pegylated Pa Peptides,NA,NA
5782,26196285,2015,IALILEPICCQERAA,IALILEPICCQERAA{ct:dPEG03},PA-dPEG03,dPEG03,Free,Linear,L,None,15,Hemolytic,12.57 % Hemolysis at 0.77 mM,Human,Pegylated Pa Peptides,NA,NA
5783,26196285,2015,IALILEPICCQERAA,IALILEPICCQERAA{ct:dPEG02},PA-dPEG02,dPEG02,Free,Linear,L,None,15,Hemolytic,11.62 % Hemolysis at 0.77 mM,Human,Pegylated Pa Peptides,NA,NA
6238,26905802,2016,WILEYLWKVPFDFWRGVI,WILEYLWKVPFDFWRGVI,E1P47,Free,Free,Linear,L,None,18,"Antiviral, Anti-HIV",100 % Hemolysis at 0 µM,Rabbit,Gb Virus C,α-Helix,NA
6239,26905802,2016,WILEYLWKVPFDFWRGVI,WILEYLWKVPFDFWRGVI,E1P47,Free,Free,Linear,L,None,18,"Antiviral, Anti-HIV",50 % Hemolysis at 1 µM,Rabbit,Gb Virus C,α-Helix,NA
6240,26905802,2016,WILEYLWKVPFDFWRGVI,WILEYLWKVPFDFWRGVI,E1P47,Free,Free,Linear,L,None,18,"Antiviral, Anti-HIV",25 % Hemolysis at 2 µM,Rabbit,Gb Virus C,α-Helix,NA
6241,26905802,2016,WILEYLWKVPFDFWRGVI,WILEYLWKVPFDFWRGVI,E1P47,Free,Free,Linear,L,None,18,"Antiviral, Anti-HIV",<25 % Hemolysis at 3 µM,Rabbit,Gb Virus C,α-Helix,NA
6242,26905802,2016,WILEYLWKVPFDFWRGVI,WILEYLWKVPFDFWRGVI,E1P47,Free,Free,Linear,L,None,18,"Antiviral, Anti-HIV",<25 % Hemolysis at 4 µM,Rabbit,Gb Virus C,α-Helix,NA
6243,26905802,2016,WILEYLWKVPFDFWRGVI,WILEYLWKVPFDFWRGVI,E1P47,Free,Free,Linear,L,None,18,"Antiviral, Anti-HIV",<25 % Hemolysis at 5 µM,Rabbit,Gb Virus C,α-Helix,NA
6461,27598770,2016,MQFITDLIKKAVDFFKGLFGNK,MQFITDLIKKAVDFFKGLFGNK,WRK,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 2.78 µM,Human,Staphylococci,α-Helix,NA
6462,27598770,2016,MQFITDLIKKAVDFFKGLFDNK,MQFITDLIKKAVDFFKGLFDNK,WarnG20D,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 12.36 µM,Human,Warnericin Rk Derivative,α-Helix,NA
6463,27598770,2016,MQFITDLIKKAVDVFKGLFGNK,MQFITDLIKKAVDVFKGLFGNK,WarnF14V,Free,Free,Linear,L,None,22,Anti-Legionella,10 % Hemolysis at 12.5 µM,Human,Warnericin Rk Derivative,α-Helix,NA
6666,27008420,2016,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Anti-plant-pathogenic bacteria and fungi,4 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic
6667,27008420,2016,KKLKK(CO-C7H15)FKKLQ,KKLKK({nnr:CO-C7H15})FKKLQ{cyc:N-C},BPC498,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,78 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic
6668,27008420,2016,KKLKK(CO-C3H7)FKKLQ,KKLKK({nnr:CO-C3H7})FKKLQ{cyc:N-C},BPC500,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,28 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6669,27008420,2016,KKLKK(CO-C4H9)FKKLQ,KKLKK({nnr:CO-C4H9})FKKLQ{cyc:N-C},BPC526,Free,Free,Cyclic,L,CO-C4H9 = pentanoyl,10,Anti-plant-pathogenic bacteria and fungi,62 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6670,27008420,2016,KKLKK(CO-isoC5H11)FKKLQ,KKLKK({nnr:CO-isoC5H11})FKKLQ{cyc:N-C},BPC504,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,89 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6671,27008420,2016,KKLKK(CO-nC5H11)FKKLQ,KKLKK({nnr:CO-nC5H11})FKKLQ{cyc:N-C},BPC528,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,98 ± 7 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6672,27008420,2016,KKLKK(LK-CO-nC5H11)FKKLQ,KKLKK(LK-{nnr:CO-nC5H11})FKKLQ{cyc:N-C},BPC596,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,93 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6673,27008420,2016,KKLKK(CO-C6H13)FKKLQ,KKLKK({nnr:CO-C6H13})FKKLQ{cyc:N-C},BPC592,Free,Free,Cyclic,L,CO-C6H13 = 2-methylhexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6674,27008420,2016,KKLKK(CO-C8H17)FKKLQ,KKLKK({nnr:CO-C8H17})FKKLQ{cyc:N-C},BPC594,Free,Free,Cyclic,L,CO-C8H17 = 4-methyloctanoyl,10,Anti-plant-pathogenic bacteria and fungi,93 ± 11 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6675,27008420,2016,KKLKK(CO-C11H23)FKKLQ,KKLKK({nnr:CO-C11H23})FKKLQ{cyc:N-C},BPC530,Free,Free,Cyclic,L,CO-C11H23 = lauroyl,10,Anti-plant-pathogenic bacteria and fungi,89 ± 7 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6676,27008420,2016,KKLKK(CO-C11H22OH)FKKLQ,KKLKK({nnr:CO-C11H22OH})FKKLQ{cyc:N-C},BPC524,Free,Free,Cyclic,L,CO-C11H22OH = 12-hydroxylauroyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 8 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6677,27008420,2016,KKLKK(CO-C15H31)FKKLQ,KKLKK({nnr:CO-C15H31})FKKLQ{cyc:N-C},BPC502,Free,Free,Cyclic,L,CO-C15H31 = palmitoyl,10,Anti-plant-pathogenic bacteria and fungi,78 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6678,27008420,2016,KKLKK(CO-C17H33)FKKLQ,KKLKK({nnr:CO-C17H33})FKKLQ{cyc:N-C},BPC622,Free,Free,Cyclic,L,CO-C17H33 = oleoyl,10,Anti-plant-pathogenic bacteria and fungi,91 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6679,27008420,2016,KKLKKFKK(CO-nC5H11)LQ,KKLKKFKK({nnr:CO-nC5H11})LQ{cyc:N-C},BPC582,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,92 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6680,27008420,2016,KKLKKFK(CO-nC5H11)KLQ,KKLKKFK({nnr:CO-nC5H11})KLQ{cyc:N-C},BPC584,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,72 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6681,27008420,2016,KKLK(CO-nC5H11)KFKKLQ,KKLK({nnr:CO-nC5H11})KFKKLQ{cyc:N-C},BPC586,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,92 ± 9 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6682,27008420,2016,KK(CO-nC5H11)LKKFKKLQ,KK({nnr:CO-nC5H11})LKKFKKLQ{cyc:N-C},BPC588,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,95 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6683,27008420,2016,KK(CO-C3H7)LKKFKKLQ,KK({nnr:CO-C3H7})LKKFKKLQ{cyc:N-C},BPC708,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,2 ± 0.5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6684,27008420,2016,K(CO-nC5H11)KLKKFKKLQ,K({nnr:CO-nC5H11})KLKKFKKLQ{cyc:N-C},BPC590,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 9 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6685,27008420,2016,K(CO-C3H7)KLKKFKKLQ,K({nnr:CO-C3H7})KLKKFKKLQ{cyc:N-C},BPC710,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,7 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6686,27008420,2016,KKLKK(CO-C3H7)fKKLQ,KKLKK{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC712,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,30 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6687,27008420,2016,KKLKK(LK-CO-C3H7)fKKLQ,KKLKKLK-{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC726,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,0 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6688,27008420,2016,KKLKK(CO-nC5H11)fKKLQ,KKLKK{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC624,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,53 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6689,27008420,2016,KKLKK(CO-isoC5H11)fKKLQ,KKLKK{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC626,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,51 ± 7 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6690,27008420,2016,KKLKK(LK-CO-nC5H11)fKKLQ,KKLKKLK-{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC674,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,51 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6691,27008420,2016,KKLKK(CO-C7H15)fKKLQ,KKLKK{nnr:CO-C7H15}F{d}KKLQ{cyc:N-C},BPC668,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,79 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6692,27008420,2016,KK(CO-C3H7)LKKfKKLQ,KK{nnr:CO-C3H7}LKKF{d}KKLQ{cyc:N-C},BPC714,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6693,27008420,2016,KK(CO-nC5H11)LKKfKKLQ,KK{nnr:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C},BPC680,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,77 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6694,27008420,2016,K(CO-C3H7)KLKKfKKLQ,K{nnr:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C},BPC716,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,2 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6695,27008420,2016,K(CO-nC5H11)KLKKfKKLQ,K{nnr:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C},BPC686,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,10 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6696,27008420,2016,KKLKk(CO-C3H7)FKKLQ,KKLKK{d}{nnr:CO-C3H7}FKKLQ{cyc:N-C},BPC702,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,1 ± 0.1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6697,27008420,2016,KKLKk(LK-CO-C3H7)FKKLQ,KKLKK{d}LK-{nnr:CO-C3H7}FKKLQ{cyc:N-C},BPC724,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,3 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6698,27008420,2016,KKLKk(CO-nC5H11)FKKLQ,KKLKK{d}{nnr:CO-nC5H11}FKKLQ{cyc:N-C},BPC628,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,19 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6699,27008420,2016,KKLKk(CO-isoC5H11)FKKLQ,KKLKK{d}{nnr:CO-isoC5H11}FKKLQ{cyc:N-C},BPC630,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,22 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6700,27008420,2016,KKLKk(LK-CO-nC5H11)FKKLQ,KKLKK{d}LK-{nnr:CO-nC5H11}FKKLQ{cyc:N-C},BPC672,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,33 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6701,27008420,2016,KKLKk(CO-C7H15)FKKLQ,KKLKK{d}{nnr:CO-C7H15}FKKLQ{cyc:N-C},BPC666,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,61 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6702,27008420,2016,Kk(CO-nC5H11)LKKFKKLQ,KK{d}{nnr:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC678,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,68 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6703,27008420,2016,Kk(CO-C3H7)LKKFKKLQ,KK{d}{nnr:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC704,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,9 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6704,27008420,2016,k(CO-nC5H11)KLKKFKKLQ,K{d}{nnr:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC684,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,8 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6705,27008420,2016,k(CO-C3H7)KLKKFKKLQ,K{d}{nnr:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC706,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,35 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6706,27008420,2016,KKLKk(CO-nC5H11)fKKLQ,KKLKK{d}{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC632,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,21 ± 13 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6707,27008420,2016,KKLKk(CO-isoC5H11)fKKLQ,KKLKK{d}{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC634,Free,Free,Cyclic,Mix,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,7 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6708,27008420,2016,KKLKK(CO-C3H7)HKKLQ,KKLKK({nnr:CO-C3H7})HKKLQ{cyc:N-C},BPC718,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6709,27008420,2016,KKLKK(LK-CO-C3H7)HKKLQ,KKLKK(LK-{nnr:CO-C3H7})HKKLQ{cyc:N-C},BPC728,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,12,Anti-plant-pathogenic bacteria and fungi,0 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Non-hemolytic
6710,27008420,2016,KKLKK(CO-nC5H11)HKKLQ,KKLKK({nnr:CO-nC5H11})HKKLQ{cyc:N-C},BPC636,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,5 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6711,27008420,2016,KKLKK(CO-isoC5H11)HKKLQ,KKLKK({nnr:CO-isoC5H11})HKKLQ{cyc:N-C},BPC638,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,6 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6712,27008420,2016,KKLKK(LK-CO-nC5H11)HKKLQ,KKLKK(LK-{nnr:CO-nC5H11})HKKLQ{cyc:N-C},BPC676,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,3 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6713,27008420,2016,KKLKK(CO-C7H15)HKKLQ,KKLKK({nnr:CO-C7H15})HKKLQ{cyc:N-C},BPC670,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,34 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6714,27008420,2016,KK(CO-nC5H11)LKKHKKLQ,KK({nnr:CO-nC5H11})LKKHKKLQ{cyc:N-C},BPC682,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,20 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6715,27008420,2016,KK(CO-C3H7)LKKHKKLQ,KK({nnr:CO-C3H7})LKKHKKLQ{cyc:N-C},BPC720,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6716,27008420,2016,K(CO-nC5H11)KLKKHKKLQ,K({nnr:CO-nC5H11})KLKKHKKLQ{cyc:N-C},BPC688,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,1 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6717,27008420,2016,K(CO-C3H7)KLKKHKKLQ,K({nnr:CO-C3H7})KLKKHKKLQ{cyc:N-C},BPC722,Free,Free,Cyclic,L,CO-C3H7= butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6718,27008420,2016,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Anti-plant-pathogenic bacteria and fungi,6 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6719,27008420,2016,KKLKK(CO-C7H15)FKKLQ,KKLKK({nnr:CO-C7H15})FKKLQ{cyc:N-C},BPC498,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 12 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6720,27008420,2016,KKLKK(CO-C3H7)FKKLQ,KKLKK({nnr:CO-C3H7})FKKLQ{cyc:N-C},BPC500,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,38 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6721,27008420,2016,KKLKK(CO-C4H9)FKKLQ,KKLKK({nnr:CO-C4H9})FKKLQ{cyc:N-C},BPC526,Free,Free,Cyclic,L,CO-C4H9 = pentanoyl,10,Anti-plant-pathogenic bacteria and fungi,78 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6722,27008420,2016,KKLKK(CO-isoC5H11)FKKLQ,KKLKK({nnr:CO-isoC5H11})FKKLQ{cyc:N-C},BPC504,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,93 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6723,27008420,2016,KKLKK(CO-nC5H11)FKKLQ,KKLKK({nnr:CO-nC5H11})FKKLQ{cyc:N-C},BPC528,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6724,27008420,2016,KKLKK(LK-CO-nC5H11)FKKLQ,KKLKK(LK-{nnr:CO-nC5H11})FKKLQ{cyc:N-C},BPC596,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,100 ± 11 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6725,27008420,2016,KKLKK(CO-C6H13)FKKLQ,KKLKK({nnr:CO-C6H13})FKKLQ{cyc:N-C},BPC592,Free,Free,Cyclic,L,CO-C6H13 = 2-methylhexanoyl,10,Anti-plant-pathogenic bacteria and fungi,98 ± 6 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6726,27008420,2016,KKLKK(CO-C8H17)FKKLQ,KKLKK({nnr:CO-C8H17})FKKLQ{cyc:N-C},BPC594,Free,Free,Cyclic,L,CO-C8H17 = 4-methyloctanoyl,10,Anti-plant-pathogenic bacteria and fungi,96 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6727,27008420,2016,KKLKK(CO-C11H23)FKKLQ,KKLKK({nnr:CO-C11H23})FKKLQ{cyc:N-C},BPC530,Free,Free,Cyclic,L,CO-C11H23 = lauroyl,10,Anti-plant-pathogenic bacteria and fungi,91 ± 9 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6728,27008420,2016,KKLKK(CO-C11H22OH)FKKLQ,KKLKK({nnr:CO-C11H22OH})FKKLQ{cyc:N-C},BPC524,Free,Free,Cyclic,L,CO-C11H22OH = 12-hydroxylauroyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 6 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6729,27008420,2016,KKLKK(CO-C15H31)FKKLQ,KKLKK({nnr:CO-C15H31})FKKLQ{cyc:N-C},BPC502,Free,Free,Cyclic,L,CO-C15H31 = palmitoyl,10,Anti-plant-pathogenic bacteria and fungi,99 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6730,27008420,2016,KKLKK(CO-C17H33)FKKLQ,KKLKK({nnr:CO-C17H33})FKKLQ{cyc:N-C},BPC622,Free,Free,Cyclic,L,CO-C17H33 = oleoyl,10,Anti-plant-pathogenic bacteria and fungi,97 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6731,27008420,2016,KKLKKFKK(CO-nC5H11)LQ,KKLKKFKK({nnr:CO-nC5H11})LQ{cyc:N-C},BPC582,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,96 ± 10 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6732,27008420,2016,KKLKKFK(CO-nC5H11)KLQ,KKLKKFK({nnr:CO-nC5H11})KLQ{cyc:N-C},BPC584,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,97 ± 12 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6733,27008420,2016,KKLK(CO-nC5H11)KFKKLQ,KKLK({nnr:CO-nC5H11})KFKKLQ{cyc:N-C},BPC586,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,95 ± 20 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6734,27008420,2016,KK(CO-nC5H11)LKKFKKLQ,KK({nnr:CO-nC5H11})LKKFKKLQ{cyc:N-C},BPC588,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,92 ± 12 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6735,27008420,2016,KK(CO-C3H7)LKKFKKLQ,KK({nnr:CO-C3H7})LKKFKKLQ{cyc:N-C},BPC708,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6736,27008420,2016,K(CO-nC5H11)KLKKFKKLQ,K({nnr:CO-nC5H11})KLKKFKKLQ{cyc:N-C},BPC590,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 9 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6737,27008420,2016,K(CO-C3H7)KLKKFKKLQ,K({nnr:CO-C3H7})KLKKFKKLQ{cyc:N-C},BPC710,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,13 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6738,27008420,2016,KKLKK(CO-C3H7)fKKLQ,KKLKK{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC712,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,38 ± 7 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6739,27008420,2016,KKLKK(LK-CO-C3H7)fKKLQ,KKLKKLK-{nnr:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC726,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,4 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6740,27008420,2016,KKLKK(CO-nC5H11)fKKLQ,KKLKK{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC624,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,64 ± 9 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6741,27008420,2016,KKLKK(CO-isoC5H11)fKKLQ,KKLKK{nnr:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC626,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,54 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6742,27008420,2016,KKLKK(LK-CO-nC5H11)fKKLQ,KKLKKLK-{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC674,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,56 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6743,27008420,2016,KKLKK(CO-C7H15)fKKLQ,KKLKK{nnr:CO-C7H15}F{d}KKLQ{cyc:N-C},BPC668,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,79 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6744,27008420,2016,KK(CO-C3H7)LKKfKKLQ,KK{nnr:CO-C3H7}LKKF{d}KKLQ{cyc:N-C},BPC714,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,3 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6745,27008420,2016,KK(CO-nC5H11)LKKfKKLQ,KK{nnr:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C},BPC680,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,81 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6746,27008420,2016,K(CO-C3H7)KLKKfKKLQ,K{nnr:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C},BPC716,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,4 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6747,27008420,2016,K(CO-nC5H11)KLKKfKKLQ,K{nnr:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C},BPC686,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,14 ± 0.4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6748,27008420,2016,KKLKk(CO-C3H7)FKKLQ,KKLKK{d}{nnr:CO-C3H7}FKKLQ{cyc:N-C},BPC702,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,2 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6749,27008420,2016,KKLKk(LK-CO-C3H7)FKKLQ,KKLKK{d}LK-{nnr:CO-C3H7}FKKLQ{cyc:N-C},BPC724,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,3 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6750,27008420,2016,KKLKk(CO-nC5H11)FKKLQ,KKLKK{d}{nnr:CO-nC5H11}FKKLQ{cyc:N-C},BPC628,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,34 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6751,27008420,2016,KKLKk(CO-isoC5H11)FKKLQ,KKLKK{d}{nnr:CO-isoC5H11}FKKLQ{cyc:N-C},BPC630,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,28 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6752,27008420,2016,KKLKk(LK-CO-nC5H11)FKKLQ,KKLKK{d}LK-{nnr:CO-nC5H11}FKKLQ{cyc:N-C},BPC672,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,33 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6753,27008420,2016,KKLKk(CO-C7H15)FKKLQ,KKLKK{d}{nnr:CO-C7H15}FKKLQ{cyc:N-C},BPC666,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,73 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6754,27008420,2016,Kk(CO-nC5H11)LKKFKKLQ,KK{d}{nnr:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC678,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,73 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6755,27008420,2016,Kk(CO-C3H7)LKKFKKLQ,KK{d}{nnr:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC704,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,16 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6756,27008420,2016,k(CO-nC5H11)KLKKFKKLQ,K{d}{nnr:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC684,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,13 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6757,27008420,2016,k(CO-C3H7)KLKKFKKLQ,K{d}{nnr:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC706,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,46 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6758,27008420,2016,KKLKk(CO-nC5H11)fKKLQ,KKLKK{d}{nnr:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC632,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,22 ± 10 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6759,27008420,2016,KKLKk(CO-isoC5H11)fKKLQ,KKLKK{d}({nnr:CO-isoC5H11})F{d}KKLQ{cyc:N-C},BPC634,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,17 ± 8 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6760,27008420,2016,KKLKK(CO-C3H7)HKKLQ,KKLKK({nnr:CO-C3H7})HKKLQ{cyc:N-C},BPC718,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,4 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6761,27008420,2016,KKLKK(LK-CO-C3H7)HKKLQ,KKLKK(LK-{nnr:CO-C3H7})HKKLQ{cyc:N-C},BPC728,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,12,Anti-plant-pathogenic bacteria and fungi,7 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6762,27008420,2016,KKLKK(CO-nC5H11)HKKLQ,KKLKK({nnr:CO-nC5H11})HKKLQ{cyc:N-C},BPC636,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,16 ± 5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6763,27008420,2016,KKLKK(CO-isoC5H11)HKKLQ,KKLKK({nnr:CO-isoC5H11})HKKLQ{cyc:N-C},BPC638,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,8 ± 5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6764,27008420,2016,KKLKK(LK-CO-nC5H11)HKKLQ,KKLKK(LK-{nnr:CO-nC5H11})HKKLQ{cyc:N-C},BPC676,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6765,27008420,2016,KKLKK(CO-C7H15)HKKLQ,KKLKK({nnr:CO-C7H15})HKKLQ{cyc:N-C},BPC670,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,40 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6766,27008420,2016,KK(CO-nC5H11)LKKHKKLQ,KK({nnr:CO-nC5H11})LKKHKKLQ{cyc:N-C},BPC682,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,27 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6767,27008420,2016,KK(CO-C3H7)LKKHKKLQ,KK({nnr:CO-C3H7})LKKHKKLQ{cyc:N-C},BPC720,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,4 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6768,27008420,2016,K(CO-nC5H11)KLKKHKKLQ,K({nnr:CO-nC5H11})KLKKHKKLQ{cyc:N-C},BPC688,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,1 ± 0.2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Non-hemolytic
6769,27008420,2016,K(CO-C3H7)KLKKHKKLQ,K({nnr:CO-C3H7})KLKKHKKLQ{cyc:N-C},BPC722,Free,Free,Cyclic,L,CO-C3H7= butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 0.1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic
6770,26450121,2016,GIHDILKYGKPS,GIHDILKYGKPS,Myxinidin,Free,Free,Linear,L,None,12,Anti‑biofilm,0 % Hemolysis at 50-400 µM,Human,Epidermal Mucus Of The Hagfish,α-Helical,Non-hemolytic
6771,26450121,2016,GIHHILKYGKPS,GIHHILKYGKPS,Myxinidin 1,Free,Free,Linear,L,None,12,Anti‑biofilm,0 % Hemolysis at 50-400 µM,Human,Epidermal Mucus Of The Hagfish,α-Helical,Non-hemolytic
6772,26450121,2016,KIKWILKYWKWS,KIKWILKYWKWS,Myxinidin 2,Free,Free,Linear,L,None,12,Anti‑biofilm,10 % Hemolysis at 50 µM,Human,Myxinidin Analogs,α-Helical,NA
6773,26450121,2016,KIKWILKYWKWS,KIKWILKYWKWS,Myxinidin 2,Free,Free,Linear,L,None,12,Anti‑biofilm,<20 % Hemolysis at 100 µM,Human,Myxinidin Analogs,α-Helical,NA
6774,26450121,2016,KIKWILKYWKWS,KIKWILKYWKWS,Myxinidin 2,Free,Free,Linear,L,None,12,Anti‑biofilm,30 % Hemolysis at 200 µM,Human,Myxinidin Analogs,α-Helical,NA
6775,26450121,2016,KIKWILKYWKWS,KIKWILKYWKWS,Myxinidin 2,Free,Free,Linear,L,None,12,Anti‑biofilm,50 % Hemolysis at 400 µM,Human,Myxinidin Analogs,α-Helical,NA
6776,26450121,2016,RIRWILRYWRWS,RIRWILRYWRWS,Myxinidin 3,Free,Free,Linear,L,None,12,Anti‑biofilm,12 % Hemolysis at 25 µM,Human,Myxinidin Analogs,α-Helical,NA
6777,26450121,2016,RIRWILRYWRWS,RIRWILRYWRWS,Myxinidin 4,Free,Free,Linear,L,None,12,Anti‑biofilm,30 % Hemolysis at 50 µM,Human,Myxinidin Analogs,α-Helical,NA
6778,26450121,2016,RIRWILRYWRWS,RIRWILRYWRWS,Myxinidin 5,Free,Free,Linear,L,None,12,Anti‑biofilm,<50 % Hemolysis at 100 µM,Human,Myxinidin Analogs,α-Helical,NA
6779,26450121,2016,RIRWILRYWRWS,RIRWILRYWRWS,Myxinidin 6,Free,Free,Linear,L,None,12,Anti‑biofilm,60 % Hemolysis at 200 µM,Human,Myxinidin Analogs,α-Helical,NA
6780,26450121,2016,RIRWILRYWRWS,RIRWILRYWRWS,Myxinidin 7,Free,Free,Linear,L,None,12,Anti‑biofilm,~60 % Hemolysis at 400 µM,Human,Myxinidin Analogs,α-Helical,NA
6781,25546564,2016,VRPPPASKSL,VRPPPASKSL,1,Free,Free,Linear,L,None,10,Antioxidant,<25 % Hemolysis at 1 mg/mL,Rat,Synthetic,NA,NA
6782,25546564,2016,LPGGGHGDL,LPGGGHGDL,2,Free,Free,Linear,L,None,10,Antioxidant,<35 % Hemolysis at 1 mg/mL,Rat,Synthetic,NA,NA
6783,25546564,2016,FLKMN,FLKMN,3,Free,Free,Linear,L,None,5,Antioxidant,35 % Hemolysis at 1 mg/mL,Rat,Synthetic,NA,NA
6784,25546564,2016,GKFNV,GKFNV,4,Free,Free,Linear,L,None,5,Antioxidant,<35 % Hemolysis at 1 mg/mL,Rat,Synthetic,NA,NA
6785,25546564,2016,LPGGGT,LPGGGT,5,Free,Free,Linear,L,None,6,Antioxidant,<45 % Hemolysis at 1 mg/mL,Rat,Synthetic,NA,NA
6786,25546564,2016,HA,HA,6,Free,Free,Linear,L,None,2,Antioxidant,45 % Hemolysis at 1 mg/mL,Rat,Synthetic,NA,NA
6787,25546564,2016,KEER,KEER,7,Free,Free,Linear,L,None,4,Antioxidant,<40 % Hemolysis at 1 mg/mL,Rat,Synthetic,NA,NA
7237,28126555,2017,RCGNQQFKVFVNGQ,RCGNQQFKVFVNGQ,G4,Free,Free,Linear,L,None,14,Batericidal,0 % Hemolysis at 100 µM,Fish,Channa Striatus,α-Helix,Non-hemolytic
7238,28126555,2017,RCGNQQFKVFVNGQWWWWW,RCGNQQFKVFVNGQWWWWW,G4W,Free,Free,Linear,L,None,19,Batericidal,0 % Hemolysis at 100 µM,Fish,Fish Galectin 4 Derived Membrane,α-Helix,Non-hemolytic
7293,28004513,2017,GVSRCLSRRGVSRCLSRR,GVSRCLSRRGVSRCLSRR,2Ser_L,Free,Free,Linear,L,None,12,Antitumour,0.0 ± 0.4 % Hemolysis at 5 μg/ml,Human,Synthesized Θ-Defensin Analogues,NA,Non-hemolytic
7294,28004513,2017,GVSRCLSRRGVSRCLSRR,GVSRCLSRRGVSRCLSRR,2Ser_L,Free,Free,Linear,L,None,12,Antitumour,0.0 ± 0.5 % Hemolysis at 10 μg/ml,Human,Synthesized Θ-Defensin Analogues,NA,Non-hemolytic
7295,28004513,2017,GVSRCLSRRGVSRCLSRR,GVSRCLSRRGVSRCLSRR,2Ser_L,Free,Free,Linear,L,None,12,Antitumour,0.0 ± 0.1 % Hemolysis at 25 μg/ml,Human,Synthesized Θ-Defensin Analogues,NA,Non-hemolytic
7349,28608418,2017,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,OA-A1,Free,Free,Linear,L,None,20,Anti-diabetic,1.82% ± 0.14 % Hemolysis at 1 nM,Human,Skin Secretions Of Odorrana Andersonii,NA,NA
7350,28608418,2017,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,OA-A1,Free,Free,Linear,L,None,20,Anti-diabetic,2.82% ± 0.17 % Hemolysis at 10 nM,Human,Skin Secretions Of Odorrana Andersonii,NA,NA
7351,28608418,2017,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,OA-A1,Free,Free,Linear,L,None,20,Anti-diabetic,1.03% ± 0.86 % Hemolysis at 100 nM,Human,Skin Secretions Of Odorrana Andersonii,NA,NA
7352,28608418,2017,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,OA-A1,Free,Free,Linear,L,None,20,Anti-diabetic,2.72% ± 0.54 % Hemolysis at 1 µM,Human,Skin Secretions Of Odorrana Andersonii,NA,NA
7353,28608418,2017,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,OA-A1,Free,Free,Linear,L,None,20,Anti-diabetic,2.58% ± 0.11 % Hemolysis at 10 µM,Human,Skin Secretions Of Odorrana Andersonii,NA,NA
7354,28608418,2017,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,OA-A1,Free,Free,Linear,L,None,20,Anti-diabetic,1.26% ± 0.39 % Hemolysis at 100 µM,Human,Skin Secretions Of Odorrana Andersonii,NA,NA
7377,28883642,2017,LCLRNWDQGHRP,LCLRNWDQGHRP,L12P,Free,Free,Linear,L,None,12,Fungicidal,0.32 % Hemolysis at 50 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7378,28883642,2017,LCLRNWDQGHRP,LCLRNWDQGHRP,L12P,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 50 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7379,28883642,2017,LCLRNWDQGHRP,LCLRNWDQGHRP,L12P,Free,Free,Linear,L,None,12,Fungicidal,0.16 % Hemolysis at 100 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7380,28883642,2017,LCLRNWDQGHRP,LCLRNWDQGHRP,L12P,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 100 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7381,28883642,2017,LCLRNWDQGHRP,LCLRNWDQGHRP,L12P,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 250 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7382,28883642,2017,LCLRNWDQGHRP,LCLRNWDQGHRP,L12P,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 250 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7383,28883642,2017,LCLRNWDQGHRP,LCLRNWDQGHRP,L12P,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 500 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7384,28883642,2017,LCLRNWDQGHRP,LCLRNWDQGHRP,L12P,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 500 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7385,28883642,2017,WTFGQGTKVEIK,WTFGQGTKVEIK,W12K,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 50 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7386,28883642,2017,WTFGQGTKVEIK,WTFGQGTKVEIK,W12K,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 50 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7387,28883642,2017,WTFGQGTKVEIK,WTFGQGTKVEIK,W12K,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 100 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7388,28883642,2017,WTFGQGTKVEIK,WTFGQGTKVEIK,W12K,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 100 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7389,28883642,2017,WTFGQGTKVEIK,WTFGQGTKVEIK,W12K,Free,Free,Linear,L,None,12,Fungicidal,0.21 % Hemolysis at 250 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7390,28883642,2017,WTFGQGTKVEIK,WTFGQGTKVEIK,W12K,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 250 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7391,28883642,2017,WTFGQGTKVEIK,WTFGQGTKVEIK,W12K,Free,Free,Linear,L,None,12,Fungicidal,0.16 % Hemolysis at 500 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7392,28883642,2017,WTFGQGTKVEIK,WTFGQGTKVEIK,W12K,Free,Free,Linear,L,None,12,Fungicidal,0 % Hemolysis at 500 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7393,28883642,2017,GYCSGGSCYS,GYCSGGSCYS,G10S,Free,Free,Linear,L,None,10,Fungicidal,0 % Hemolysis at 50 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7394,28883642,2017,GYCSGGSCYS,GYCSGGSCYS,G10S,Free,Free,Linear,L,None,10,Fungicidal,0.59 % Hemolysis at 50 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7395,28883642,2017,GYCSGGSCYS,GYCSGGSCYS,G10S,Free,Free,Linear,L,None,10,Fungicidal,0 % Hemolysis at 100 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7396,28883642,2017,GYCSGGSCYS,GYCSGGSCYS,G10S,Free,Free,Linear,L,None,10,Fungicidal,0 % Hemolysis at 100 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7397,28883642,2017,GYCSGGSCYS,GYCSGGSCYS,G10S,Free,Free,Linear,L,None,10,Fungicidal,0.11 % Hemolysis at 250 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7398,28883642,2017,GYCSGGSCYS,GYCSGGSCYS,G10S,Free,Free,Linear,L,None,10,Fungicidal,0.51 % Hemolysis at 250 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7399,28883642,2017,GYCSGGSCYS,GYCSGGSCYS,G10S,Free,Free,Linear,L,None,10,Fungicidal,0.53 % Hemolysis at 500 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7400,28883642,2017,GYCSGGSCYS,GYCSGGSCYS,G10S,Free,Free,Linear,L,None,10,Fungicidal,0.98 % Hemolysis at 500 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7401,28883642,2017,LLVLRSLGPWHPGHCLLR,LLVLRSLGPWHPGHCLLR,L18R,Free,Free,Linear,L,None,18,Fungicidal,0 % Hemolysis at 50 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7402,28883642,2017,LLVLRSLGPWHPGHCLLR,LLVLRSLGPWHPGHCLLR,L18R,Free,Free,Linear,L,None,18,Fungicidal,4.4 % Hemolysis at 50 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7403,28883642,2017,LLVLRSLGPWHPGHCLLR,LLVLRSLGPWHPGHCLLR,L18R,Free,Free,Linear,L,None,18,Fungicidal,0 % Hemolysis at 100 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7404,28883642,2017,LLVLRSLGPWHPGHCLLR,LLVLRSLGPWHPGHCLLR,L18R,Free,Free,Linear,L,None,18,Fungicidal,5.8 % Hemolysis at 100 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7405,28883642,2017,LLVLRSLGPWHPGHCLLR,LLVLRSLGPWHPGHCLLR,L18R,Free,Free,Linear,L,None,18,Fungicidal,0 % Hemolysis at 250 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7406,28883642,2017,LLVLRSLGPWHPGHCLLR,LLVLRSLGPWHPGHCLLR,L18R,Free,Free,Linear,L,None,18,Fungicidal,7.54 % Hemolysis at 250 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7407,28883642,2017,LLVLRSLGPWHPGHCLLR,LLVLRSLGPWHPGHCLLR,L18R,Free,Free,Linear,L,None,18,Fungicidal,0.2 % Hemolysis at 500 µM in 30min,Human,Synthetic,NA,Non-hemolytic
7408,28883642,2017,LLVLRSLGPWHPGHCLLR,LLVLRSLGPWHPGHCLLR,L18R,Free,Free,Linear,L,None,18,Fungicidal,9.66 % Hemolysis at 500 µM in 120min,Human,Synthetic,NA,Non-hemolytic
7424,28834399,2017,YaF{Cyn},YA{d}F{nnr:Cyn},1,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,0.8±0.1 % Hemolysis at 0 µM,Human,Synthetic Peptidomimetics,NA,NA
7425,28834399,2017,YaF{Cyn},YA{d}F{nnr:Cyn},1,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,2.2±0.0 % Hemolysis at 100 µM,Human,Synthetic Peptidomimetics,NA,NA
7426,28834399,2017,YaF{Cyn},YA{d}F{nnr:Cyn},1,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,2.4±0.1 % Hemolysis at 250 µM,Human,Synthetic Peptidomimetics,NA,NA
7427,28834399,2017,YaW{cyn},YA{d}W{cyn},2,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,1.1±0.0 % Hemolysis at 0 µM,Human,Synthetic Peptidomimetics,NA,NA
7428,28834399,2017,YaW{cyn},YA{d}W{cyn},2,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,1.7±0.0 % Hemolysis at 100 µM,Human,Synthetic Peptidomimetics,NA,NA
7429,28834399,2017,YaW{cyn},YA{d}W{cyn},2,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, a = D-Ala",3,Antitumour,2.4±0.0 % Hemolysis at 250 µM,Human,Synthetic Peptidomimetics,NA,NA
7430,28834399,2017,YtF{Cyn},YT{d}F{nnr:Cyn},3,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,1.2±0.1 % Hemolysis at 0 µM,Human,Synthetic Peptidomimetics,NA,NA
7431,28834399,2017,YtF{Cyn},YT{d}F{nnr:Cyn},3,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,1.8±0.1 % Hemolysis at 100 µM,Human,Synthetic Peptidomimetics,NA,NA
7432,28834399,2017,YtF{Cyn},YT{d}F{nnr:Cyn},3,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,1.8±0.1 % Hemolysis at 250 µM,Human,Synthetic Peptidomimetics,NA,NA
7433,28834399,2017,YtW{Cyn},YT{d}W{nnr:Cyn},4,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,0.8±0.1 % Hemolysis at 0 µM,Human,Synthetic Peptidomimetics,NA,NA
7434,28834399,2017,YtW{Cyn},YT{d}W{nnr:Cyn},4,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,1.0±0.1 % Hemolysis at 100 µM,Human,Synthetic Peptidomimetics,NA,NA
7435,28834399,2017,YtW{Cyn},YT{d}W{nnr:Cyn},4,Free,Free,Linear,Mix,"Cyn = trans-1-cinnamilpiperazine, t = D-Thr",3,Antitumour,0.9±0.0 % Hemolysis at 250 µM,Human,Synthetic Peptidomimetics,NA,NA
7508,28987278,2017,RSVSKSR,RSVSKSR,REPRSV,Free,Free,Linear,L,None,7,"LPS-neutralizing, angiogenic activities",4.6 % Hemolysis at 500 µM,Sheep,Peptic Hydrolysates Of Rice Endosperm Protein,NA,Non-hemolytic
7509,28987278,2017,RRVIEPR,RRVIEPR,REP-RRV,Free,Free,Linear,L,None,7,"LPS-neutralizing, angiogenic activities",2.5 % Hemolysis at 500 µM,Sheep,Peptic Hydrolysates Of Rice Endosperm Protein,NA,Non-hemolytic
7510,28987278,2017,ERFQPMFRRPG,ERFQPMFRRPG,REP-ERF,Free,Free,Linear,L,None,12,"LPS-neutralizing, angiogenic activities",3.2 % Hemolysis at 500 µM,Sheep,Peptic Hydrolysates Of Rice Endosperm Protein,NA,Non-hemolytic
7511,28987278,2017,RVRQNIDNPNRADTYNPRAG,RVRQNIDNPNRADTYNPRAG,REP-RVR,Free,Free,Linear,L,None,20,"LPS-neutralizing, angiogenic activities",9.5 % Hemolysis at 500 µM,Sheep,Peptic Hydrolysates Of Rice Endosperm Protein,NA,Non-hemolytic
8278,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P2,Free,Free,Linear,L,None,12,Antibiofilm,0.84 ± 1.42 % Hemolysis at 1 μg/mL,Human,Brevibacillus Strain,α-Helix,Non-hemolytic
8279,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P3,Free,Free,Linear,L,None,12,Antibiofilm,0 % Hemolysis at 2 μg/mL,Human,Brevibacillus Strain,α-Helix,Non-hemolytic
8280,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P4,Free,Free,Linear,L,None,12,Antibiofilm,0 % Hemolysis at 4 μg/mL,Human,Brevibacillus Strain,α-Helix,Non-hemolytic
8281,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P5,Free,Free,Linear,L,None,12,Antibiofilm,0 % Hemolysis at 8 μg/mL,Human,Brevibacillus Strain,α-Helix,Non-hemolytic
8282,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P6,Free,Free,Linear,L,None,12,Antibiofilm,<10 % Hemolysis at 16 μg/mL,Human,Brevibacillus Strain,α-Helix,Non-hemolytic
8283,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P7,Free,Free,Linear,L,None,12,Antibiofilm,10 % Hemolysis at 32 μg/mL,Human,Brevibacillus Strain,α-Helix,NA
8284,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P8,Free,Free,Linear,L,None,12,Antibiofilm,9.92 ± 1.04 % Hemolysis at 64 μg/mL,Human,Brevibacillus Strain,α-Helix,NA
8285,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P9,Free,Free,Linear,L,None,12,Antibiofilm,16.62 ± 0.85 % Hemolysis at 128 μg/mL,Human,Brevibacillus Strain,α-Helix,NA
8286,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P10,Free,Free,Linear,L,None,12,Antibiofilm,<40 % Hemolysis at 256 μg/mL,Human,Brevibacillus Strain,α-Helix,NA
8287,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P11,Free,Free,Linear,L,None,12,Antibiofilm,72.03 ± 5.61 % Hemolysis at 512 μg/mL,Human,Brevibacillus Strain,α-Helix,NA
8365,38097636,2023,KWKLFKKIGAVLKVL,KWKLFKKIGAVLKVL{ct:Amid},C(1–7)M(2–9),Amidation,Free,Linear,L,None,15,Antibioflm,50 % Hemolysis at 88.89±4.62 μg/mL,Human,Synthetic,α-Helical,NA
8366,38097636,2023,KWKLFKKIGKVLKVL,KWKLFKKIGKVLKVL{ct:Amid},CM-10K,Amidation,Free,Linear,L,None,15,Antibioflm,50 % Hemolysis at 85.78±9.01 μg/mL,Human,Synthetic,α-Helical,NA
8367,38097636,2023,KWKLFKKIGKVLKKL,KWKLFKKIGKVLKKL{ct:Amid},CM-10K14K,Amidation,Free,Linear,L,None,15,Antibioflm,50 % Hemolysis at 561.90±88.19 μg/mL,Human,Synthetic,α-Helical,NA
8368,38097636,2023,VWKLFKKIGKVLKKL,VWKLFKKIGKVLKKL{ct:Amid},CM-1V10K14K,Amidation,Free,Linear,L,None,15,Antibioflm,50 % Hemolysis at 118.90±8.19 μg/mL,Human,Synthetic,α-Helical,NA
8369,38097636,2023,VWKLFKKIGAVLKKL,VWKLFKKIGAVLKKL{ct:Amid},CM-1V14K,Amidation,Free,Linear,L,None,15,Antibioflm,50 % Hemolysis at 131.70±9.23 μg/mL,Human,Synthetic,α-Helical,NA
8370,38097636,2023,KWKLFKKIGAVLKVLA,KWKLFKKIGAVLKVLA{ct:Amid},CM-A,Amidation,Free,Linear,L,None,16,Antibioflm,50 % Hemolysis at 42.58±1.98 μg/mL,Human,Synthetic,α-Helical,NA
8378,38247578,2023,KGGDLGLFEPTL,KGGDLGLFEPTL,EYHp6,Free,Free,Linear,L,None,12,Anti-Salmonella,0 % Hemolysis at 4 mM,Human,Egg Yolk Hydrolysate,NA,Non-hemolytic
8379,38247578,2023,KGGDLGLFEPTL,KGGDLGLFEPTL,EYHp6,Free,Free,Linear,L,None,12,Anti-Salmonella,<20 % Hemolysis at 8 mM,Human,Egg Yolk Hydrolysate,NA,NA
8419,38467553,2024,GA-YYLK,{nnr:GA}-YYLK{ct:Amid},AB-10,Amidation,Free,Linear,L,GA = gallic acid,6,Antioxidant (Antiradical),0 % Hemolysis at 1000 μg/mL,Human,Synthetic,NA,Non-hemolytic
8420,38467553,2024,GA-YYLK,{nnr:GA}-YYLK{ct:Amid},AB-10,Amidation,Free,Linear,L,GA = gallic acid,6,Antioxidant (Antiradical),0 % Hemolysis at 500 μg/mL,Human,Synthetic,NA,Non-hemolytic
8421,38467553,2024,GA-YYLK,{nnr:GA}-YYLK{ct:Amid},AB-10,Amidation,Free,Linear,L,GA = gallic acid,6,Antioxidant (Antiradical),0 % Hemolysis at 100 μg/mL,Human,Synthetic,NA,Non-hemolytic
8422,38467553,2024,(GA-KKIRRLK),({nnr:GA}-KKIRRLK){ct:Amid},AB-11,Amidation,Free,Linear,L,GA = gallic acid,9,Antioxidant (Antiradical),<10 % Hemolysis at 1000 μg/mL,Human,Synthetic,NA,NA
8423,38467553,2024,(GA-KKIRRLK),({nnr:GA}-KKIRRLK){ct:Amid},AB-11,Amidation,Free,Linear,L,GA = gallic acid,9,Antioxidant (Antiradical),<10 % Hemolysis at 500 μg/mL,Human,Synthetic,NA,NA
8424,38467553,2024,(GA-KKIRRLK),({nnr:GA}-KKIRRLK){ct:Amid},AB-11,Amidation,Free,Linear,L,GA = gallic acid,9,Antioxidant (Antiradical),0 % Hemolysis at 100 μg/mL,Human,Synthetic,NA,Non-hemolytic
8425,38467553,2024,GA-KKIRARLKYAC,{nnr:GA}-KKIRARLKYAC{ct:Amid},AB-12,Amidation,Free,Linear,L,GA = gallic acid,13,Antioxidant (Antiradical),0 % Hemolysis at 1000 μg/mL,Human,Synthetic,NA,Non-hemolytic
8426,38467553,2024,GA-KKIRARLKYAC,{nnr:GA}-KKIRARLKYAC{ct:Amid},AB-12,Amidation,Free,Linear,L,GA = gallic acid,13,Antioxidant (Antiradical),0 % Hemolysis at 500 μg/mL,Human,Synthetic,NA,Non-hemolytic
8427,38467553,2024,GA-KKIRARLKYAC,{nnr:GA}-KKIRARLKYAC{ct:Amid},AB-12,Amidation,Free,Linear,L,GA = gallic acid,13,Antioxidant (Antiradical),0 % Hemolysis at 100 μg/mL,Human,Synthetic,NA,Non-hemolytic
8428,38467553,2024,RRRRRRRRKKKKKKKACAC,RRRRRRRRKKKKKKKACAC{ct:Amid},AB-13,Amidation,Free,Linear,L,None,19,Antioxidant (Antiradical),0 % Hemolysis at 1000 μg/mL,Human,Synthetic,NA,Non-hemolytic
8429,38467553,2024,RRRRRRRRKKKKKKKACAC,RRRRRRRRKKKKKKKACAC{ct:Amid},AB-13,Amidation,Free,Linear,L,None,19,Antioxidant (Antiradical),0 % Hemolysis at 500 μg/mL,Human,Synthetic,NA,Non-hemolytic
8430,38467553,2024,RRRRRRRRKKKKKKKACAC,RRRRRRRRKKKKKKKACAC{ct:Amid},AB-13,Amidation,Free,Linear,L,None,19,Antioxidant (Antiradical),0 % Hemolysis at 100 μg/mL,Human,Synthetic,NA,Non-hemolytic
8431,38467553,2024,(WKKIRVRLSWKKIRVRLS)KAC,(WKKIRVRLSWKKIRVRLS)KAC{ct:Amid},AB-14,Amidation,Free,Linear,L,None,21,Antioxidant (Antiradical),<20 % Hemolysis at 1000 μg/mL,Human,Synthetic,NA,NA
8432,38467553,2024,(WKKIRVRLSWKKIRVRLS)KAC,(WKKIRVRLSWKKIRVRLS)KAC{ct:Amid},AB-14,Amidation,Free,Linear,L,None,21,Antioxidant (Antiradical),10 % Hemolysis at 500 μg/mL,Human,Synthetic,NA,NA
8433,38467553,2024,(WKKIRVRLSWKKIRVRLS)KAC,(WKKIRVRLSWKKIRVRLS)KAC{ct:Amid},AB-14,Amidation,Free,Linear,L,None,21,Antioxidant (Antiradical),0 % Hemolysis at 100 μg/mL,Human,Synthetic,NA,Non-hemolytic
8434,38467553,2024,(GAKKIRARLKGAKKIRARLK)KYAC,({nnr:GA}KKIRARLK{nnr:GA}KKIRARLK)KYAC{ct:Amid},AB-15,Amidation,Free,Linear,L,GA = gallic acid,24,Antioxidant (Antiradical),<20 % Hemolysis at 1000 μg/mL,Human,Synthetic,NA,NA
8435,38467553,2024,(GAKKIRARLKGAKKIRARLK)KYAC,({nnr:GA}KKIRARLK{nnr:GA}KKIRARLK)KYAC{ct:Amid},AB-15,Amidation,Free,Linear,L,GA = gallic acid,24,Antioxidant (Antiradical),<10 % Hemolysis at 500 μg/mL,Human,Synthetic,NA,NA
8436,38467553,2024,(GAKKIRARLKGAKKIRARLK)KYAC,({nnr:GA}KKIRARLK{nnr:GA}KKIRARLK)KYAC{ct:Amid},AB-15,Amidation,Free,Linear,L,GA = gallic acid,24,Antioxidant (Antiradical),<10 % Hemolysis at 100 μg/mL,Human,Synthetic,NA,NA
8437,38467553,2024,(KKLRLKTAFKKKLRLKTAFK)KAC,(KKLRLKTAFKKKLRLKTAFK)KAC{ct:Amid},ST-10,Amidation,Free,Linear,L,None,23,Antioxidant (Antiradical),0 % Hemolysis at 1000 μg/mL,Human,Synthetic,NA,Non-hemolytic
8438,38467553,2024,(KKLRLKTAFKKKLRLKTAFK)KAC,(KKLRLKTAFKKKLRLKTAFK)KAC{ct:Amid},ST-10,Amidation,Free,Linear,L,None,23,Antioxidant (Antiradical),0 % Hemolysis at 500 μg/mL,Human,Synthetic,NA,Non-hemolytic
8439,38467553,2024,(KKLRLKTAFKKKLRLKTAFK)KAC,(KKLRLKTAFKKKLRLKTAFK)KAC{ct:Amid},ST-10,Amidation,Free,Linear,L,None,23,Antioxidant (Antiradical),0 % Hemolysis at 100 μg/mL,Human,Synthetic,NA,Non-hemolytic
8440,38467553,2024,GA-KK,{nnr:GA}-KK{ct:Amid},AST-1,Amidation,Free,Linear,L,GA = gallic acid,4,Antioxidant (Antiradical),0 % Hemolysis at 1000 μg/mL,Human,Synthetic,NA,Non-hemolytic
8441,38467553,2024,GA-KK,{nnr:GA}-KK{ct:Amid},AST-1,Amidation,Free,Linear,L,GA = gallic acid,4,Antioxidant (Antiradical),0 % Hemolysis at 500 μg/mL,Human,Synthetic,NA,Non-hemolytic
8442,38467553,2024,GA-KK,{nnr:GA}-KK{ct:Amid},AST-1,Amidation,Free,Linear,L,GA = gallic acid,4,Antioxidant (Antiradical),0 % Hemolysis at 100 μg/mL,Human,Synthetic,NA,Non-hemolytic
8473,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 0.19 µM,Human,Synthetic,α-Helical,NA
8474,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 0.39 µM,Human,Synthetic,α-Helical,NA
8475,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 0.78 µM,Human,Synthetic,α-Helical,NA
8476,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 1.56 µM,Human,Synthetic,α-Helical,NA
8477,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 3.12 µM,Human,Synthetic,α-Helical,NA
8478,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 6.25 µM,Human,Synthetic,α-Helical,NA
8479,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 12.5 µM,Human,Synthetic,α-Helical,NA
8480,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 25 µM,Human,Synthetic,α-Helical,NA
8481,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 50 µM,Human,Synthetic,α-Helical,NA
8482,38657271,2024,pKSRLHKWANDAicEDRTYQ,P{d}KSRLHKWAND{nnr:Aic}EDRTYQ{nt:Acet}{ct:Amid},SR16,Amidation,Acetylation,Linear,Mix,"p = D-Proline, Aic = α-aminoisobutyric acid",18,Antiviral,<5 % Hemolysis at 100 µM,Human,Synthetic,α-Helical,NA
8576,38399250,2024,FVVWGCADYRGSCRTACFAYEYSLGAKGCADGYICCVPNTFRLM,FVVWGCADYRGSCRTACFAYEYSLGAKGCADGYICCVPNTFRLM,CFBD-1,Free,Free,Linear,L,None,44,Antiviral,>100 % Hemolysis at 100 µM,Human,Salamandra Salamandra,NA,NA
8754,29136469,2017,DabVDabfLDabvLS,{nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2}{ct:Amid},C7Val2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.95 ± 0.45 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA
8756,29136469,2017,DabFDabfLDabvLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2}{ct:Amid},C7Phe2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,1.28 ± 1.65 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA
8761,29136469,2017,DabIDabfLDabvLDab,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3}{ct:Amid},Dab9-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,2.25 ± 2.18 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA
8762,29136469,2017,DabDabDabfLDabvLDab,{nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3}{ct:Amid},"Dab2,9-Pat",Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.80 ± 0.40 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8763,29136469,2017,OIOfLOvLS,{nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid},Orn-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Orn = Ornithine",9,ND = not detected,1.12 ± 0.47 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8765,29136469,2017,DabITlLDabvLS,{nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4}{ct:Amid},C10Thr3Leu4-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,24.9 ± 2.71 % Hemolysis at 128 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA
8771,29136469,2017,DabVDabfLDabvLS,{nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Val2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.79 ± 0.63 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8773,29136469,2017,DabFDabfLDabvLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.60 ± 1.35 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8778,29136469,2017,DabIDabfLDabvLDab,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},Dab9-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.73 ± 0.50 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8779,29136469,2017,DabDabDabfLDabvLDab,{nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},"Dab2,9-Pat",Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.41 ± 0.53 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8780,29136469,2017,OIOfLOvLS,{nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid}{nt:R3 = octanoyl}{ct:Amid},Orn-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Orn = Ornithine",9,ND = not detected,0.69 ± 0.64 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8782,29136469,2017,DabITlLDabvLS,{nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10Thr3Leu4-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,10.0 ± 1.03 % Hemolysis at 64 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA
8788,29136469,2017,DabVDabfLDabvLS,{nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Val2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.32 ± 0.74 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8790,29136469,2017,DabFDabfLDabvLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.49 ± 1.22 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8795,29136469,2017,DabIDabfLDabvLDab,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},Dab9-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.80 ± 0.68 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8796,29136469,2017,DabDabDabfLDabvLDab,{nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},"Dab2,9-Pat",Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.38 ± 0.62 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8797,29136469,2017,OIOfLOvLS,{nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid}{nt:R3 = octanoyl}{ct:Amid},Orn-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Orn = Ornithine",9,ND = not detected,0.44 ± 0.30 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8799,29136469,2017,DabITlLDabvLS,{nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10Thr3Leu4-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,5.06 ± 1.14 % Hemolysis at 32 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA
8805,29136469,2017,DabVDabfLDabvLS,{nnr:Dab}V{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Val2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,−0.17 ± 0.19 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8807,29136469,2017,DabFDabfLDabvLS,{nnr:Dab}F{nnr:Dab}F{d}L{nnr:Dab}V{d}LS{nt:R2 = heptanoyl}{ct:Amid},C7Phe2-Pat,Amidation,R2 = heptanoyl,Linear,Mix,"R2 = heptanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.28 ± 1.11 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8812,29136469,2017,DabIDabfLDabvLDab,{nnr:Dab}I{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},Dab9-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.52 ± 0.58 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8813,29136469,2017,DabDabDabfLDabvLDab,{nnr:Dab}{nnr:Dab}{nnr:Dab}F{d}L{nnr:Dab}V{d}L{nnr:Dab}{nt:R3 = octanoyl}{ct:Amid},"Dab2,9-Pat",Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,0.37 ± 0.62 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8814,29136469,2017,OIOfLOvLS,{nnr:O}I{nnr:O}F{d}L{nnr:O}V{d}LS{nt:R3}{ct:Amid}{nt:R3 = octanoyl}{ct:Amid},Orn-Pat,Amidation,R3 = octanoyl,Linear,Mix,"R3 = octanoyl, Orn = Ornithine",9,ND = not detected,0.86 ± 0.72 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,Low hemolytic
8816,29136469,2017,DabITlLDabvLS,{nnr:Dab}ITL{d}L{nnr:Dab}V{d}LS{nt:R4 = decanoyl}{ct:Amid},C10Thr3Leu4-Pat,Amidation,R4 = decanoyl,Linear,Mix,"R4 = decanoyl, Dab = 2,4-diaminobutyric acid",9,ND = not detected,1.25 ± 0.71 % Hemolysis at 16 μg/ml,Rabbit,Synthetic Paenipeptins Analogues,NA,NA
8824,29188836,2017,fPVRLfPVRL,F{d}PVRLF{d}PVRL{cyc:N-C},GS-2,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 10.03±0.49 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8825,29188836,2017,aPVRLfPVRL,A{d}PVRLF{d}PVRL{cyc:N-C},MGR-1,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 67.18±2.94 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8826,29188836,2017,fAVRLfPVRL,F{d}AVRLF{d}PVRL{cyc:N-C},MGR-2,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 55.03±1.77 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8827,29188836,2017,fPARLfPVRL,F{d}PARLF{d}PVRL{cyc:N-C},MGR-3,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 30.56±1.80 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8828,29188836,2017,fPVALfPVRL,F{d}PVALF{d}PVRL{cyc:N-C},MGR-4,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 14.41±0.51 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8829,29188836,2017,fPVRAfPVRL,F{d}PVRAF{d}PVRL{cyc:N-C},MGR-5,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 36.33±1.98 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8830,29188836,2017,aPVRLaPVRL,A{d}PVRLA{d}PVRL{cyc:N-C},DGR-1,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 137.40±6.20 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8831,29188836,2017,fAVRLfAVRL,F{d}AVRLF{d}AVRL{cyc:N-C},DGR-2,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 199.90±9.80 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8832,29188836,2017,fPARLfPARL,F{d}PARLF{d}PARL{cyc:N-C},DGR-3,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 88.95±7.51 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8833,29188836,2017,fPVALfPVAL,F{d}PVALF{d}PVAL{cyc:N-C},DGR-4,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at >200 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8834,29188836,2017,fPVRAfPVRA,F{d}PVRAF{d}PVRA{cyc:N-C},DGR-5,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at >200 (mean±SD, μM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic
8890,28650592,2018,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC{ct:disulfide bridge},OM-LV20,disulfide bridge,Free,Linear,L,None,20,Wound healing activity,0 % Hemolysis at 1 mM,Human,Frog(Odorrana Margaretae),NA,Non-hemolytic
8926,29205108,2018,WAGGFGVAGGAMALGGGIAAAVG,WAGGFGVAGGAMALGGGIAAAVG,α2 peptide,Free,Free,Linear,L,None,23,ND,~50 % Hemolysis at 100 μM,Sheep,Bordetella Pertussis (Bacteria)- Adenylate Cyclase Toxin (Cyaa),NA,NA
8927,29205108,2018,GAEIALQLTGGTVELASSIALALAAAR,GAEIALQLTGGTVELASSIALALAAAR,α3 peptide,Free,Free,Linear,L,None,27,ND,~5 % Hemolysis at 100 μM,Sheep,Bordetella Pertussis (Bacteria)- Adenylate Cyclase Toxin (Cyaa),NA,NA
8928,29205108,2018,WAGGFGVAGGAMALGGGIAAAVGAGMSLTDDAPAGQKAAAGAEIALQLTGGTVELASSIALALAAAR,WAGGFGVAGGAMALGGGIAAAVGAGMSLTDDAPAGQKAAAGAEIALQLTGGTVELASSIALALAAAR,α2-loop-α3 peptide,Free,Free,Linear,L,None,67,ND,~10 % Hemolysis at 100 μM,Sheep,Bordetella Pertussis (Bacteria)- Adenylate Cyclase Toxin (Cyaa),NA,NA
8933,28918200,2018,KIKEKLIEA,KIKEKLIEA{ct:Carboxyl (COO-)},Pep-5,Carboxyl (COO-),Free,Linear,L,None,9,ND,0 % Hemolysis at 125 μM,Rat,Scorpion Tityus Obscurus,NA,Non-hemolytic
8934,28918200,2018,KPVEPVG,KPVEPVG{ct:Carboxyl (COO-)},Pep-9,Carboxyl (COO-),Free,Linear,L,None,7,ND,~25 % Hemolysis at 125 μM,Rat,Scorpion Tityus Obscurus,NA,NA
8935,28918200,2018,VYWLPAVLGSLLGFTP,VYWLPAVLGSLLGFTP{ct:Carboxyl (COO-)},Pep-14,Carboxyl (COO-),Free,Linear,L,None,16,ND,0 % Hemolysis at 125 μM,Rat,Scorpion Tityus Obscurus,NA,Non-hemolytic
8936,28918200,2018,PHWLFFGVSVLC,PHWLFFGVSVLC{ct:Carboxyl (COO-)},Pep-16,Carboxyl (COO-),Free,Linear,L,None,12,ND,0 % Hemolysis at 125 μM,Rat,Scorpion Tityus Obscurus,NA,Non-hemolytic
8937,28918200,2018,VTLTLPPAES,VTLTLPPAES{ct:Amid},Pep-17,Amidation,Free,Linear,L,None,10,ND,0 % Hemolysis at 125 μM,Rat,Scorpion Tityus Obscurus,NA,Non-hemolytic
8938,28918200,2018,KETNAKPP,KETNAKPP{ct:Carboxyl (COO-)},Pep-18,Carboxyl (COO-),Free,Linear,L,None,8,ND,0 % Hemolysis at 125 μM,Rat,Scorpion Tityus Obscurus,NA,Non-hemolytic
8965,29343843,2018,IGRDPTWSHLAASCLKCIFDDLPKTHN,IGRDPTWSHLAASCLKCIFDDLPKTHN,Cathelicidin-OA1,Free,Free,Linear,L,None,27,Antioxidant activity,5.4 ± 0.14 % Hemolysis at 1 nM,Human,Frog (Odorrana Andersonii),NA,NA
8966,29343843,2018,IGRDPTWSHLAASCLKCIFDDLPKTHN,IGRDPTWSHLAASCLKCIFDDLPKTHN,Cathelicidin-OA1,Free,Free,Linear,L,None,27,Antioxidant activity,4.5 ± 0.61 % Hemolysis at 10 nM,Human,Frog (Odorrana Andersonii),NA,NA
8967,29343843,2018,IGRDPTWSHLAASCLKCIFDDLPKTHN,IGRDPTWSHLAASCLKCIFDDLPKTHN,Cathelicidin-OA1,Free,Free,Linear,L,None,27,Antioxidant activity,5.4 ± 0.81 % Hemolysis at 100 nM,Human,Frog (Odorrana Andersonii),NA,NA
8968,29343843,2018,IGRDPTWSHLAASCLKCIFDDLPKTHN,IGRDPTWSHLAASCLKCIFDDLPKTHN,Cathelicidin-OA1,Free,Free,Linear,L,None,27,Antioxidant activity,6.9 ± 0.57 % Hemolysis at 1 μM,Human,Frog (Odorrana Andersonii),NA,NA
8969,29343843,2018,IGRDPTWSHLAASCLKCIFDDLPKTHN,IGRDPTWSHLAASCLKCIFDDLPKTHN,Cathelicidin-OA1,Free,Free,Linear,L,None,27,Antioxidant activity,5.0 ± 0.86 % Hemolysis at 10 μM,Human,Frog (Odorrana Andersonii),NA,NA
8970,29343843,2018,IGRDPTWSHLAASCLKCIFDDLPKTHN,IGRDPTWSHLAASCLKCIFDDLPKTHN,Cathelicidin-OA1,Free,Free,Linear,L,None,27,Antioxidant activity,7.7 ± 0.11 % Hemolysis at 100 μM,Human,Frog (Odorrana Andersonii),NA,NA
8974,29359791,2018,ALAGTIIAGASLTFQVLDKVLEELGKVSRK,ALAGTIIAGASLTFQVLDKVLEELGKVSRK{ct:Amid},StII1-30,Amidation,Free,Linear,L,None,30,Candidacidal,50 % Hemolysis at 42.5 μM,Human,Derived From Sticholysin Ii (Sea Anemone Stichodactyla Helianthus),amphiphilic α-Helix,NA
8975,29359791,2018,VLDKVLEELGKVSRKIAVGI,VLDKVLEELGKVSRKIAVGI{ct:Amid},StII16-35,Amidation,Free,Linear,L,None,20,Candidacidal,50 % Hemolysis at 128 μM,Human,Derived From Sticholysin Ii (Sea Anemone Stichodactyla Helianthus),amphiphilic α-Helix,NA
9035,29249197,2018,RADARADARADARADA,RADARADARADARADA{nt:Acet}{ct:NHCOCH3},RADA 16-I hydrogels,NHCOCH3,Acetylation,Linear,L,Ac = N-acetyl (NHCOCH3),16,Hemostatic agent,0.78 ± 0.1 % Hemolysis at 0.1 w/v,Rabbit,Synthesised Monomer Peptide,β-Sheet at higher conc,Low hemolytic
9036,29249197,2018,RADARADARADARADA,RADARADARADARADA{nt:Acet}{ct:NHCOCH3},RADA 16-I hydrogels,NHCOCH3,Acetylation,Linear,L,Ac = N-acetyl (NHCOCH3),16,Hemostatic agent,1±0.1 % Hemolysis at 0.2 w/v,Rabbit,Synthesised Monomer Peptide,Betα-Sheet at higher conc,Low hemolytic
9037,29249197,2018,RADARADARADARADA,RADARADARADARADA{nt:Acet}{ct:NHCOCH3},RADA 16-I hydrogels,NHCOCH3,Acetylation,Linear,L,Ac = N-acetyl (NHCOCH3),16,Hemostatic agent,1.07±0.1 % Hemolysis at 0.3 w/v,Rabbit,Synthesised Monomer Peptide,Betα-Sheet at higher conc,Low hemolytic
9038,29249197,2018,RADARADARADARADA,RADARADARADARADA{nt:Acet}{ct:NHCOCH3},RADA 16-I hydrogels,NHCOCH3,Acetylation,Linear,L,Ac = N-acetyl (NHCOCH3),16,Hemostatic agent,1.1±0.1 % Hemolysis at 0.5 w/v,Rabbit,Synthesised Monomer Peptide,Betα-Sheet at higher conc,Low hemolytic
9129,29643444,2018,TVLRGCWTKSFPPKPCI,TVLRGCWTKSFPPKPCI{ct:Amid},K9-HECI,Amidation,Free,Linear,L,None,17,Anti-proliferation of cancer cells,~5 % Hemolysis at 128 µM,Horse,Analogue Of Heci,NA,Low hemolytic
9138,29670183,2018,IITHPNFNGNTLDNDIMLIK,IITHPNFNGNTLDNDIMLIK,Lunathrombase,Free,Free,Linear,L,None,20,"Anticoagulant, in-vitro thrombolytic activity, Antiplatelet",7.65 ± 0.53(m/mm3) % Hemolysis at 10 mg/kg,Goat,Serine Protease From Leaves Of Leucas Indica Plant,"e CD spectrum of lunathrombase demonstrated that it consists of 23.4% α-Helix, 17% Beta Sheets, with a Turn of 28.2% and 31% Random coils",Non-hemolytic
9166,29307075,2018,KWKLFKKIGAVLKVL (Cl−),KWKLFKKIGAVLKVL ({nnr:Cl−}){ct:Amid},CAMEL chloride,Amidation,Free,Linear,L,Cl− = Counter-ion chloride,15,Antistaphylococcal,65 % Hemolysis at 256 µg/mL,Human,Synthetic Peptide,NA,NA
9295,29752337,2018,GLLSGHYGRVVSTQSGHYGRG,GLLSGHYGRVVSTQSGHYGRG,OA-GL21,Free,Free,Linear,L,None,21,Wound-healing,0 % Hemolysis at 50 μM,Human,Frog Skin Secretions Of Odorrana Andersonii,"aqueous = Helical conformation, membrane-mimetic environments = Helical conformation",Non-hemolytic
9302,29799150,2018,EEEEAAAGkwklfkklpkflhlakkf,EEEEAAAGK{d}W{d}K{d}L{d}F{d}K{d}K{d}L{d}P{d}K{d}F{d}L{d}H{d}L{d}A{d}K{d}K{d}F{d}{nt:Acet}{ct:Amid},Pro‐P18,Amidation,Acetylation,Linear,Mix,None,26,ND,0 % Hemolysis at 10 μM,Human,Cecropin/Magainin Hybrid,NA,Non-hemolytic
9304,29799150,2018,EEEEAAAGwglrrllkygkrs,EEEEAAAGW{d}G{d}L{d}R{d}R{d}L{d}L{d}K{d}Y{d}G{d}K{d}R{d}S{d}{nt:Acet}{ct:Amid},Pro‐WMR,Amidation,Acetylation,Linear,Mix,None,21,ND,0 % Hemolysis at 10 μM,Human,Myxinidin Analogue From Hagfish,NA,Non-hemolytic
9414,30011202,2018,VVKCSFRPGSPAPRCK,VVKCSFRPGSPAPRCK,odorranain-A-OT,Free,Free,Linear,L,None,16,Antioxidant,5 % Hemolysis at 150 μM,Human,Frog Odorranain,NA,NA
9415,30011202,2018,FVPAILCSILKTC,FVPAILCSILKTC,odorranain-G-OT,Free,Free,Linear,L,None,13,Antioxidant,4 % Hemolysis at 150 μM,Human,Frog Odorranain,NA,NA
9416,30011202,2018,FFRTSCRSVC,FFRTSCRSVC,MFL,Free,Free,Linear,L,None,10,Antioxidant,7 % Hemolysis at 150 μM,Human,"Derived From Margaratain-B1, Andersnin-C1, And Pleurain-R1",NA,NA
9420,30011202,2018,TSRCIFYRRCVCS,TSRCIFYRRCVCS,AFL,Free,Free,Linear,L,None,10,Antioxidant,21 % Hemolysis at 150 μM,Human,"Derived From Margaratain-B1, Andersnin-C1, And Pleurain-R1",NA,NA
9424,30011202,2018,CVRFRTNTARTVCIAP,CVRFRTNTARTVCIAP,PFL,Free,Free,Linear,L,None,16,Antioxidant,5 % Hemolysis at 150 μM,Human,"Derived From Margaratain-B1, Andersnin-C1, And Pleurain-R1",NA,NA
9470,30045878,2018,ARGKKECKDDRCRLLMKRGSFSYV,ARGKKECKDDRCRLLMKRGSFSYV,Cathelicidin-NV,Free,Free,Linear,L,None,24,Wound healing-promoting activity,0 % Hemolysis at 200 μg/ml,Rabbit,Frog Nanorana Ventripunctata,NA,Non-hemolytic
9476,30216370,2018,ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI,ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI,α4,Free,Free,Linear,L,None,30,Antibiofilm,0 % Hemolysis at 100 μM,Human,Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1),Helical amphipathic structure,Non-hemolytic
9477,30216370,2018,ILKKWWGTSGGLLGGLLGKVTSVIKGLNNI,ILKKWWGTSGGLLGGLLGKVTSVIKGLNNI,α4M1,Free,Free,Linear,L,None,30,Antibiofilm,0 % Hemolysis at 100 μM,Human,Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1),Helical amphipathic structure,Non-hemolytic
9889,30521892,2019,RYAKMKRRRRRVARRHRRR,RYAKMKRRRRRVARRHRRR,PEP-NKSM,Free,Free,Linear,L,None,19,"biofilm Anti-adherent activity, Antibiofilm",12 % Hemolysis at 256 µM,Human,Derived From Human Virus Proteomes,α-Helix,Low hemolytic
9893,30842341,2019,GLLSGINAEWPC,GLLSGINAEWPC,OA-GL12,Free,Free,Linear,L,None,12,"Wound-healing peptide, Antioxidant",8.9 ± 0.43 % Hemolysis at 0.1 nM,Human,Frog Odorrana Andersonii,NA,NA
9894,30842341,2019,GLLSGINAEWPC,GLLSGINAEWPC,OA-GL12,Free,Free,Linear,L,None,12,"Wound-healing peptide, Antioxidant",9.8 ± 0.45 % Hemolysis at 1 nM,Human,Frog Odorrana Andersonii,NA,NA
9895,30842341,2019,GLLSGINAEWPC,GLLSGINAEWPC,OA-GL12,Free,Free,Linear,L,None,12,"Wound-healing peptide, Antioxidant",9.9 ± 0.75 % Hemolysis at 10 nM,Human,Frog Odorrana Andersonii,NA,NA
9896,30337232,2019,KFNKYGR,KFNKYGR,FSB-KFN,Free,Free,Linear,L,None,7,LPS-neutralizing and angiogenic activities,<0.10 % Hemolysis at 500 µM,Sheep,Putative Uncharacterized Protein,NA,Non-hemolytic
9897,30337232,2019,FPFPRPPHQK,FPFPRPPHQK,FSB-FPF,Free,Free,Linear,L,None,10,LPS-neutralizing and angiogenic activities,<0.10 % Hemolysis at 500 µM,Sheep,Beta-Conglycinin Alpha Subunit,NA,Non-hemolytic
9898,30337232,2019,GQSSRPQDRHQK,GQSSRPQDRHQK,FSB-GQS,Free,Free,Linear,L,None,12,LPS-neutralizing and angiogenic activities,<0.10 % Hemolysis at 500 µM,Sheep,Glycinin G1,NA,Non-hemolytic
9899,30337232,2019,QRFDQRSPQ,QRFDQRSPQ,FSB-QRF,Free,Free,Linear,L,None,9,LPS-neutralizing and angiogenic activities,<0.10 % Hemolysis at 500 µM,Sheep,Uncharacterized Protein,NA,Non-hemolytic
9900,30337232,2019,ERQFPFPRPPHQK,ERQFPFPRPPHQK,FSB-ERQ,Free,Free,Linear,L,None,13,LPS-neutralizing and angiogenic activities,<0.10 % Hemolysis at 500 µM,Sheep,Beta-Conglycinin Alpha Subunit,NA,Non-hemolytic
9901,30337232,2019,GEIPRPRPRPQHPE,GEIPRPRPRPQHPE,FSB-GEI,Free,Free,Linear,L,None,14,LPS-neutralizing and angiogenic activities,<0.10 % Hemolysis at 500 µM,Sheep,Beta-Conglycinin Alpha Subunit,NA,Non-hemolytic
9902,30337232,2019,EQPRPIPFPRPQPR,EQPRPIPFPRPQPR,FSB-EQP,Free,Free,Linear,L,None,14,LPS-neutralizing and angiogenic activities,0.24 % Hemolysis at 500 µM,Sheep,Beta-Conglycinin Alpha Subunit,NA,Non-hemolytic
9917,30973929,2019,EVlADlV,EVL{d}ADL{d}V{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP1,Amidation,Palmityl,Cyclic,Mix,None,7,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",40 % Hemolysis at 10 μg/mL,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA
9918,30973929,2019,EVlDlV,EVL{d}DL{d}V{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP2,Amidation,Palmityl,Cyclic,Mix,None,6,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",100 % Hemolysis at 10 μg/mL,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA
9919,30973929,2019,EVlDl,EVL{d}DL{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP3,Amidation,Palmityl,Cyclic,Mix,None,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",80 % Hemolysis at 10 μg/mL,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA
9920,30973929,2019,EVll,EVL{d}L{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP4,Amidation,Palmityl,Cyclic,Mix,None,4,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",5 % Hemolysis at 10 μg/mL,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,Low hemolytic
9921,30973929,2019,EVlDl,EVL{d}DL{d}{nt:Palmityl}{ct:Amid},SLP5,Amidation,Palmityl,Linear,Mix,None,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",25 % Hemolysis at 10 μg/mL,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA
9922,30973929,2019,KVlKl,KVL{d}KL{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP6,Amidation,Palmityl,Cyclic,Mix,None,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",90 % Hemolysis at 10 μg/mL,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA
9923,30973929,2019,EVLDL,EVLDL{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP7,Amidation,Palmityl,Cyclic,L,None,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",30 % Hemolysis at 10 μg/mL,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA
9924,30973929,2019,EVllD,EVL{d}L{d}D{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP8,Amidation,Palmityl,Cyclic,Mix,None,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",100 % Hemolysis at 10 μg/mL,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA
9925,30973929,2019,EDVll,EDVL{d}L{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP9,Amidation,Palmityl,Cyclic,Mix,None,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",50 % Hemolysis at 10 μg/mL,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA
9926,30973929,2019,EVlDl,EVlDl{cyc:N-C}{nt:Heptaalkyl-biphenyl-acid}{ct:Amid},SLP10,Amidation,Heptaalkyl-biphenyl-acid,Cyclic,Mix,Heptaalkyl-biphenyl-acid,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",55 % Hemolysis at 10 μg/mL,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA
10346,31001677,2019,GKPRPYSPRPTSHPRPIRV,GKPRPYSPRPTSHPRPIRV,Drosocin,Free,Free,Linear,L,None,19,Antiparasitic,<20 % Hemolysis at 100 μM,Mouse,Drosophila Melanogaster,NA,NA
10347,31001677,2019,HRHQGPIFDTRPSPFNPNQPRPGPIY,HRHQGPIFDTRPSPFNPNQPRPGPIY,Mtk-1,Free,Free,Linear,L,None,26,Antiparasitic,<20 % Hemolysis at 100 μM,Mouse,Drosophila Melanogaster,NA,Low hemolytic
10348,31001677,2019,HRRQGPIFDTRPSPFNPNQPRPGPIY,HRRQGPIFDTRPSPFNPNQPRPGPIY,Mtk-2,Free,Free,Linear,L,None,26,Antiparasitic,<20 % Hemolysis at 100 μM,Mouse,Drosophila Melanogaster,NA,NA
10349,31001677,2019,EWRPHGSIGGSGLRPGRPQTLPPQRPRRPDFNGPRHRF,EWRPHGSIGGSGLRPGRPQTLPPQRPRRPDFNGPRHRF,LSer-PRP2,Free,Free,Linear,L,None,38,Antiparasitic,<20 % Hemolysis at 100 μM,Mouse,Lucilia Sericata,NA,NA
10350,31001677,2019,SPFVDRPRRPIQHNGPKPRIITNPPFNPNARPAW,SPFVDRPRRPIQHNGPKPRIITNPPFNPNARPAW,LSer-PRP3,Free,Free,Linear,L,None,34,Antiparasitic,<20 % Hemolysis at 100 μM,Mouse,Lucilia Sericata,NA,NA
10351,31001677,2019,GFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG,GFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG,Stomoxyn,Free,Free,Linear,L,None,42,Antiparasitic,<20 % Hemolysis at 100 μM,Mouse,Lucilia Sericata,NA,NA
10352,31001677,2019,KWKIFKKIEKAGRNIRDGIIKAGPAVSVVGEAATIYKTG,KWKIFKKIEKAGRNIRDGIIKAGPAVSVVGEAATIYKTG,CecA,Free,Free,Linear,L,None,39,Antiparasitic,<20 % Hemolysis at 100 μM,Mouse,Galleria Mellonella,NA,NA
10353,31001677,2019,KWKFFKKIERVGQNIRDGIIKAGPAVQVVGQAATIYKGK,KWKFFKKIERVGQNIRDGIIKAGPAVQVVGQAATIYKGK,CecB,Free,Free,Linear,L,None,39,Antiparasitic,<20 % Hemolysis at 100 μM,Mouse,Galleria Mellonella,NA,Low hemolytic
10354,31001677,2019,RWKVFKKIERMGQHIRDGIIKAGPAVAVVGQASTIISG,RWKVFKKIERMGQHIRDGIIKAGPAVAVVGQASTIISG,CecC,Free,Free,Linear,L,None,38,Antiparasitic,<20 % Hemolysis at 100 μM,Mouse,Galleria Mellonella,NA,NA
10355,31001677,2019,ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD,ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD,CecD,Free,Free,Linear,L,None,39,Antiparasitic,<20 % Hemolysis at 100 μM,Mouse,Galleria Mellonella,NA,NA
10356,31001677,2019,GKPRPYSPRPTSHPRPIRV,GKPRPYSPRPTSHPRPIRV,Drosocin,Free,Free,Linear,L,None,19,Antiparasitic,<20 % Hemolysis at 100 μM,Pig,Drosophila Melanogaster,low hemolytic,NA
10357,31001677,2019,HRHQGPIFDTRPSPFNPNQPRPGPIY,HRHQGPIFDTRPSPFNPNQPRPGPIY,Mtk-1,Free,Free,Linear,L,None,26,Antiparasitic,<20 % Hemolysis at 100 μM,Pig,Drosophila Melanogaster,NA,NA
10358,31001677,2019,HRRQGPIFDTRPSPFNPNQPRPGPIY,HRRQGPIFDTRPSPFNPNQPRPGPIY,Mtk-2,Free,Free,Linear,L,None,26,Antiparasitic,<20 % Hemolysis at 100 μM,Pig,Drosophila Melanogaster,NA,NA
10359,31001677,2019,EWRPHGSIGGSGLRPGRPQTLPPQRPRRPDFNGPRHRF,EWRPHGSIGGSGLRPGRPQTLPPQRPRRPDFNGPRHRF,LSer-PRP2,Free,Free,Linear,L,None,38,Antiparasitic,<20 % Hemolysis at 100 μM,Pig,Lucilia Sericata,low hemolytic,NA
10360,31001677,2019,SPFVDRPRRPIQHNGPKPRIITNPPFNPNARPAW,SPFVDRPRRPIQHNGPKPRIITNPPFNPNARPAW,LSer-PRP3,Free,Free,Linear,L,None,34,Antiparasitic,<20 % Hemolysis at 100 μM,Pig,Lucilia Sericata,low hemolytic,NA
10361,31001677,2019,GFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG,GFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG,Stomoxyn,Free,Free,Linear,L,None,42,Antiparasitic,<20 % Hemolysis at 100 μM,Pig,Lucilia Sericata,low hemolytic,NA
10362,31001677,2019,KWKIFKKIEKAGRNIRDGIIKAGPAVSVVGEAATIYKTG,KWKIFKKIEKAGRNIRDGIIKAGPAVSVVGEAATIYKTG,CecA,Free,Free,Linear,L,None,39,Antiparasitic,<20 % Hemolysis at 100 μM,Pig,Galleria Mellonella,low hemolytic,NA
10363,31001677,2019,KWKFFKKIERVGQNIRDGIIKAGPAVQVVGQAATIYKGK,KWKFFKKIERVGQNIRDGIIKAGPAVQVVGQAATIYKGK,CecB,Free,Free,Linear,L,None,39,Antiparasitic,<20 % Hemolysis at 100 μM,Pig,Galleria Mellonella,NA,Low hemolytic
10364,31001677,2019,RWKVFKKIERMGQHIRDGIIKAGPAVAVVGQASTIISG,RWKVFKKIERMGQHIRDGIIKAGPAVAVVGQASTIISG,CecC,Free,Free,Linear,L,None,38,Antiparasitic,<20 % Hemolysis at 100 μM,Pig,Galleria Mellonella,NA,NA
10365,31001677,2019,ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD,ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD,CecD,Free,Free,Linear,L,None,39,Antiparasitic,<20 % Hemolysis at 100 μM,Pig,Galleria Mellonella,NA,NA
10393,30927490,2019,ACYCRIPACIAGERR,ACYCRIPACIAGERR,HNP‐F,Free,Free,Linear,L,None,15,Hemostatic drug,8.2 % Hemolysis at 5 μM,Mouse,Anterior‐Half Fragment Of Hnp,NA,NA
10396,30927490,2019,ACYCRIPACIAGERR,ACYCRIPACIAGERR,HNP‐F,Free,Free,Linear,L,None,15,Hemostatic drug,8.8 % Hemolysis at 500 μM,Mouse,Anterior‐Half Fragment Of Hnp,NA,Low hemolytic
10399,30927490,2019,ACYCRIPACIAGERR,ACYCRIPACIAGERR,HNP‐F,Free,Free,Linear,L,None,15,Hemostatic drug,9.5 % Hemolysis at 5000 μM,Mouse,Anterior‐Half Fragment Of Hnp,NA,Low hemolytic
10783,31324383,2019,IPHVYNSPSPIKPNRL,IPHVYNSPSPIK{d}PNRL,SBH-IPH,Free,Free,Linear,L,None,16,ND = not detected,1.3 % Hemolysis at 1000 µM,Sheep,Soybean Uncharacterized Protein,NA,Non-hemolytic
10784,31324383,2019,AKGITVIGAR,AK{d}GITVIGAR,SBH-AKG,Free,Free,Linear,L,None,10,ND = not detected,0 % Hemolysis at 1000 µM,Sheep,Soybean Uncharacterized Protein,NA,Non-hemolytic
10785,31324383,2019,VRKRPLVAL,VRK{d}RPLVAL,SBH-VRK,Free,Free,Linear,L,None,9,ND = not detected,1.61 % Hemolysis at 1000 µM,Sheep,Soybean Uncharacterized Protein,NA,Non-hemolytic
10786,31324383,2019,PSVIKKGISK,PSVIK{d}K{d}GISK{d},SBH-PSV,Free,Free,Linear,L,None,10,ND = not detected,2.46 % Hemolysis at 1000 µM,Sheep,Soybean Uncharacterized Protein,NA,Non-hemolytic
10787,31324383,2019,NRVFGALKGAL,NRVF{d}GALK{d}GAL,SBH-NRV,Free,Free,Linear,L,None,11,ND = not detected,0.055 % Hemolysis at 1000 µM,Sheep,Soybean Uncharacterized Protein,NA,Non-hemolytic
10788,31324383,2019,FKNQYGHVR,F{d}K{d}NQYGHVR,SBH-FKN,Free,Free,Linear,L,None,9,ND = not detected,0.84 % Hemolysis at 1000 µM,Sheep,Soybean Beta-Conglycinin Alpha’ Chain,NA,Non-hemolytic
10789,31324383,2019,RTRGGFMVSR,RTRGGF{d}MVSR,SBH-RTR,Free,Free,Linear,L,None,10,ND = not detected,0.85 % Hemolysis at 1000 µM,Sheep,Soybean Alpha-Galactosidase,NA,Non-hemolytic
10794,31324383,2019,DRRPPPRRDVV,DRRPPPRRDVV,SBH-DRR,Free,Free,Linear,L,None,11,ND = not detected,2.1 % Hemolysis at 1000 µM,Sheep,Soybean Uncharacterized Protein,NA,Non-hemolytic
10795,31324383,2019,KKIQVIGKARVPI,K{d}K{d}IQVIGK{d}ARVPI,SBH-KKI,Free,Free,Linear,L,None,13,ND = not detected,1.9 % Hemolysis at 1000 µM,Sheep,Soybean Uncharacterized Protein,NA,Non-hemolytic
10819,30678611,2019,FFTTSCRSGC,FFTTSCRSGC,OA-FF10,Free,Free,Linear,L,None,10,Promoted Wound healing and proliferation of human keratinocytes (HaCaT),0 % Hemolysis at 100 µM,Human,"Frog Species, Odorrana Andersonii",NA,Non-hemolytic
10824,32435168,2020,GWINEKKMQQKIDEKIGKNIIGGMAKAVIHKMAKNEFQCVANVDTLGNCKKHCAKTTGEKGYCHGTKCKCGIELSY,GWINEKKMQQKIDEKIGKNIIGGMAKAVIHKMAKNEFQCVANVDTLGNCKKHCAKTTGEKGYCHGTKCKCGIELSY,Smp76,Free,Free,Linear,L,None,76,Antiviral,50 % Hemolysis at >10 μg/ml,Human,Scorpion Scorpio Maurus Palmatus,NA,NA
10877,33479615,2020,GHrKPAQP,GHR{d}KPAQP,P1,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",50 % Hemolysis at >50 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic
10878,33479615,2020,errKPAQP,E{d}R{d}R{d}KPAQP,P2,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",0 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic
10879,33479615,2020,eeEKPAQP,E{d}E{d}EKPAQP,P4,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",50 % Hemolysis at >50 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic
10880,33479615,2020,efrTMVHPK,E{d}F{d}R{d}TMVHPK,P5,Free,Free,Linear,Mix,None,9,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",0 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic
10881,33479615,2020,edRKHAQA,E{d}D{d}RKHAQA,P8,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",50 % Hemolysis at >40 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic
10882,33479615,2020,kEFHKTAQP,K{d}EFHKTAQP,P9,Free,Free,Linear,Mix,None,9,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",50 % Hemolysis at >60 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic
10883,33479615,2020,frrRPLRA,F{d}R{d}R{d}RPLRA,P13,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",0 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic
10884,33479615,2020,DdhKTAHQ,DD{d}H{d}KTAHQ,P14,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",50 % Hemolysis at >40 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic
10885,33479615,2020,GwRKPAQP,GW{d}RKPAQP,P16,Free,Free,Linear,Mix,None,8,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",0 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic
10886,33479615,2020,wKrLHHKPA,W{d}KR{d}LHHKPA,P18,Free,Free,Linear,Mix,None,9,"Neuraminidase inhibitor, Anti-influenza (H1N1 influenza virus), Antiviral",0 % Hemolysis at 100 µM,Rabbit,Synthetic Peptide,NA,Low hemolytic
10937,31862270,2020,PFKISIHL,{conj:Lauric acid}PFKISIHL,Lauric acid – Jellein (L-Jellein),Free,Lauric acid,Linear,L,None,8,Anti-leishmanial,0 % Hemolysis at 500 μg/ml,Human,Lauric Acid Conjugated Jellein,NA,Non-hemolytic
10938,31862270,2020,LPKPPKPVSKMRMATPLLMQALPM,LPKPPKPVSKMRMATPLLMQALPM,CLIP,Free,Free,Linear,L,None,24,Anti-leishmanial,0 % Hemolysis at 500 μg/ml,Human,Mhc Class Ii Associated Invariant Chain Peptide,NA,Non-hemolytic
11019,32342079,2020,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,Antimicobial,5 % Hemolysis at 0.25 μM,Human,Honey Bee,α-Helical,NA
11080,32612531,2020,AKACTPRLHDCSHDRHSCCRGELFKDVCYCFYPEGEDKTEVCSCQQPKSHKYIEKVVDKTKTLVG,AKACTPRLHDCSHDRHSCCRGELFKDVCYCFYPEGEDKTEVCSCQQPKSHKYIEKVVDKTKTLVG,LCTX-F2,Free,Free,Linear,L,None,65,Procoagulant,0.74 % Hemolysis at 100 µg/ml,Rabbit,Chinese Wolf Spider Lycosa Singoriensis,NA,Non-hemolytic
11181,32543191,2020,AAAAMAGPK,AAAAMAGPK{ct:Amid},Rice-derived-peptide-3 (RDP3),Amidation,Free,Linear,L,None,9,"Anti-gout, Anti-inflammation",4.5±0.13 % Hemolysis at 100 µg/mL,Human,Shelled Oryza Sativa Fruits,NA,Non-hemolytic
11182,32543191,2020,AAAAMAGPK,AAAAMAGPK{ct:Amid},Rice-derived-peptide-3 (RDP3),Amidation,Free,Linear,L,None,9,"Anti-gout, Anti-inflammation",5.0±0.07 % Hemolysis at 500 µg/mL,Human,Shelled Oryza Sativa Fruits,NA,Non-hemolytic
11183,32543191,2020,AAAAMAGPK,AAAAMAGPK{ct:Amid},Rice-derived-peptide-3 (RDP3),Amidation,Free,Linear,L,None,9,"Anti-gout, Anti-inflammation",4.5±0.15 % Hemolysis at 1 mg/mL,Human,Shelled Oryza Sativa Fruits,NA,Non-hemolytic
11518,32673701,2020,rRrRrRRR,R{d}RR{d}RR{d}RRR,rR8,Free,Free,Linear,Mix,None,8,Antimalarial,0 % Hemolysis at 5 μM,Human,Derived From A Cell-Penetrating Peptide,Random coil,Non-hemolytic
11519,32673701,2020,rRrRrRRR,R{d}RR{d}RR{d}RRR,rR8,Free,Free,Linear,Mix,None,8,Antimalarial,0 % Hemolysis at 10 μM,Human,Derived From A Cell-Penetrating Peptide,Random coil,Non-hemolytic
11520,32673701,2020,rRrRrRRR,R{d}RR{d}RR{d}RRR,rR8,Free,Free,Linear,Mix,None,8,Antimalarial,0.8 % Hemolysis at 20 μM,Human,Derived From A Cell-Penetrating Peptide,Random coil,Non-hemolytic
11521,32673701,2020,rRrRrRRR,R{d}RR{d}RR{d}RRR,rR8,Free,Free,Linear,Mix,None,8,Antimalarial,1.3 % Hemolysis at 40 μM,Human,Derived From A Cell-Penetrating Peptide,Random coil,Non-hemolytic
11522,32673701,2020,KKKKKKKKKYYKYKKKEKEKK,KKKKKKKKKYYKYKKKEKEKK,JR21,Free,Free,Linear,L,None,21,Antimalarial,0 % Hemolysis at 5 μM,Human,Designed Based On The Junctional Region Of Pfdhfr-Ts,Helical,Non-hemolytic
11523,32673701,2020,KKKKKKKKKYYKYKKKEKEKK,KKKKKKKKKYYKYKKKEKEKK,JR21,Free,Free,Linear,L,None,21,Antimalarial,0 % Hemolysis at 10 μM,Human,Designed Based On The Junctional Region Of Pfdhfr-Ts,Helical,Non-hemolytic
11524,32673701,2020,KKKKKKKKKYYKYKKKEKEKK,KKKKKKKKKYYKYKKKEKEKK,JR21,Free,Free,Linear,L,None,21,Antimalarial,0.8 % Hemolysis at 20 μM,Human,Designed Based On The Junctional Region Of Pfdhfr-Ts,Helical,Non-hemolytic
11525,32673701,2020,KKKKKKKKKYYKYKKKEKEKK,KKKKKKKKKYYKYKKKEKEKK,JR21,Free,Free,Linear,L,None,21,Antimalarial,1 % Hemolysis at 40 μM,Human,Designed Based On The Junctional Region Of Pfdhfr-Ts,Helical,Non-hemolytic
11526,32673701,2020,rRrRrRRR-KKKKKKKKKYYKYKKKEKEKK,R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK,rR8-JR21,Free,Free,Linear,Mix,None,29,Antimalarial,0 % Hemolysis at 5 μM,Human,Combination Of Rr8 And Jr21 Sequences,Random coil and Helical,Non-hemolytic
11527,32673701,2020,rRrRrRRR-KKKKKKKKKYYKYKKKEKEKK,R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK,rR8-JR21,Free,Free,Linear,Mix,None,29,Antimalarial,0 % Hemolysis at 10 μM,Human,Combination Of Rr8 And Jr21 Sequences,Random coil and Helical,Non-hemolytic
11528,32673701,2020,rRrRrRRR-KKKKKKKKKYYKYKKKEKEKK,R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK,rR8-JR21,Free,Free,Linear,Mix,None,29,Antimalarial,0.8 % Hemolysis at 20 μM,Human,Combination Of Rr8 And Jr21 Sequences,Random coil and Helical,Non-hemolytic
11529,32673701,2020,rRrRrRRR-KKKKKKKKKYYKYKKKEKEKK,R{d}RR{d}RR{d}RRR-KKKKKKKKKYYKYKKKEKEKK,rR8-JR21,Free,Free,Linear,Mix,None,29,Antimalarial,1.3 % Hemolysis at 40 μM,Human,Combination Of Rr8 And Jr21 Sequences,Random coil and Helical,Non-hemolytic
11575,32726461,2020,VLESFKVSFLSALEEYTKKL,VLESFKVSFLSALEEYTKKL{nt:H}{ct:OH},apoA‐I221–240,OH,H,Linear,L,None,20,Anti‐inflammatory,1.34 ± 0.66 % Hemolysis at 200 μM,mouse,Apolipoprotein A-I (Apoa-I) Mimetic Peptides,"aqueous = Disordered, 50% TFE = α‐Helical",Non-hemolytic
11587,32726461,2020,FLEKLKELLEHLKELLTKLL,FLEKLKELLEHLKELLTKLL{nt:H}{ct:OH},P12,OH,H,Linear,L,None,20,"Anti‐atherosclerotic, Anti‐inflammatory and Antioxidant",1.71 ± 0.73 % Hemolysis at 200 μM,mouse,Modfied Apoa‐I221–240 Synthetic Peptide,"aqueous = Disordered, 50% TFE = α‐Helical",Non-hemolytic
11593,32726461,2020,DWFKAFYDKVAEKFKEAF,DWFKAFYDKVAEKFKEAF{nt:Acet}{ct:Amid},L‐4F,Amidation,Acetylation,Linear,L,None,18,"Anti‐atherosclerotic, Anti‐inflammatory and Antioxidant",2.10 ± 0.48 % Hemolysis at 200 μM,mouse,Synthetic Peptide,"aqueous = α‐Helical, 50% TFE = α‐Helical",Non-hemolytic
11636,32891601,2020,GKWMTLLKHILK,GKWMTLLKHILK{ct:Amid},P5T,Amidation,Free,Linear,L,None,12,Anti-leishmanial,6.5 ± 0.9 % Hemolysis at 64 μM,Human,"Analogues Of The Halictine-2 (Honeybee, Halictus Sexcinctus)","10 mM PB = Disordered, 10 mM SDS or 50% TFE = α-Helix",Non-hemolytic
11717,33396521,2020,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,D-lp1,Free,Free,Linear,L,None,47,Antiyeast,<10 % Hemolysis at 400 μg/mL,Sheep,Plant Barley (Hordeum Vulgare) Endosperm,Triple Stranded antiparallel Betα-Sheets and Alpha Helix,Non-hemolytic
11718,33352972,2020,GLNALKKVFQGIHEAIKLINNHVQ,GLNALKKVFQGIHEAIKLINNHVQ{ct:Amid},Pseudin-2,Amidation,Free,Linear,L,None,24,Antiyeast,Hemolysis at 64 μM,Mouse,Paradox Frog Pseudis Paradoxa,α-Helical,NA
11719,33352972,2020,GLNAAKKVFQGAHEAIKLINNHVQ,GLNAAKKVFQGAHEAIKLINNHVQ{ct:Amid},P2-LZ1,Amidation,Free,Linear,L,None,24,Antiyeast,Hemolysis at 64 μM,Mouse,Synthetic Analogous Peptide,α-Helical,NA
11720,33352972,2020,GANALKKVAQGIHEAIKLINNHVQ,GANALKKVAQGIHEAIKLINNHVQ{ct:Amid},P2-LZ2,Amidation,Free,Linear,L,None,24,Antiyeast,Hemolysis at 64 μM,Mouse,Synthetic Analogous Peptide,α-Helical,NA
11721,33352972,2020,GLNALKKVFQGAHEAIKLANNHVQ,GLNALKKVFQGAHEAIKLANNHVQ{ct:Amid},P2-LZ3,Amidation,Free,Linear,L,None,24,Antiyeast,Hemolysis at 64 μM,Mouse,Synthetic Analogous Peptide,α-Helical,NA
11722,33352972,2020,GLNALKKVAQGIHEAAKLINNHVQ,GLNALKKVAQGIHEAAKLINNHVQ{ct:Amid},P2-LZ4,Amidation,Free,Linear,L,None,24,Antiyeast,Hemolysis at 64 μM,Mouse,Synthetic Analogous Peptide,α-Helical,NA
11723,33352972,2020,GLNALKKVKQGKHEAIKLINNHVQ,GLNALKKVKQGKHEAIKLINNHVQ{ct:Amid},P2-LZ5,Amidation,Free,Linear,L,None,24,Antiyeast,Hemolysis at 64 μM,Mouse,Synthetic Analogous Peptide,α-Helical,NA
11737,33049300,2021,RRGFFKPYGKKPKKVAKKPYYHCGWKYCGWKYCGWKHCGWKY,RRGFFKPYGKKPKKVAKKPYYHCGWKYCGWKYCGWKHCGWKY,Gj-CATH3,Free,Free,Linear,L,None,42,Antioxidant,12.18 ± 1.38 % Hemolysis at 80 μM,Sheep,Lizard Gekko Japonicus Cathelicidins,NA,NA
11739,33049300,2021,CGWKYCGWKYCGWKHCGWKY,CGWKYCGWKYCGWKHCGWKY,Gj-CATH3-(23–42)-peptide,Free,Free,Linear,L,None,20,Antioxidant,7.75 ± 0.89 % Hemolysis at 80 μM,Sheep,Gj-Cath3 Analogues,NA,NA
11740,33049300,2021,CGWKHCGWKY,CGWKHCGWKY,Gj-CATH3-(33–42)-peptide,Free,Free,Linear,L,None,10,"Antioxidant, Wound healing",1.05 ± 0.23 % Hemolysis at 80 μM,Sheep,Gj-Cath3 Analogues,NA,Non-hemolytic
11741,33049300,2021,CGWKY,CGWKY,Gj-CATH3-(38–42)-peptide,Free,Free,Linear,L,None,5,"Antioxidant, Wound healing",0.7 ± 0.14   % Hemolysis at 80 μM,Sheep,Gj-Cath3 Analogues,NA,Non-hemolytic
11851,33830736,2021,RKVRGPPVSCIKRDSPIQ,RKVRGPPVSCIKRDSPIQ,LP-2,Free,Free,Linear,L,None,18,Anti-osteoclastogenic,0 % Hemolysis at 100 µM,Human,Fragment From The N-Terminus Of The N-Lobe Of Human Lactoferrin,aqueous environmen = nano-globular assembly Helical and β-Sheet,Non-hemolytic
11852,33689880,2021,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,Peptide 2,Free,Free,Linear,L,None,20,Anti-inflammatory,0.22 % Hemolysis at 21.875 µM,Human,Frog Skin Secretions Of Bombina Maxima,NA,Non-hemolytic
11853,33689880,2021,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,Peptide 2,Free,Free,Linear,L,None,20,Anti-inflammatory,0.26 % Hemolysis at 43.75 µM,Human,Frog Skin Secretions Of Bombina Maxima,NA,Non-hemolytic
11854,33689880,2021,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,Peptide 2,Free,Free,Linear,L,None,20,Anti-inflammatory,0.31 % Hemolysis at 87.5 µM,Human,Frog Skin Secretions Of Bombina Maxima,NA,Non-hemolytic
11855,33689880,2021,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,Peptide 2,Free,Free,Linear,L,None,20,Anti-inflammatory,0.32 % Hemolysis at 175 µM,Human,Frog Skin Secretions Of Bombina Maxima,NA,Non-hemolytic
11856,33689880,2021,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,Peptide 2,Free,Free,Linear,L,None,20,Anti-inflammatory,0.33 % Hemolysis at 350 µM,Human,Frog Skin Secretions Of Bombina Maxima,NA,Non-hemolytic
11857,33689880,2021,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,Peptide 2,Free,Free,Linear,L,None,20,Anti-inflammatory,0.33 % Hemolysis at 700 µM,Human,Frog Skin Secretions Of Bombina Maxima,NA,Non-hemolytic
11858,33689880,2021,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,Peptide 2,Free,Free,Linear,L,None,20,Anti-inflammatory,0.4 % Hemolysis at 1.4 mM,Human,Frog Skin Secretions Of Bombina Maxima,NA,Non-hemolytic
11859,33689880,2021,LVGKLLKGAVGDVCGLLPIC,LVGKLLKGAVGDVCGLLPIC,Peptide 2,Free,Free,Linear,L,None,20,Anti-inflammatory,0.56 % Hemolysis at 2.8 mM,Human,Frog Skin Secretions Of Bombina Maxima,NA,Non-hemolytic
11995,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",50 % Hemolysis at 886.5 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic
11996,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0 % Hemolysis at 1 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic
11997,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0 % Hemolysis at 2 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic
11998,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0.4 % Hemolysis at 4 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic
11999,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0.7 % Hemolysis at 8 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic
12000,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",1.4 % Hemolysis at 16 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic
12001,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",1.5 % Hemolysis at 32 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic
12002,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",1.8 % Hemolysis at 64 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic
12003,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",2.4 % Hemolysis at 128 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic
12004,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",10.6 % Hemolysis at 256 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic
12005,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",50 % Hemolysis at 16.77 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12006,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0.1 % Hemolysis at 1 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12007,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0.3 % Hemolysis at 2 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12008,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",2 % Hemolysis at 4 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12009,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",2.5 % Hemolysis at 8 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12010,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",5.4 % Hemolysis at 16 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12011,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",16.9 % Hemolysis at 32 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12012,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",40.3 % Hemolysis at 64 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12013,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",99.3 % Hemolysis at 128 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12014,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",99.5 % Hemolysis at 256 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12015,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",50 % Hemolysis at 33.26 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12016,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0 % Hemolysis at 1 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12017,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0 % Hemolysis at 2 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12018,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0.4 % Hemolysis at 4 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12019,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0.5 % Hemolysis at 8 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12020,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0.9 % Hemolysis at 16 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12021,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",2.5 % Hemolysis at 32 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12022,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",8.7 % Hemolysis at 64 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12023,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",23.6 % Hemolysis at 128 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12024,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",65.6 % Hemolysis at 256 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12025,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",50 % Hemolysis at 0.99 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12026,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",6.1 % Hemolysis at 1 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12027,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",15 % Hemolysis at 2 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12028,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",33.7 % Hemolysis at 4 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12029,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",61.6 % Hemolysis at 8 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12030,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",96.2 % Hemolysis at 16 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12031,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",97.6 % Hemolysis at 32 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12032,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",97.9 % Hemolysis at 64 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12033,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",99.8 % Hemolysis at 128 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12034,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",100 % Hemolysis at 256 μM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA
12083,34021418,2021,RKPRPHQFIGLM,RKPRPHQFIGLM,RM12,Free,Free,Linear,L,None,12,Antioxidant,15-20 % Hemolysis at 320 μM,Fish,Muscle Transcriptome Of A Freshwater Murrel Channa Striatus,Random coil,Low hemolytic
12084,34022355,2021,GILGKLWEGVKSIF,GILGKLWEGVKSIF,Hp1404,Free,Free,Linear,L,None,14,"Anti-Acinetobacter baumannii, Anti-Carbapenem-resistant Acinetobacter baumannii (CRAB",10 % Hemolysis at 32.3 μM,Human,Scorpion Heterometrus Petersii,α-Helical,NA
12085,34022355,2021,FLWGLIPGAISAVTSLIKK,FLWGLIPGAISAVTSLIKK,ctriporin,Free,Free,Linear,L,None,19,Anti-Acinetobacter baumannii,10 % Hemolysis at 14.9 μM,Human,Scorpion Chaerilus Tricostatus,NA,NA
12086,34022355,2021,FLGSLFSIGSKLLPGVIKLFQRKKQ,FLGSLFSIGSKLLPGVIKLFQRKKQ,Im5,Free,Free,Linear,L,None,25,Anti-Acinetobacter baumannii,10 % Hemolysis at 2.7 μM,Human,Scorpion Isometrus Maculatus,NA,NA
12087,34058259,2021,EEVQRDVSIMPYKIIGADNGDAWLDVKGQKMAPPQISAEVLKK,EEVQRDVSIMPYKIIGADNGDAWLDVKGQKMAPPQISAEVLKK,DP1,Free,Free,Linear,L,None,43,Anti-Salmonella,1 % Hemolysis at 100 µg/ml,Human,Synthetic Multi-Epitope Dnak Peptides,NA,Non-hemolytic
12088,34058259,2021,LPYITADATGPKHMNIKVTRAKLESLVE,LPYITADATGPKHMNIKVTRAKLESLVE,DP2,Free,Free,Linear,L,None,28,Anti-Salmonella,1 % Hemolysis at 100 µg/ml,Human,Synthetic Multi-Epitope Dnak Peptides,NA,Non-hemolytic
12089,34058259,2021,AEDNQSAVTIHVLQGERKRASDNKSLG,AEDNQSAVTIHVLQGERKRASDNKSLG,DP3,Free,Free,Linear,L,None,27,Anti-Salmonella,1 % Hemolysis at 100 µg/ml,Human,Synthetic Multi-Epitope Dnak Peptides,NA,Non-hemolytic
12090,34058259,2021,HVSAKDKNSGKEQKITIK,HVSAKDKNSGKEQKITIK,DP4,Free,Free,Linear,L,None,18,Anti-Salmonella,1 % Hemolysis at 100 µg/ml,Human,Synthetic Multi-Epitope Dnak Peptides,NA,Non-hemolytic
12091,34058259,2021,TRNQGDHLLHSTRKQVEEAGDKLPADDKTAIESALSALETALKG,TRNQGDHLLHSTRKQVEEAGDKLPADDKTAIESALSALETALKG,DP5,Free,Free,Linear,L,None,44,Anti-Salmonella,1 % Hemolysis at 100 µg/ml,Human,Synthetic Multi-Epitope Dnak Peptides,NA,Non-hemolytic
12092,34058259,2021,ETALKGEDKAAIEAKMQELAQVSQKLMEIA,ETALKGEDKAAIEAKMQELAQVSQKLMEIA,DP6,Free,Free,Linear,L,None,30,Anti-Salmonella,1 % Hemolysis at 100 µg/ml,Human,Synthetic Multi-Epitope Dnak Peptides,NA,Non-hemolytic
12093,34058259,2021,HAQQQAGSADASANNAKDDDVVDAEFEEVKDKK,HAQQQAGSADASANNAKDDDVVDAEFEEVKDKK,DP7,Free,Free,Linear,L,None,33,Anti-Salmonella,1 % Hemolysis at 100 µg/ml,Human,Synthetic Multi-Epitope Dnak Peptides,NA,Non-hemolytic
12094,34129853,2021,INWKGIAAMGKKLL,INWKGIAAMGKKLL,Vp1a,Free,Free,Linear,L,None,14,Antioxidant,2.37 % Hemolysis at 120 μM,mouse,Asian Hornet Vespa Velutina,NA,Non-hemolytic
12097,34129853,2021,FLPIIDKLLGGLLGKK,FLPIIDKLLGGLLGKK,Vp2b,Free,Free,Linear,L,None,16,Antioxidant,2.12 % Hemolysis at 120 μM,mouse,Asian Hornet Vespa Velutina,NA,Non-hemolytic
12219,34635758,2021,CTKTDVHFC,CTKTDVHFC{cyc:N-C},CP2,Free,Free,Cyclic,L,None,9,Antiviral against WNV (West Nile virus),0.2 % Hemolysis at 6 μM,Sheep,Synthetic Cyclic Peptide,NA,Low hemolytic
12220,34635758,2021,CIHSSTRAC,CIHSSTRAC{cyc:N-C},CP4,Free,Free,Cyclic,L,None,9,Antiviral against WNV (West Nile virus),0.2 % Hemolysis at 6 μM,Sheep,Synthetic Cyclic Peptide,NA,Low hemolytic
12221,34635758,2021,CTYENHRTC,CTYENHRTC{cyc:N-C},CP12,Free,Free,Cyclic,L,None,9,Antiviral against WNV (West Nile virus),0.2 % Hemolysis at 6 μM,Sheep,Synthetic Cyclic Peptide,NA,Low hemolytic
12222,34635758,2021,CLAQSHPLC,CLAQSHPLC{cyc:N-C},CP16,Free,Free,Cyclic,L,None,9,Antiviral against WNV (West Nile virus),0.2 % Hemolysis at 6 μM,Sheep,Synthetic Cyclic Peptide,NA,Low hemolytic
12438,35111812,2022,YPASFDDDFDALDDLDDLDLDDLLDLEPADLVLLDMWANMMDSQDFEDFE,YPASFDDDFDALDDLDDLDLDDLLDLEPADLVLLDMWANMMDSQDFEDFE,TanP,Free,Free,Linear,L,None,50,"Chelating, Antioxidant, Anti-inflammatory",3 % Hemolysis at 50 μM,Human,Tityus Stigmurus Scorpion Venom,NA,Low hemolytic
12546,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid},LL37-1,Amidation,Free,Linear,L,None,23,Antibiofilm,≤5 % Hemolysis at 1.5 μM,Human,Ll37 Analogous,α-Helical,NA
12550,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid},LL37-1,Amidation,Free,Linear,L,None,23,Antibiofilm,≤5 % Hemolysis at 2.5 μM,Human,Ll37 Analogous,α-Helical,NA
12554,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid},LL37-1,Amidation,Free,Linear,L,None,23,Antibiofilm,≤5 % Hemolysis at 5 μM,Human,Ll37 Analogous,α-Helical,NA
12558,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid},LL37-1,Amidation,Free,Linear,L,None,23,Antibiofilm,≤20 % Hemolysis at 10 μM,Human,Ll37 Analogous,α-Helical,NA
12650,36551443,2022,RGGRLCYCRRRFCVCVGR,RGGRLCYCRRRFCVCVGR,PG-1,Free,Free,Linear,L,None,18,Antimycobacterial,100 % Hemolysis at 1000 µg/mL,Human,Sus Domesticus,NA,NA
12651,36551443,2022,AVKKLLRWWSRWWKK,AVKKLLRWWSRWWKK,AK 15-6,Free,Free,Linear,L,None,15,Antimycobacterial,33.57 % Hemolysis at 1000 µg/mL,Human,Mycobac Teriophage,NA,NA
12652,36551443,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,AM-mel,Free,Free,Linear,L,None,26,Antimycobacterial,100 % Hemolysis at 1000 µg/mL,Human,Apis Mellifera,NA,NA
12653,36551443,2022,GRRRRSVQWCA,GRRRRSVQWCA,hLF 1-11(L-form),Free,Free,Linear,L,None,11,Antimycobacterial,<1 % Hemolysis at 4000 µg/mL,Human,Homo Sapiens,NA,Non-hemolytic
12654,36551443,2022,grrrrsvqwca,G{d}R{d}R{d}R{d}R{d}S{d}V{d}Q{d}W{d}C{d}A{d},hLF 1-11(D-form),Free,Free,Linear,D,None,11,Antimycobacterial,<1 % Hemolysis at 4000 µg/mL,Human,Homo Sapiens,NA,Non-hemolytic
12669,36508333,2022,FPWIIS,FPWIIS{ct:Amid},BmT-2,Amidation,Free,Linear,L,None,6,Antioxidant,0 % Hemolysis at 400 µg/mL,Human,Crude Venom Of Bothrops Moojeni,NA,Non-hemolytic
12825,36737967,2023,YPVEPF,YPVEPF,YPVEPF,Free,Free,Linear,L,None,6,α-glucosidase inhibitory,0 % Hemolysis at 1 mg/mL,mouse,Chinese Rubing Cheese Whey Protien Hypoglycemic Peptides,antiparallel (50.50 %) and Random coil (35.20 %) structures,Non-hemolytic
12850,37336295,2023,FVDLKKIANIINSIFGK,FVDLKKIANIINSIFGK{ct:Amid},Temporin-1CEa,Amidation,Free,Linear,L,None,17,Antimycobacterial,50 % Hemolysis at 95.74 µM,Human,Chinese Brown Frog Rana Chensinensis,NA,NA
12851,37336295,2023,FVDLKKIANIINSIFKK,FVDLKKIANIINSIFKK{ct:Amid},LK1,Amidation,Free,Linear,L,None,17,Antimycobacterial,50 % Hemolysis at 1467 µM,Human,Analog Of Temporin-1Cea,NA,NA
12852,37336295,2023,FVKLKKILNIILSIFKK,FVKLKKILNIILSIFKK{ct:Amid},LK2(6)AN(2L),Amidation,Free,Linear,L,None,17,Antimycobacterial,50 % Hemolysis at 28.34 µM,Human,Analog Of Temporin-1Cea,NA,NA
12853,37336295,2023,IKKILSKIKKLLK,IKKILSKIKKLLK{ct:Amid},LK6,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Temporin-1Ceb,NA,Low hemolytic
12854,37336295,2023,IWLSKIKKLLK,IWLSKIKKLLK{ct:Amid},I4W,Amidation,Free,Linear,L,None,11,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Lk6,NA,Low hemolytic
12855,37336295,2023,IKKWWSKIKKLLK,IKKWWSKIKKLLK{ct:Amid},I4WL5W,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Lk6,NA,Low hemolytic
12856,37336295,2023,IKKIWSKIKKLLK,IKKIWSKIKKLLK{ct:Amid},L5W,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Lk6,NA,Low hemolytic
12857,37336295,2023,IKKILSKIKKWLK,IKKILSKIKKWLK{ct:Amid},L11W,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Lk6,NA,Low hemolytic
12858,37336295,2023,IKKILSKIKKLWK,IKKILSKIKKLWK{ct:Amid},L12W,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Lk6,NA,Low hemolytic
12859,37336295,2023,WKKIWSKIKKLLK,WKKIWSKIKKLLK{ct:Amid},I1WL5W,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Lk6,NA,Low hemolytic
12860,37336295,2023,WKKILSKIKKLLK,WKKILSKIKKLLK{ct:Amid},I1W,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Lk6,NA,Low hemolytic
12861,37336295,2023,SAVGRHGRRFGLRKHRKH,SAVGRHGRRFGLRKHRKH{ct:Amid},Chensinin-1,Amidation,Free,Linear,L,None,18,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Frog Rana Chensinensis,NA,Low hemolytic
12862,37336295,2023,SKVWRHWRRFWHRAHRKL,SKVWRHWRRFWHRAHRKL{ct:Amid},Chensinin-1b,Amidation,Free,Linear,L,None,18,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Chensinin-1,NA,Low hemolytic
12863,37336295,2023,SKVWRHWRRFWHRAHRK(C8)L,SKVWRHWRRFWHRAHRK({nnr:C8})L,OA-C1b,Free,Free,Linear,L,C8 = C8,19,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Lipidated Analog Of Chensinin-1B,NA,Low hemolytic
12864,37336295,2023,SKVWRHWRRFWHRAHRK(C12)L,SKVWRHWRRFWHRAHRK({nnr:C12})L,LA-C1b,Free,Free,Linear,L,C12 = C12,19,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Lipidated Analog Of Chensinin-1B,NA,Low hemolytic
12865,37336295,2023,SKVWRHWRRFWHRAHRK(C16)L,SKVWRHWRRFWHRAHRK({nnr:C16})L,PA-C1b,Free,Free,Linear,L,C16 = C16,19,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Lipidated Analog Of Chensinin-1B,NA,Low hemolytic
12866,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{ct:Amid},D-W3R6,Amidation,Free,Linear,D,None,11,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of W3R6,NA,Low hemolytic
12867,37336295,2023,VWRRWRRFWRR,VWRRWRRFWRR{ct:Amid},W3R6,Amidation,Free,Linear,L,None,11,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Chensinin-1,"40% H2O/TFE-d3 = Random coil, 50%H2O/TFE-d3 = α-Helical",Low hemolytic
12868,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{ct:Amid},D-Arg-W3R6,Amidation,Free,Linear,D,None,11,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Diastereomer Of W3R6,NA,Low hemolytic
12869,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:Acetylation(CH3COOH)}{ct:Amid},AC-D-W3R6,Amidation,Acetylation(CH3COOH),Linear,D,None,11,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Lipidated Analog Of D-W3R6 (Acetyl),NA,Low hemolytic
12870,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:butanoyl = CH3(CH2)2COOH}{ct:Amid},BA-D-W3R6,Amidation,butanoyl = CH3(CH2)2COOH,Linear,D,None,11,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Lipidated Analog Of D-W3R6 (Butanoyl),NA,Low hemolytic
12871,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:octanoyl = C8H16O2}{ct:Amid},OA-D-W3R6,Amidation,octanoyl = C8H16O2,Linear,D,None,11,Antimycobacterial,50 % Hemolysis at 100 µM,Human,Lipidated Analog Of D-W3R6 (Octanoyl),NA,NA
12872,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:lauric acyl = C12H24O2}{ct:Amid},LA-D-W3R6,Amidation,lauric acyl = C12H24O2,Linear,D,None,11,Antimycobacterial,50 % Hemolysis at 25 µM,Human,Lipidated Analog Of D-W3R6 (Lauric Acid),NA,NA
12873,37336295,2023,vwrrwrrfwrr,V{d}W{d}R{d}R{d}W{d}R{d}R{d}F{d}W{d}R{d}R{d}{nt:palmitic acyl = C16H32O2}{ct:Amid},PA-D-W3R6,Amidation,palmitic acyl = C16H32O2,Linear,D,None,11,Antimycobacterial,50 % Hemolysis at 25 µM,Human,Lipidated Analog Of D-W3R6 (Palmitic Acid),NA,NA
12874,37336295,2023,ILPILSLIGGLL,ILPILSLIGGLL{ct:Amid},Temporin-1CEb,Amidation,Free,Linear,L,None,12,Antimycobacterial,50 % Hemolysis at 122 µM,Human,Rana Chensinensis,NA,NA
12875,37336295,2023,IIPLPLGYFAKKT,IIPLPLGYFAKKT{ct:Amid},Temporin-1CEc,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Rana Chensinensis,NA,Low hemolytic
12876,37336295,2023,IIPLPLKKFAKKT,IIPLPLKKFAKKT{ct:Amid},2 K,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Temporin-1Cec,NA,Low hemolytic
12877,37336295,2023,KIPKPLKKFAKKT,KIPKPLKKFAKKT{ct:Amid},4 K,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Temporin-1Cec,NA,Low hemolytic
12878,37336295,2023,IIPLPLKKFLKKL,IIPLPLKKFLKKL{ct:Amid},2 K2L,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Temporin-1Cec,NA,Low hemolytic
12879,37336295,2023,KIPKPLKKFLKKL,KIPKPLKKFLKKL{ct:Amid},4 K2L,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Temporin-1Cec,NA,Low hemolytic
12880,37336295,2023,IILLLLKKFLKKL,IILLLLKKFLKKL{ct:Amid},2 K4L,Amidation,Free,Linear,L,None,14,Antimycobacterial,50 % Hemolysis at 62.5 µM,Human,Analog Of Temporin-1Cec,NA,NA
12881,37336295,2023,KILKLLKKFLKKL,KILKLLKKFLKKL{ct:Amid},4 K4L,Amidation,Free,Linear,L,None,13,Antimycobacterial,50 % Hemolysis at >500 µM,Human,Analog Of Temporin-1Cec,NA,Low hemolytic
13035,35647551,2022,BFKVARRTVAKYRENIeL,{nnr:B}FKVARRTVAKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},WT,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,0.12 ± 0.07 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic
13036,35647551,2022,BFKVXRRTXAKYRENIeL,{nnr:B}FKV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},2,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,6.6 ± 0.3 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic
13037,35647551,2022,BFKVARRXVAKXRENIeL,{nnr:B}FKVARR{nnr:X}VAK{nnr:X}RE{nnr:NIe}L{nt:Acet}{ct:Amid},10,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,10.7 ± 0.3 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic
13038,35647551,2022,BFKVXRRTXAKYRENIe|,{nnr:B}FKV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}|{nt:Acet}{ct:Amid},14,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,35.0 ± 0.5 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic
13039,35647551,2022,BFKVXKRTXAKYRENIeL,{nnr:B}FKV{nnr:X}KRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},17,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,3.3 ± 0.7 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic
13040,35647551,2022,BFKVXRKTXAKYRENIeL,{nnr:B}FKV{nnr:X}RKT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},18,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,3.3 ± 0.05 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic
13041,35647551,2022,BFKVXRRTXGKYRENIeL,{nnr:B}FKV{nnr:X}RRT{nnr:X}GKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},31,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,0.53 ± 0.05 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic
13042,35647551,2022,BFRVXRRTXAKYRENIeL,{nnr:B}FRV{nnr:X}RRT{nnr:X}AKYRE{nnr:NIe}L{nt:Acet}{ct:Amid},33,Amidation,Acetylation,Stapled,L,"B = β-alanine {nnr:Bala} – β-Alanine , X = (S)-2-4-(pentenyl)alanine, Z = (R)-2-(7- octenyl)alanine, Nle = Norleucine, O = Ornithine, stapled b/w X and X",16,Antivirulente,1.5 ± 0.03 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic
13305,35246675,2022,KETTTIVR,KETTTIVR,MoHpP-2,Free,Free,Linear,L,None,8,α-glucosidase inhibitory peptide,7.18 % Hemolysis at 4 mg/mL,Rabbit,Moringa Oleifera,α-Helix,Low hemolytic
13306,35246675,2022,KETTTIVR,KETTTIVR,MoHpP-2,Free,Free,Linear,L,None,8,α-glucosidase inhibitory peptide,4.23 % Hemolysis at 2 mg/mL,Rabbit,Moringa Oleifera,α-Helix,Low hemolytic
13325,35378215,2022,MDKLQLKGMSYSMCTGKF,MDKLQLKGMSYSMCTGKF,PD1 CD44,Free,Free,Linear,L,None,18,Antiviral,8 % Hemolysis at 196.3 µM,Human,Human,α-Helix,NA
13347,35832307,2022,GLFKWHPRCGEEQSMWT,GLFKWHPRCGEEQSMWT{ct:Amid},OA-GL17d,Amidation,Free,Linear,L,None,17,Cell proliferation,6.26 ± 0.14 % Hemolysis at 100 μg/mL,mouse,Odorrana Andersonii Frog Skin,α-Helix,Non-hemolytic
13348,35832307,2022,GLFKWHPRCGEEQSMWT,GLFKWHPRCGEEQSMWT{ct:Amid},OA-GL17d,Amidation,Free,Linear,L,None,17,Cell proliferation,6.99 ± 0.28 % Hemolysis at 500 μg/mL,mouse,Odorrana Andersonii Frog Skin,α-Helix,Non-hemolytic
13349,35832307,2022,GLFKWHPRCGEEQSMWT,GLFKWHPRCGEEQSMWT{ct:Amid},OA-GL17d,Amidation,Free,Linear,L,None,17,Cell proliferation,8.49 ± 0.46 % Hemolysis at 1 mg/mL,mouse,Odorrana Andersonii Frog Skin,α-Helix,Non-hemolytic
13679,35812346,2022,RRRRRRRRRRRRRRRRRR,RRRRRRRRRRRRRRRRRR{nt:H}{ct:OH},R18 (acetate),OH,H,Linear,L,None,18,Mast cell degranulation inducer,low Hemolysis at 16 μM,Human,Synthetic,NA,Low hemolytic
13680,35812346,2022,RRRRRRRRRRRRRRRRRR,RRRRRRRRRRRRRRRRRR{nt:H}{ct:OH},R18 (HCl),OH,H,Linear,L,None,18,Mast cell degranulation inducer,No Hemolysis at 16 μM,Human,Synthetic,NA,Non-hemolytic
13681,35812346,2022,rrrrrrrrrrrrrrrrrr,R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}R{d}{nt:H}{ct:OH},R18D (acetate),OH,H,Linear,D,Lower case r = d-arginine,18,Mast cell degranulation inducer,No Hemolysis at 16 μM,Human,Synthetic,NA,Non-hemolytic
13682,35812346,2022,GRKKRRQRRRKLSSIESDV,GRKKRRQRRRKLSSIESDV{nt:H}{ct:OH},Tat-NR2B9c (TFA),OH,H,Linear,L,TFA = Trifluoroacetic acid,19,Mast cell degranulation inducer,No Hemolysis at 16 μM,Human,Synthetic,NA,Non-hemolytic
13683,35812346,2022,PRRRRSSSRPIRRRRPRRASRRRRRGGRRRR,PRRRRSSSRPIRRRRPRRASRRRRRGGRRRR{nt:H}{ct:OH},Protamine (sulfate),OH,H,Linear,L,None,31,Mast cell degranulation inducer,No Hemolysis at 16 μM,Human,Synthetic,NA,Non-hemolytic
13769,2317508,1990,FLPLIAGLLGKLF,FLPLIAGLLGKLF{ct:Amid},Hemolytic protein B9,Amidation,Free,Linear,L,None,13,Hemolytic,4 % Hemolysis at 1nmol/ml,Human,Rana Esculenta (Edible Frog) (Pelophylax Esculentus),α-Helix,NA
13770,2317508,1990,FLPLIAGLLGKLF,FLPLIAGLLGKLF{ct:Amid},Hemolytic protein B9,Amidation,Free,Linear,L,None,13,Hemolytic,5 % Hemolysis at 1.5nmol/ml,Human,Rana Esculenta (Edible Frog) (Pelophylax Esculentus),α-Helix,NA
13771,2317508,1990,FLPLIAGLLGKLF,FLPLIAGLLGKLF{ct:Amid},Hemolytic protein B9,Amidation,Free,Linear,L,None,13,Hemolytic,17 % Hemolysis at 2nmol/ml,Human,Rana Esculenta (Edible Frog) (Pelophylax Esculentus),α-Helix,NA
13772,2317508,1990,FLPLIAGLLGKLF,FLPLIAGLLGKLF{ct:Amid},Hemolytic protein B9,Amidation,Free,Linear,L,None,13,Hemolytic,20 % Hemolysis at 2.5nmol/ml,Human,Rana Esculenta (Edible Frog) (Pelophylax Esculentus),α-Helix,NA
13773,2317508,1990,FLPLIAGLLGKLF,FLPLIAGLLGKLF{ct:Amid},Hemolytic protein B9,Amidation,Free,Linear,L,None,13,Hemolytic,35 % Hemolysis at 3nmol/ml,Human,Rana Esculenta (Edible Frog) (Pelophylax Esculentus),α-Helix,NA
13774,2317508,1990,FLPLIAGLLGKLF,FLPLIAGLLGKLF{ct:Amid},Hemolytic protein B9,Amidation,Free,Linear,L,None,13,Hemolytic,90 % Hemolysis at 3.5nmol/ml,Human,Rana Esculenta (Edible Frog) (Pelophylax Esculentus),α-Helix,NA
13813,2578459,1985,IKITTMLAKLGKVLAHV,IKITTMLAKLGKVLAHV{ct:Amid},Bombolitin I,Amidation,Free,Linear,L,None,17,hemolytic,50 % Hemolysis at 4μg/mL,Pig,"American Common Bumblebee, Megabombus Pennsylvanicus",Helix,NA
13815,2578459,1985,IKIMDILAKLGKVLAHV,IKIMDILAKLGKVLAHV{ct:Amid},Bombolitin III,Amidation,Free,Linear,L,None,17,hemolytic,50 % Hemolysis at 2.8μg/mL,Pig,"American Common Bumblebee, Megabombus Pennsylvanicus",Helix,NA
13816,2578459,1985,INIKDILAKLVKVLGHV,INIKDILAKLVKVLGHV{ct:Amid},Bombolitin IV,Amidation,Free,Linear,L,None,17,hemolytic,50 % Hemolysis at 1.8μg/mL,Pig,"American Common Bumblebee, Megabombus Pennsylvanicus",NA,NA
13817,2578459,1985,INVLGILGLLGKALSHL,INVLGILGLLGKALSHL{ct:Amid},Bombolitin V,Amidation,Free,Linear,L,None,17,hemolytic,50 % Hemolysis at 0.7μg/mL,Pig,"American Common Bumblebee, Megabombus Pennsylvanicus",NA,NA
13831,2317508,1990,FLPLIAGLIGKLF,FLPLIAGLIGKLF{ct:Amid},Peptide B9,Amidation,Free,Linear,L,None,13,Hemolytic,Hemolytic,Human,"Frog Rana Esculenta, Europe",NA,NA
13832,16207177,2006,GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD,GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD{cyc:N-C},Kalata B8,Free,Free,Cyclic,L,None,31,"Antiviral, Anti-HIV, Hemolytic",0 % Hemolysis at 370µM,Human,"Plant African Herb, Oldenlandia Affinis",Beta,Non-hemolytic
13836,16872274,2006,GLPTCGETCFGGTCNTPGCTCDPWPVCTHN,GLPTCGETCFGGTCNTPGCTCDPWPVCTHN{cyc:N-C},Cycloviolacin O24,Free,Free,Cyclic,L,None,30,"Antiviral, Anti-HIV, Hemolytic",75 % Hemolytic at 25µg/ml,Human,Plant Viola Odorata,Bridge,NA
13860,22074926,2012,GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD,GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD{cyc:N-C},Parigidin-br1,Free,Free,Cyclic,L,None,32,"Insecticidal, Hemolytic",28 % Hemolytic at 20µM,Human,Plant Palicourea Rigida (Rubiaceae),Bridge,NA
13861,22074926,2012,GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD,GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD{cyc:N-C},Parigidin-br1,Free,Free,Cyclic,L,None,32,"Insecticidal, Hemolytic",41 % Hemolytic at 40µM,Human,Plant Palicourea Rigida (Rubiaceae),Bridge,NA
13992,29649486,2018,MNRLIILCLVAATIYSTIALPMKEDISNEERPTSVNEKPVKKSVAVAGAVIQGAALAFQVLDKILTSLGGIGRKIAIGVDNESGMKWAARNVYFYSGTSDTVLPYSVPHSKAFLYGARKTRGSVRGAVGVLAYSMSDGNTLGILFSVPYDYNWYSNWWNIKVYRGYKRANKWMYHDLYYYARPHKGNNEWHEKSLGYGLKSKGFMTSSGQTKLEIRVSRA,MNRLIILCLVAATIYSTIALPMKEDISNEERPTSVNEKPVKKSVAVAGAVIQGAALAFQVLDKILTSLGGIGRKIAIGVDNESGMKWAARNVYFYSGTSDTVLPYSVPHSKAFLYGARKTRGSVRGAVGVLAYSMSDGNTLGILFSVPYDYNWYSNWWNIKVYRGYKRANKWMYHDLYYYARPHKGNNEWHEKSLGYGLKSKGFMTSSGQTKLEIRVSRA,Deep-sea actinoporin Cjtox I (DELTA-actitoxin-Cja1a) (DELTA-AITX-Cja1a),Free,Free,Linear,L,None,220,Cytolytic,Hemolytic,Horse,Cribrinopsis Japonica (Deep-Sea Anemone),NA,NA
13993,17761205,2007,MNFKYSILFICFGTLDRGLIPECPFNEYDILFFVYTRQQRDGIVLTEETLQNYDLFKKSTISRQVVFIDHGFLSNGNNENFIAMAKALIEKDNFLVISVDWKKGACNAFASTLDYLGYSTAVGNTRHVGKYVADFTKLLVEQYKVSMSNIRLIGHSLGAHTSGFAGKEVQELKLNKYSNIDGLDPAGPSFDSNDCPERLCETDAEYVQIIHTSNILGVYSKIGTVDFYMNYGSHQPGCGRFFSPSCSHTKAVKYLTECIKHECCLIGTPWKKYFSTPKPISQCTKDTCVCVGLNAKSYPARGSFYVPVEATAPYCHNEGIKL,MNFKYSILFICFGTLDRGLIPECPFNEYDILFFVYTRQQRDGIVLTEETLQNYDLFKKSTISRQVVFIDHGFLSNGNNENFIAMAKALIEKDNFLVISVDWKKGACNAFASTLDYLGYSTAVGNTRHVGKYVADFTKLLVEQYKVSMSNIRLIGHSLGAHTSGFAGKEVQELKLNKYSNIDGLDPAGPSFDSNDCPERLCETDAEYVQIIHTSNILGVYSKIGTVDFYMNYGSHQPGCGRFFSPSCSHTKAVKYLTECIKHECCLIGTPWKKYFSTPKPISQCTKDTCVCVGLNAKSYPARGSFYVPVEATAPYCHNEGIKL,Phospholipase A1 (PLA1) (EC 3.1.1.32) (allergen Poly p 1),Free,Free,Linear,L,None,322,Allergic,17±4 % Hemolytic at 100µM,Rat,Polybia Paulista (Neotropical Social Wasp) (Swarm-Founding Polistine Wasp),NA,NA
13998,17451767,2007,NLVQFKTLIMKIAGRSVVYKYFYYGCYCGWGGIGQPRDATDRCCFVHD,NLVQFKTLIMKIAGRSVVYKYFYYGCYCGWGGIGQPRDATDRCCFVHD,Acidic phospholipase A2 (Bp-PLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),Free,Free,Linear,L,None,48,Anticoagulation,High Hemolytic,mouse,Bothrops Pauloensis (Neuwied'S Lancehead) (Bothrops Neuwiedi Pauloensis),NA,NA
14002,10930841,2000,MRALWIVAVLLVGVEGSLFELGKMIWQETGKNPVKNYGLYGCNCGVGGRGEPLDATDRCCFVHKCCYKKLTDCDSKKDRYSYKWKNKAIVCGKNQPCMQEMCECDKAFAICLRENLDTYNKSFRYHLKPSCKKTSEQC,MRALWIVAVLLVGVEGSLFELGKMIWQETGKNPVKNYGLYGCNCGVGGRGEPLDATDRCCFVHKCCYKKLTDCDSKKDRYSYKWKNKAIVCGKNQPCMQEMCECDKAFAICLRENLDTYNKSFRYHLKPSCKKTSEQC,Basic phospholipase A2 homolog acutohaemolysin (svPLA2 homolog) (Dac-K49),Free,Free,Linear,L,None,138,"Hemolytic, Anticoagulant",50 % Hemolytic at 100µg,Rabbit,Deinagkistrodon Acutus (Hundred-Pace Snake) (Agkistrodon Acutus),NA,NA
14015,31295915,2019,SAEVAGAVIEGAKLTFNVLQ,SAEVAGAVIEGAKLTFNVLQ,FraA,Free,Free,Linear,L,None,20,actinoporins,HC(50) % Hemolytic at 0.4 ± 0.02nM,Sheep,Actinia Fragacea (Strawberry Anemone),β-sandwich flanked by two α-helices,NA
14016,31295915,2019,SAEVAGAIIDGASLTFDVLQ,SAEVAGAIIDGASLTFDVLQ,FraB,Free,Free,Linear,L,None,20,actinoporins,HC(50) % Hemolytic at 0.3 ± 0.02nM,Sheep,Actinia Fragacea (Strawberry Anemone),β-sandwich flanked by two α-helices,NA
14017,31295915,2019,SADVAGAVIDGAGLG,SADVAGAVIDGAGLG,FraC d,Free,Free,Linear,L,None,15,actinoporins,HC(50) % Hemolytic at 1.6 ± 0.3nM,Sheep,Actinia Fragacea (Strawberry Anemone),β-sandwich flanked by two α-helices,NA
14018,31295915,2019,SVAVAGAVIKGAALTFNILQ,SVAVAGAVIKGAALTFNILQ,FraD,Free,Free,Linear,L,None,20,actinoporins,HC(50) % Hemolytic at 0.4 ± 0.3nM,Sheep,Actinia Fragacea (Strawberry Anemone),β-sandwich flanked by two α-helices,NA
14019,31295915,2019,SADVAGAVIDGAGLGFDVLK,SADVAGAVIDGAGLGFDVLK,FraE,Free,Free,Linear,L,None,20,actinoporins,HC(50) % Hemolytic at 1.6 ± 0.2nM,Sheep,Actinia Fragacea (Strawberry Anemone),β-sandwich flanked by two α-helices,NA
14020,32092412,2021,MRSLGALLLLLSACLAVSAGPVPTPPDNIQVQENFNISRIYGKWYNLAIGSTCPWLKKIMDRMTVSTLVLGEGATEAEISMTSTRWRKGVCEETSGAYEKTDTDGKFLYHKSKWNITMESYVVHTNYDEYAIFLTKKFSRHHGPTITAKLYGRAPQLRETLLQDFRVVAQGVGIPEDSIFTMADRGECVPGEQEPEPILIPRVRRAVLPQEEEGSGGGQLVTEVTKKEDSCQLGYSAGPCMGMTSRYFYNGTSMACETFQYGGCMGNGNNFVTEKECLQTCRTVAACNLPIVRGPCRAFIQLWAFDAVKGKCVLFPYGGCQGNGNKFYSEKECREYCGVPGDGDEELLRFSN,MRSLGALLLLLSACLAVSAGPVPTPPDNIQVQENFNISRIYGKWYNLAIGSTCPWLKKIMDRMTVSTLVLGEGATEAEISMTSTRWRKGVCEETSGAYEKTDTDGKFLYHKSKWNITMESYVVHTNYDEYAIFLTKKFSRHHGPTITAKLYGRAPQLRETLLQDFRVVAQGVGIPEDSIFTMADRGECVPGEQEPEPILIPRVRRAVLPQEEEGSGGGQLVTEVTKKEDSCQLGYSAGPCMGMTSRYFYNGTSMACETFQYGGCMGNGNNFVTEKECLQTCRTVAACNLPIVRGPCRAFIQLWAFDAVKGKCVLFPYGGCQGNGNKFYSEKECREYCGVPGDGDEELLRFSN,Protein AMBP (Protein HC) [Cleaved into: Alpha-1-microglobulin (EC 1.6.2.-) (Alpha-1 microglycoprotein) (Complex-forming glycoprotein heterogeneous in charge); Inter-alpha-trypsin inhibitor light chain (ITI-LC) (Bikunin) (EDC1) (HI-30) (Uronic-acid-rich protein); Trypstatin],Free,Free,Linear,L,None,352,Antioxidant,Hemolytic,Human,Homo Sapiens (Human),NA,NA
14021,10978735,2001,ALAGTIIAGASLTFQVLDKVLEELGKVSRKIAVGIDNESGGTWTALNAYFRSGTTDVILPEFVPNTKALLYSGRKDTGPVATGAVAAFAYYMSSGNTLGVMFSVPFDYNWYSNWWDVKIYSGKRRADQGMYEDLYYGNPYRGDNGWHEKNLGYGLRMKGIMTSAGEAKMQIKISR,ALAGTIIAGASLTFQVLDKVLEELGKVSRKIAVGIDNESGGTWTALNAYFRSGTTDVILPEFVPNTKALLYSGRKDTGPVATGAVAAFAYYMSSGNTLGVMFSVPFDYNWYSNWWDVKIYSGKRRADQGMYEDLYYGNPYRGDNGWHEKNLGYGLRMKGIMTSAGEAKMQIKISR,DELTA-stichotoxin-She4b (DELTA-SHTX-She4b) (Cytolysin III) (Sticholysin II) (St II) (St-II) (StII) (StnII) (Sticholysin-2) (STCH2),Free,Free,Linear,L,None,175,Cytolytic,50 % Hemolytic at 30-45ng/ml,Human,Stichodactyla Helianthus (Sun Anemone) (Stoichactis Helianthus),NA,NA
14022,20624979,2010,MKTRIVSSVTTTLLLGSILMNPVAGAADSDINIKTGTTDIGSNTTVKTGDLVTYDKENGMHKKVFYSFIDDKNHNKKLLVIRTKGTIAGQYRVYSEEGANKSGLAWPSAFKVQLQLPDNEVAQISDYYPRNSIDTKEYMSTLTYGFNGNVTGDDTGKIGGLIGANVSIGHTLKYVQPDFKTILESPTDKKVGWKVIFNNMVNQNWGPYDRDSWNPVYGNQLFMKTRNGSMKAADNFLDPNKASSLLSSGFSPDFATVITMDRKASKQQTNIDVIYERVRDDYQLHWTSTNWKGTNTKDKWTDRSSERYKIDWEKEEMTN,MKTRIVSSVTTTLLLGSILMNPVAGAADSDINIKTGTTDIGSNTTVKTGDLVTYDKENGMHKKVFYSFIDDKNHNKKLLVIRTKGTIAGQYRVYSEEGANKSGLAWPSAFKVQLQLPDNEVAQISDYYPRNSIDTKEYMSTLTYGFNGNVTGDDTGKIGGLIGANVSIGHTLKYVQPDFKTILESPTDKKVGWKVIFNNMVNQNWGPYDRDSWNPVYGNQLFMKTRNGSMKAADNFLDPNKASSLLSSGFSPDFATVITMDRKASKQQTNIDVIYERVRDDYQLHWTSTNWKGTNTKDKWTDRSSERYKIDWEKEEMTN,Alpha-hemolysin (Alpha-HL) (Alpha-toxin),Free,Free,Linear,L,None,319,Cytolytic,Hemolytic,Human,Staphylococcus Aureus,β-barrel,NA
14023,20624979,2010,MKTRIVSSVTTTLLLGSILMNPVAGAADSDINIKTGTTDIGSNTTVKTGDLVTYDKENGMHKKVFYSFIDDKNHNKKLLVIRTKGTIAGQYRVYSEEGANKSGLAWPSAFKVQLQLPDNEVAQISDYYPRNSIDTKEYMSTLTYGFNGNVTGDDTGKIGGLIGANVSIGHTLKYVQPDFKTILESPTDKKVGWKVIFNNMVNQNWGPYDRDSWNPVYGNQLFMKTRNGSMKAADNFLDPNKASSLLSSGFSPDFATVITMDRKASKQQTNIDVIYERVRDDYQLHWTSTNWKGTNTKDKWTDRSSERYKIDWEKEEMTN,MKTRIVSSVTTTLLLGSILMNPVAGAADSDINIKTGTTDIGSNTTVKTGDLVTYDKENGMHKKVFYSFIDDKNHNKKLLVIRTKGTIAGQYRVYSEEGANKSGLAWPSAFKVQLQLPDNEVAQISDYYPRNSIDTKEYMSTLTYGFNGNVTGDDTGKIGGLIGANVSIGHTLKYVQPDFKTILESPTDKKVGWKVIFNNMVNQNWGPYDRDSWNPVYGNQLFMKTRNGSMKAADNFLDPNKASSLLSSGFSPDFATVITMDRKASKQQTNIDVIYERVRDDYQLHWTSTNWKGTNTKDKWTDRSSERYKIDWEKEEMTN,Alpha-hemolysin (Alpha-HL) (Alpha-toxin),Free,Free,Linear,L,None,319,Cytolytic,Hemolytic,Rabbit,Staphylococcus Aureus,β-barrel,NA
14028,8077197,1994,MQQSHQAGYANAADRESGIPAAVLDGIKAVAKEKNATLMFRLVNPHSTSLIAEGVATKGLGVHAKSSDWGLQAGYIPVNPNLSKLFGRAPEVIARADNDVNSSLAHGHTAVDLTLSKERLDYLRQAGLVTGMADGVVASNHAGYEQFEFRVKETSDGRYAVQYRRKGGDDFEAVKVIGNAAGIPLTADIDMFAIMPHLSNFRDSARSSVTSGDSVTDYLARTRRAASEATGGLDRERIDLLWKIARAGARSAVGTEARRQFRYDGDMNIGVITDFELEVRNALNRRAHAVGAQDVVQHGTEQNNPFPEADEKIFVVSATGESQMLTRGQLKEYIGQQRGEGYVFYENRAYGVAGKSLFDDGLGAAPGVPSGRSKFSPDVLETVPASPGLRRPSLGAVERQDSGYDSLDGVGSRSFSLGEVSDMAAVEAAELEMTRQVLHAGARQDDAEPGVSGASAHWGQRALQGAQAVAAAQRLVHAIALMTQFGRAGSTNTPQEAASLSAAVFGLGEASSAVAETVSGFFRGSSRWAGGFGVAGGAMALGGGIAAAVGAGMSLTDDAPAGQKAAAGAEIALQLTGGTVELASSIALALAAARGVTSGLQVAGASAGAAAGALAAALSPMEIYGLVQQSHYADQLDKLAQESSAYGYEGDALLAQLYRDKTAAEGAVAGVSAVLSTVGAAVSIAAAASVVGAPVAVVTSLLTGALNGILRGVQQPIIEKLANDYARKIDELGGPQAYFEKNLQARHEQLANSDGLRKMLADLQAGWNASSVIGVQTTEISKSALELAAITGNADNLKSVDVFVDRFVQGERVAGQPVVLDVAAGGIDIASRKGERPALTFITPLAAPGEEQRRRTKTGKSEFTTFVEIVGKQDRWRIRDGAADTTIDLAKVVSQLVDANGVLKHSIKLDVIGGDGDDVVLANASRIHYDGGAGTNTVSYAALGRQDSITVSADGERFNVRKQLNNANVYREGVATQTTAYGKRTENVQYRHVELARVGQLVEVDTLEHVQHIIGGAGNDSITGNAHDNFLAGGSGDDRLDGGAGNDTLVGGEGQNTVIGGAGDDVFLQDLGVWSNQLDGGAGVDTVKYNVHQPSEERLERMGDTGIHADLQKGTVEKWPALNLFSVDHVKNIENLHGSRLNDRIAGDDQDNELWGHDGNDTIRGRGGDDILRGGLGLDTLYGEDGNDIFLQDDETVSDDIDGGAGLDTVDYSAMIHPGRIVAPHEYGFGIEADLSREWVRKASALGVDYYDNVRNVENVIGTSMKDVLIGDAQANTLMGQGGDDTVRGGDGDDLLFGGDGNDMLYGDAGNDTLYGGLGDDTLEGGAGNDWFGQTQAREHDVLRGGDGVDTVDYSQTGAHAGIAAGRIGLGILADLGAGRVDKLGEAGSSAYDTVSGIENVVGTELADRITGDAQANVLRGAGGADVLAGGEGDDVLLGGDGDDQLSGDAGRDRLYGEAGDDWFFQDAANAGNLLDGGDGRDTVDFSGPGRGLDAGAKGVFLSLGKGFASLMDEPETSNVLRNIENAVGSARDDVLIGDAGANVLNGLAGNDVLSGGAGDDVLLGDEGSDLLSGDAGNDDLFGGQGDDTYLFGVGYGHDTIYESGGGHDTIRINAGADQLWFARQGNDLEIRILGTDDALTVHDWYRDADHRVEIIHAANQAVDQAGIEKLVEAMAQYPDPGAAAAAPPAARVPDTLMQSLAVNWR,MQQSHQAGYANAADRESGIPAAVLDGIKAVAKEKNATLMFRLVNPHSTSLIAEGVATKGLGVHAKSSDWGLQAGYIPVNPNLSKLFGRAPEVIARADNDVNSSLAHGHTAVDLTLSKERLDYLRQAGLVTGMADGVVASNHAGYEQFEFRVKETSDGRYAVQYRRKGGDDFEAVKVIGNAAGIPLTADIDMFAIMPHLSNFRDSARSSVTSGDSVTDYLARTRRAASEATGGLDRERIDLLWKIARAGARSAVGTEARRQFRYDGDMNIGVITDFELEVRNALNRRAHAVGAQDVVQHGTEQNNPFPEADEKIFVVSATGESQMLTRGQLKEYIGQQRGEGYVFYENRAYGVAGKSLFDDGLGAAPGVPSGRSKFSPDVLETVPASPGLRRPSLGAVERQDSGYDSLDGVGSRSFSLGEVSDMAAVEAAELEMTRQVLHAGARQDDAEPGVSGASAHWGQRALQGAQAVAAAQRLVHAIALMTQFGRAGSTNTPQEAASLSAAVFGLGEASSAVAETVSGFFRGSSRWAGGFGVAGGAMALGGGIAAAVGAGMSLTDDAPAGQKAAAGAEIALQLTGGTVELASSIALALAAARGVTSGLQVAGASAGAAAGALAAALSPMEIYGLVQQSHYADQLDKLAQESSAYGYEGDALLAQLYRDKTAAEGAVAGVSAVLSTVGAAVSIAAAASVVGAPVAVVTSLLTGALNGILRGVQQPIIEKLANDYARKIDELGGPQAYFEKNLQARHEQLANSDGLRKMLADLQAGWNASSVIGVQTTEISKSALELAAITGNADNLKSVDVFVDRFVQGERVAGQPVVLDVAAGGIDIASRKGERPALTFITPLAAPGEEQRRRTKTGKSEFTTFVEIVGKQDRWRIRDGAADTTIDLAKVVSQLVDANGVLKHSIKLDVIGGDGDDVVLANASRIHYDGGAGTNTVSYAALGRQDSITVSADGERFNVRKQLNNANVYREGVATQTTAYGKRTENVQYRHVELARVGQLVEVDTLEHVQHIIGGAGNDSITGNAHDNFLAGGSGDDRLDGGAGNDTLVGGEGQNTVIGGAGDDVFLQDLGVWSNQLDGGAGVDTVKYNVHQPSEERLERMGDTGIHADLQKGTVEKWPALNLFSVDHVKNIENLHGSRLNDRIAGDDQDNELWGHDGNDTIRGRGGDDILRGGLGLDTLYGEDGNDIFLQDDETVSDDIDGGAGLDTVDYSAMIHPGRIVAPHEYGFGIEADLSREWVRKASALGVDYYDNVRNVENVIGTSMKDVLIGDAQANTLMGQGGDDTVRGGDGDDLLFGGDGNDMLYGDAGNDTLYGGLGDDTLEGGAGNDWFGQTQAREHDVLRGGDGVDTVDYSQTGAHAGIAAGRIGLGILADLGAGRVDKLGEAGSSAYDTVSGIENVVGTELADRITGDAQANVLRGAGGADVLAGGEGDDVLLGGDGDDQLSGDAGRDRLYGEAGDDWFFQDAANAGNLLDGGDGRDTVDFSGPGRGLDAGAKGVFLSLGKGFASLMDEPETSNVLRNIENAVGSARDDVLIGDAGANVLNGLAGNDVLSGGAGDDVLLGDEGSDLLSGDAGNDDLFGGQGDDTYLFGVGYGHDTIYESGGGHDTIRINAGADQLWFARQGNDLEIRILGTDDALTVHDWYRDADHRVEIIHAANQAVDQAGIEKLVEAMAQYPDPGAAAAAPPAARVPDTLMQSLAVNWR,Bifunctional hemolysin/adenylate cyclase (AC-HLY) (ACT) (Cyclolysin) [Cleaved into: Calmodulin-sensitive adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Adenylyl cyclase); Hemolysin],Free,Free,Linear,L,None,1706,Enzymatic,Hemolytic,Sheep,Bordetella Pertussis (Strain Tohama I / Atcc Baa-589 / Nctc 13251),NA,NA
14029,23499645,2013,VVGGDECNINEHRSLVAIFNSTGFFCSGILLNQEWVLTASHCDSTNFQMK,VVGGDECNINEHRSLVAIFNSTGFFCSGILLNQEWVLTASHCDSTNFQMK,Thrombin-like enzyme BpirSP27 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),Free,Free,Linear,L,None,50,Anticomplementary,50 % Hemolytic,Rabbit,Bothrops Pirajai (Piraja'S Lancehead),NA,NA
14030,23499645,2013,VVGGDECDINEHPFLAFLYSHGYFCGLTLINQEWVLTAAHCDRRFMRIYL,VVGGDECDINEHPFLAFLYSHGYFCGLTLINQEWVLTAAHCDRRFMRIYL,Thrombin-like enzyme BpirSP41 (SVTLE) (EC 3.4.21.-) (Fibrinogen-clotting enzyme) (Snake venom serine protease) (SVSP),Free,Free,Linear,L,None,50,Anticomplementary,50 % Hemolytic,Rabbit,Bothrops Pirajai (Piraja'S Lancehead),NA,NA
14031,23159790,2013,MMNLKYLLFFCLVQALHYCYAYGDPSLSNELDRFNPCPYSDDTVKMIILTRENKKHDFYTLNTIKNHNEFKKSTIKHQVVFITHGFTSTATAENFLAMAEALLDKGNYLVILIDWRVAACTNEMAGVKLAYYSYAASNTRLVGNYIATVTKMLVQQYNVPMANIRLIGHSLGAHTSGFAGKKVQELRLGKYSEIIGLDPAGPSFKSQECSQRICETDANYVQIIHTSNHLGTLVTLGTVDFYMNNGYNQPGCGLPIIGETCSHTRAVKYFTECIRHECCLIGVPQSKNPQPVSKCTRNECVCVGLNAKTYPKTGSFYVPVESKAPYCNNKGKII,MMNLKYLLFFCLVQALHYCYAYGDPSLSNELDRFNPCPYSDDTVKMIILTRENKKHDFYTLNTIKNHNEFKKSTIKHQVVFITHGFTSTATAENFLAMAEALLDKGNYLVILIDWRVAACTNEMAGVKLAYYSYAASNTRLVGNYIATVTKMLVQQYNVPMANIRLIGHSLGAHTSGFAGKKVQELRLGKYSEIIGLDPAGPSFKSQECSQRICETDANYVQIIHTSNHLGTLVTLGTVDFYMNNGYNQPGCGLPIIGETCSHTRAVKYFTECIRHECCLIGVPQSKNPQPVSKCTRNECVCVGLNAKTYPKTGSFYVPVESKAPYCNNKGKII,Phospholipase A1 1 (PLA1) (EC 3.1.1.32) (Allergen Ves a 1.01) (Vespapase) (allergen Vesp a 1),Free,Free,Linear,L,None,334,Anticomplementary,Hemolytic,Rabbit,Vespa Affinis (Lesser Banded Hornet),NA,NA
14032,23159790,2013,MMNLKYLLFFCLVQALHYCYAYGDPSLSNELDRFNPCPYSDDTVKMIILTRENKKHDFYTLNTIKNHNEFKKSTIKHQVVFITHGFTSTATAENFLAMAEALLDKGNYLVILIDWRVAACTNEMAGVKLAYYSYAASNTRLVGNYIATVTKMLVQQYNVPMANIRLIGHSLGAHTSGFAGKKVQELRLGKYSEIIGLDPAGPSFKSQECSQRICETDANYVQIIHTSNHLGTLVTLGTVDFYMNNGYNQPGCGLPIIGETCSHTRAVKYFTECIRHECCLIGVPQSKNPQPVSKCTRNECVCVGLNAKTYPKTGSFYVPVESKAPYCNNKGKII,MMNLKYLLFFCLVQALHYCYAYGDPSLSNELDRFNPCPYSDDTVKMIILTRENKKHDFYTLNTIKNHNEFKKSTIKHQVVFITHGFTSTATAENFLAMAEALLDKGNYLVILIDWRVAACTNEMAGVKLAYYSYAASNTRLVGNYIATVTKMLVQQYNVPMANIRLIGHSLGAHTSGFAGKKVQELRLGKYSEIIGLDPAGPSFKSQECSQRICETDANYVQIIHTSNHLGTLVTLGTVDFYMNNGYNQPGCGLPIIGETCSHTRAVKYFTECIRHECCLIGVPQSKNPQPVSKCTRNECVCVGLNAKTYPKTGSFYVPVESKAPYCNNKGKII,Phospholipase A1 1 (PLA1) (EC 3.1.1.32) (Allergen Ves a 1.01) (Vespapase) (allergen Vesp a 1),Free,Free,Linear,L,None,334,Anticomplementary,Hemolytic,Sheep,Vespa Affinis (Lesser Banded Hornet),NA,NA
14033,10484737,1999,GLLPKVKLVPEQISFILSTRENR,GLLPKVKLVPEQISFILSTRENR,Phospholipase A1 verutoxin-1 (PLA1) (VT-1) (EC 3.1.1.32) (EC 3.1.1.5),Free,Free,Linear,L,None,23,Catalytic,3 % Hemolytic at 3ug/ml,mouse,Vespa Velutina (Asian Yellow-Legged Hornet),NA,NA
14034,10484737,1999,FNPCPYSDDTVKMIILTRENKKHDF,FNPCPYSDDTVKMIILTRENKKHDF,Phospholipase A1 verutoxin-2a (PLA1) (VT-2a) (EC 3.1.1.32) (EC 3.1.1.5),Free,Free,Linear,L,None,25,Catalytic,98.8 % Hemolytic at 3ug/ml,mouse,Vespa Velutina (Asian Yellow-Legged Hornet),NA,NA
14035,10484737,1999,FNPCPYSDDTVKMIILTRENKKHDF,FNPCPYSDDTVKMIILTRENKKHDF,Phospholipase A1 verutoxin-2b (PLA1) (VT-2b) (EC 3.1.1.32) (EC 3.1.1.5),Free,Free,Linear,L,None,25,Catalytic,99.3 % Hemolytic at 3ug/ml,mouse,Vespa Velutina (Asian Yellow-Legged Hornet),NA,NA
14036,24384926,2014,NLYQFGKMINHMVGKSPIFSYGDYGCYCGWGGKGTPVDATDRCCFVHDCCYGRANGCDPKLSTYSYNFQNGNIVCGNKYGCLRHICECDRVAAICFGENVNTYDKKFLSSSRCRQTSEQC,NLYQFGKMINHMVGKSPIFSYGDYGCYCGWGGKGTPVDATDRCCFVHDCCYGRANGCDPKLSTYSYNFQNGNIVCGNKYGCLRHICECDRVAAICFGENVNTYDKKFLSSSRCRQTSEQC,Basic phospholipase A2 Cc2-PLA2 (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),Free,Free,Linear,L,None,120,Anti-platelet,43.34 ± 2.58 % Hemolytic,Sheep,Cerastes Cerastes (Horned Desert Viper),NA,NA
14039,2403529,1989,MREKVVLFLSIIMAIMLPVGNAAAAPVVHNPASTANRPVYAIAHRVLTTQGVDDAVAIGANALEIDFTAWGRGWWADHDGIPTSAGATAEEIFKHIADKRKQGANITFTWLDIKNPDYCRDARSVCSINALRDLARKYLEPAGVRVLYGFYKTVGGPAWKTITADLRDGEAVALSGPAQDVLNDFARSENKILTKQKIADYGYYNINQGFGNCYGTWNRTCDQLRKSSEARDQGKLGKTFGWTIATGQDARVNDLLGKANVDGLIFGFKITHFYRHADTENSFKAIKRWVDKHSATHHLATVADNPW,MREKVVLFLSIIMAIMLPVGNAAAAPVVHNPASTANRPVYAIAHRVLTTQGVDDAVAIGANALEIDFTAWGRGWWADHDGIPTSAGATAEEIFKHIADKRKQGANITFTWLDIKNPDYCRDARSVCSINALRDLARKYLEPAGVRVLYGFYKTVGGPAWKTITADLRDGEAVALSGPAQDVLNDFARSENKILTKQKIADYGYYNINQGFGNCYGTWNRTCDQLRKSSEARDQGKLGKTFGWTIATGQDARVNDLLGKANVDGLIFGFKITHFYRHADTENSFKAIKRWVDKHSATHHLATVADNPW,Phospholipase D (PLD) (EC 3.1.4.-) (Choline phosphatase) (SM/LPC-specific PLD) (Sphingomyelinase D) (SMaseD) (EC 3.1.4.41),Free,Free,Linear,L,None,307,Enzymatic,Hemolytic,Sheep,Corynebacterium Pseudotuberculosis,NA,NA
14046,21593408,2011,MAYVRLTSLAVLFFLAASVMKTEGGLPTCGETCTLGTCYVPDCSCSWPICMKNHIIAANAKTVNEHRLLCTSHEDCFKKGTGNYCASFPDSNIHFGWCFHAESEGYLLKDFMNMSKDDLKMPLESTN,MAYVRLTSLAVLFFLAASVMKTEGGLPTCGETCTLGTCYVPDCSCSWPICMKNHIIAANAKTVNEHRLLCTSHEDCFKKGTGNYCASFPDSNIHFGWCFHAESEGYLLKDFMNMSKDDLKMPLESTN,Cyclotide cter-M,Free,Free,Linear,L,None,127,Anti-HIV,50 % Hemolytic at >100µM,Human,Clitoria Ternatea (Butterfly Pea),NA,Low hemolytic
14051,20854656,2010,MARRARVDAELVRRGLARSRQQAAELIGAGKVRIDGLPAVKPATAVSDTTALTVVTDSERAWVSRGAHKLVGALEAFAIAVAGRRCLDAGASTGGFTEVLLDRGAAHVVAADVGYGQLAWSLRNDPRVVVLERTNARGLTPEAIGGRVDLVVADLSFISLATVLPALVGCASRDADIVPLVKPQFEVGKGQVGPGGVVHDPQLRARSVLAVARRAQELGWHSVGVKASPLPGPSGNVEYFLWLRTQTDRALSAKGLEDAVHRAISEGP,MARRARVDAELVRRGLARSRQQAAELIGAGKVRIDGLPAVKPATAVSDTTALTVVTDSERAWVSRGAHKLVGALEAFAIAVAGRRCLDAGASTGGFTEVLLDRGAAHVVAADVGYGQLAWSLRNDPRVVVLERTNARGLTPEAIGGRVDLVVADLSFISLATVLPALVGCASRDADIVPLVKPQFEVGKGQVGPGGVVHDPQLRARSVLAVARRAQELGWHSVGVKASPLPGPSGNVEYFLWLRTQTDRALSAKGLEDAVHRAISEGP,16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA (EC 2.1.1.226) (EC 2.1.1.227) (16S rRNA (cytidine1409-2'-O)-methyltransferase) (23S rRNA (cytidine1920-2'-O)-methyltransferase) (Hemolysin TlyA),Free,Free,Linear,L,None,268,Antibiotic,50 % Hemolytic at 18μmug/ml,Rabbit,Mycobacterium Tuberculosis (Strain Atcc 25618 / H37Rv),NA,NA
14092,23733617,2013,MLFPTALIFGCWALVIEGADNRRPIWNMGHMVNEVYQIDEFVDLGANSIETDITFDDDAMAEYSYHGVPCDCRRWCHKWEYVNVFLDGLRRATTPGDSKYRPELTLVVFDLKTGDLSSSTAYKGGKLFAQKLLDRYWNGGNNGGRAYIIISIPDIDHYAFITGFREALKNANHEELLDKVGYDFSGNDDLSSTRTALNKAGVKDREHVWQSDGITNCILRGLDRVREAVRNRDSSNGYINKVYYWTIEKYVSVRDALDAGVDGIMTNEPDVIVNVLNEGNYRGRFRLANYDDNPWVTFK,MLFPTALIFGCWALVIEGADNRRPIWNMGHMVNEVYQIDEFVDLGANSIETDITFDDDAMAEYSYHGVPCDCRRWCHKWEYVNVFLDGLRRATTPGDSKYRPELTLVVFDLKTGDLSSSTAYKGGKLFAQKLLDRYWNGGNNGGRAYIIISIPDIDHYAFITGFREALKNANHEELLDKVGYDFSGNDDLSSTRTALNKAGVKDREHVWQSDGITNCILRGLDRVREAVRNRDSSNGYINKVYYWTIEKYVSVRDALDAGVDGIMTNEPDVIVNVLNEGNYRGRFRLANYDDNPWVTFK,Dermonecrotic toxin LiSicTox-alphaIVA1 (EC 4.6.1.-) (Dermonecrotic toxin 7) (DT7) (LiRecDT7) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D 7) (SMD 7) (SMase D 7) (Sphingomyelinase D 7),Free,Free,Linear,L,None,299,Hemolytic,100 % Hemolytic at 25ug/ml,Human,Loxosceles Intermedia (Brown Spider),NA,NA
14094,2693022,1989,MSKITLSSLKSSLQQGLKNGKNKLNQAGTTLKNGLTQTGHSLQNGAKKLILYIPQGYDSGQGNGVQDLVKAANDLGIEVWREERSNLDIAKTSFDTTQKILGFTDRGIVLFAPQLDNLLKKNPKIGNTLGSASSISQNIGKANTVLGGIQSILGSVLSGVNLNELLQNKDPNQLELAKAGLELTNELVGNIASSVQTVDAFAEQISKLGSHLQNVKGLGGLSNKLQNLPDLGKASLGLDIISGLLSGASAGLILADKEASTEKKAAAGVEFANQIIGNVTKAVSSYILAQRVASGLSSTGPVAALIASTVALAVSPLSFLNVADKFKQADLIKSYSERFQKLGYDGDRLLADFHRETGTIDASVTTINTALAAISGGVGAASAGSLVGAPVALLVAGVTGLITTILEYSKQAMFEHVANKVHDRIVEWEKKHNKNYFEQGYDSRHLADLQDNMKFLINLNKELQAERVVAITQQRWDNQIGDLAAISRRTDKISSGKAYVDAFEEGQHQSYDSSVQLDNKNGIINISNTNRKTQSVLFRTPLLTPGEENRERIQEGKNSYITKLHIQRVDSWTVTDGDASSSVDFTNVVQRIAVKFDDAGNIIESKDTKIIANLGAGNDNVFVGSSTTVIDGGDGHDRVHYSRGEYGALVIDATAETEKGSYSVKRYVGDSKALHETIATHQTNVGNREEKIEYRREDDRFHTGYTVTDSLKSVEEIIGSQFNDIFKGSQFDDVFHGGNGVDTIDGNDGDDHLFGGAGDDVIDGGNGNNFLVGGTGNDIISGGKDNDIYVHKTGDGNDSITDSGGQDKLAFSDVNLKDLTFKKVDSSLEIINQKGEKVRIGNWFLEDDLASTVANYKATNDRKIEEIIGKGGERITSEQVDKLIKEGNNQISAEALSKVVNDYNTSKDRQNVSNSLAKLISSVGSFTSSSDFRNNLGTYVPSSIDVSNNIQLARAA,MSKITLSSLKSSLQQGLKNGKNKLNQAGTTLKNGLTQTGHSLQNGAKKLILYIPQGYDSGQGNGVQDLVKAANDLGIEVWREERSNLDIAKTSFDTTQKILGFTDRGIVLFAPQLDNLLKKNPKIGNTLGSASSISQNIGKANTVLGGIQSILGSVLSGVNLNELLQNKDPNQLELAKAGLELTNELVGNIASSVQTVDAFAEQISKLGSHLQNVKGLGGLSNKLQNLPDLGKASLGLDIISGLLSGASAGLILADKEASTEKKAAAGVEFANQIIGNVTKAVSSYILAQRVASGLSSTGPVAALIASTVALAVSPLSFLNVADKFKQADLIKSYSERFQKLGYDGDRLLADFHRETGTIDASVTTINTALAAISGGVGAASAGSLVGAPVALLVAGVTGLITTILEYSKQAMFEHVANKVHDRIVEWEKKHNKNYFEQGYDSRHLADLQDNMKFLINLNKELQAERVVAITQQRWDNQIGDLAAISRRTDKISSGKAYVDAFEEGQHQSYDSSVQLDNKNGIINISNTNRKTQSVLFRTPLLTPGEENRERIQEGKNSYITKLHIQRVDSWTVTDGDASSSVDFTNVVQRIAVKFDDAGNIIESKDTKIIANLGAGNDNVFVGSSTTVIDGGDGHDRVHYSRGEYGALVIDATAETEKGSYSVKRYVGDSKALHETIATHQTNVGNREEKIEYRREDDRFHTGYTVTDSLKSVEEIIGSQFNDIFKGSQFDDVFHGGNGVDTIDGNDGDDHLFGGAGDDVIDGGNGNNFLVGGTGNDIISGGKDNDIYVHKTGDGNDSITDSGGQDKLAFSDVNLKDLTFKKVDSSLEIINQKGEKVRIGNWFLEDDLASTVANYKATNDRKIEEIIGKGGERITSEQVDKLIKEGNNQISAEALSKVVNDYNTSKDRQNVSNSLAKLISSVGSFTSSSDFRNNLGTYVPSSIDVSNNIQLARAA,RTX-II toxin determinant A (APX-IIA) (Cytolysin IIA) (CLY-IIA) (Hemolysin IIA) (HLY-IIA),Free,Free,Linear,L,None,956,Antisera,Hemolytic,goat,Actinobacillus Pleuropneumoniae (Haemophilus Pleuropneumoniae),NA,Low hemolytic
14121,15932999,2005,MKSNVDTVLDGYTSVPVGVLDSTLANTDILTRITLVFPSSLSLSALQESWYALVRSWPILAARVRATPSTPSGLSYLIPTPATLESLETRSRNSASKPLEKHIVLLDQSSRSFSDYHPIVAKAVHSNLDRNNISIGGAPLVEHEKATICSNACTSWKQLIKQDQAFVTAQATKFADATTVTISFSHILGDAFTIKHIFQGWQTALNGQAVQELQDVGKDPFIKYLPKDTNDKKHKKNKKSEPAPDLPLQWFRYGLARKIKLISLLLWEVKVKKPEKTLGQYYIYLPQAKVDELMAQARSDLEQLRSSSATSATERDLNVSTFNVLFAWLLQNIHASTAIKPSKTSSVICIINAKTRPPAGHVPADYPRHQLWGGALGAPLRPLSAAEYVTLPLGQLALHIRESITEQVDPENIRKSVVMALKHSMWKKPSGELLFFSQNPNTYWCGCTEWRSAKFHTIDFSAAATPHHDAIQPTAAPAASVNPVAITTNMETPMTKRNRWALLGEANNGIWFTGGLTANEASNKNGFGRYIFVE,MKSNVDTVLDGYTSVPVGVLDSTLANTDILTRITLVFPSSLSLSALQESWYALVRSWPILAARVRATPSTPSGLSYLIPTPATLESLETRSRNSASKPLEKHIVLLDQSSRSFSDYHPIVAKAVHSNLDRNNISIGGAPLVEHEKATICSNACTSWKQLIKQDQAFVTAQATKFADATTVTISFSHILGDAFTIKHIFQGWQTALNGQAVQELQDVGKDPFIKYLPKDTNDKKHKKNKKSEPAPDLPLQWFRYGLARKIKLISLLLWEVKVKKPEKTLGQYYIYLPQAKVDELMAQARSDLEQLRSSSATSATERDLNVSTFNVLFAWLLQNIHASTAIKPSKTSSVICIINAKTRPPAGHVPADYPRHQLWGGALGAPLRPLSAAEYVTLPLGQLALHIRESITEQVDPENIRKSVVMALKHSMWKKPSGELLFFSQNPNTYWCGCTEWRSAKFHTIDFSAAATPHHDAIQPTAAPAASVNPVAITTNMETPMTKRNRWALLGEANNGIWFTGGLTANEASNKNGFGRYIFVE,Acetyltransferase MATC1 (EC 2.3.1.-) (Mannosylerythritol lipids (MELs) biosynthesis cluster protein MAT1),Free,Free,Linear,L,None,534,Biosurfactant,High Hemolytic,Sheep,Ustilago Maydis (Strain 521 / Fgsc 9021) (Corn Smut Fungus),NA,NA
14122,15932999,2005,MQADKHAWKEVSPNLAQRPLVGVEKLLNYAEYYQNGNFQLSAAIHLETNLTTEKLQQRFGLAVWNVRCLLPEIGTWTVGTTGDAAVDLDNATFTAIQTVEEAQKWIDETAVIVQDGTTAEELTILTTNHTIEPAGKQFRVYLVTNARQGSPAIIVNASHVLSGHRIAAQLCTIVQALVDARLVSLLQAEPDPRAALRSIFVPENLARLIGKLPISLNTAYHKRFNPTEGDLENGFEKLSERLANSALPSIGIPRLSSPATNPEYSLGTVNGEAMTIMNLRRTIGSNEYRLLIDAHKKLGITVPSVIYACIVNSIDRRCKSNTAQDAETPGANLAYSAHAKRWLPDETFMTRSPVNMAIVLGSAYVSPDELRSKQHGCDLSIDELIELAKTIRAKQDAYLDTPHIISAMEQVGDEVSAMIADTAIKQRQAGTDPHVALFENSPAICPPTLTSQGDIAFKRLYTAQGGSWDPEPAVAAGEYVYIGHSWNSGRTTDASVCFALVGFSGELRLTSYFDSRFFDAKLIESILDDVLSNLRMIATTVPVDAPEAKL,MQADKHAWKEVSPNLAQRPLVGVEKLLNYAEYYQNGNFQLSAAIHLETNLTTEKLQQRFGLAVWNVRCLLPEIGTWTVGTTGDAAVDLDNATFTAIQTVEEAQKWIDETAVIVQDGTTAEELTILTTNHTIEPAGKQFRVYLVTNARQGSPAIIVNASHVLSGHRIAAQLCTIVQALVDARLVSLLQAEPDPRAALRSIFVPENLARLIGKLPISLNTAYHKRFNPTEGDLENGFEKLSERLANSALPSIGIPRLSSPATNPEYSLGTVNGEAMTIMNLRRTIGSNEYRLLIDAHKKLGITVPSVIYACIVNSIDRRCKSNTAQDAETPGANLAYSAHAKRWLPDETFMTRSPVNMAIVLGSAYVSPDELRSKQHGCDLSIDELIELAKTIRAKQDAYLDTPHIISAMEQVGDEVSAMIADTAIKQRQAGTDPHVALFENSPAICPPTLTSQGDIAFKRLYTAQGGSWDPEPAVAAGEYVYIGHSWNSGRTTDASVCFALVGFSGELRLTSYFDSRFFDAKLIESILDDVLSNLRMIATTVPVDAPEAKL,Acyl-CoA-dependent acyltransferase MAC2 (EC 2.-.-.-) (Mannosylerythritol lipids (MELs) biosynthesis cluster protein MAC2),Free,Free,Linear,L,None,550,Biosurfactant,High Hemolytic,Sheep,Ustilago Maydis (Strain 521 / Fgsc 9021) (Corn Smut Fungus),NA,NA
14123,15932999,2005,MKVALLANPARGEINVLLATAYELIRLGHDVTFLTGSSFANAIAEFRSEQNDPILAARIHFSDLGNARAVEDFTRGMQSHLKGLRKPPGDYSSMEICQIVALVTEQEFRDAATMVRDRLLEIEPDMIAVDALSPNLVTGCRMTGLPWMFTVPCSPSLTATRKSLFDPHPMGRRRQRTLMSALENLKLTFIETYRNATKKDLYARRALLKNEFGLNSMGFNGDSAIVPPLWKDRNCVGGIHFNTPGLTDSIRQPHQIHFVGAGVTSDPENHDTPVFEAASFLKQLSPSSSTTFKPLFPPLSKTGRDLDVEWMDEAYAAGQLVVYLNMGSMFLWTDAEVRSCLRAFERLYEQSGGKIKLLFKLNKPKRTPNNTGASTPTAPISSPDFEEKQRTVMGSARPVGASNLVSEKLADAIKNVTPRRKTDADKGYSQFTLSEFEGLEYVRFTRWVHDQRSIYKHPALRVVIHHGGGNSFNEAVHYALPQMILSQWFDTHEYAILAERFGIGLRSKHAPKIDENDLVNTMTRLLQGPEAEKIRRNAKVWSIRSRNAGGAPAAARLIEAQAMLFNQQKQLELAASEVRAAVDTLSGKSSVADLESETAFTPNMLSGAASTVGSD,MKVALLANPARGEINVLLATAYELIRLGHDVTFLTGSSFANAIAEFRSEQNDPILAARIHFSDLGNARAVEDFTRGMQSHLKGLRKPPGDYSSMEICQIVALVTEQEFRDAATMVRDRLLEIEPDMIAVDALSPNLVTGCRMTGLPWMFTVPCSPSLTATRKSLFDPHPMGRRRQRTLMSALENLKLTFIETYRNATKKDLYARRALLKNEFGLNSMGFNGDSAIVPPLWKDRNCVGGIHFNTPGLTDSIRQPHQIHFVGAGVTSDPENHDTPVFEAASFLKQLSPSSSTTFKPLFPPLSKTGRDLDVEWMDEAYAAGQLVVYLNMGSMFLWTDAEVRSCLRAFERLYEQSGGKIKLLFKLNKPKRTPNNTGASTPTAPISSPDFEEKQRTVMGSARPVGASNLVSEKLADAIKNVTPRRKTDADKGYSQFTLSEFEGLEYVRFTRWVHDQRSIYKHPALRVVIHHGGGNSFNEAVHYALPQMILSQWFDTHEYAILAERFGIGLRSKHAPKIDENDLVNTMTRLLQGPEAEKIRRNAKVWSIRSRNAGGAPAAARLIEAQAMLFNQQKQLELAASEVRAAVDTLSGKSSVADLESETAFTPNMLSGAASTVGSD,Erythritol-mannosyl-transferase 1 (EC 2.4.1.-) (Mannosylerythritol lipids (MELs) biosynthesis cluster protein EMT1),Free,Free,Linear,L,None,615,Biosurfactant,High Hemolytic,Sheep,Ustilago Maydis (Strain 521 / Fgsc 9021) (Corn Smut Fungus),NA,NA
14124,15932999,2005,MINNALRTLISSATEQSLDDVLEHEFRTAVQLQQMDQFEWHQVEADLWKRTCLGHEASASFNQNIAHGHTELSLMTSWRVHQPSSSRITGSELELDQLVARVRQAWIQARYLRPEVGVELDTHTDPTVAQTMCYRLLRDEESIQEWLDETFVVKRLGDPGVATPAELCAYTYNRPLATKGKKSMLYLILPRLDDEQRTAYTIWNVSHAVTDGGSLAEVFNTLFQCVIDATPSEPYDSIYTPSAFELNVLPRMPRSVVMAYRQQYQPKPEEIAKAHKVAEVNMRMITEKMGESLALMPSTSWPERKHETVCLCRELEANEVRELLKFAKQVHSGITYLASAATILSAAETFPERKASSKGALVGMVRNARRWISATPLDASLGASTPLGSDAVFLWVPIDTHKTLEPSFSRMQELVTTARHIRHELDKHLTTPHCISSYPYVAESSIQGLNQQWSQIKAVQSPSSSSSQKEIAGIIGAQAPGFSSVGMMRIRPRFEPVSANARASGLWLERTDFTHTGRQINASPWISMFNVDGRIKLQLGFDTKFHEVEKMNQWLDRTVVWMRICAAAAATTSTSVSSTSVDATAPVFARL,MINNALRTLISSATEQSLDDVLEHEFRTAVQLQQMDQFEWHQVEADLWKRTCLGHEASASFNQNIAHGHTELSLMTSWRVHQPSSSRITGSELELDQLVARVRQAWIQARYLRPEVGVELDTHTDPTVAQTMCYRLLRDEESIQEWLDETFVVKRLGDPGVATPAELCAYTYNRPLATKGKKSMLYLILPRLDDEQRTAYTIWNVSHAVTDGGSLAEVFNTLFQCVIDATPSEPYDSIYTPSAFELNVLPRMPRSVVMAYRQQYQPKPEEIAKAHKVAEVNMRMITEKMGESLALMPSTSWPERKHETVCLCRELEANEVRELLKFAKQVHSGITYLASAATILSAAETFPERKASSKGALVGMVRNARRWISATPLDASLGASTPLGSDAVFLWVPIDTHKTLEPSFSRMQELVTTARHIRHELDKHLTTPHCISSYPYVAESSIQGLNQQWSQIKAVQSPSSSSSQKEIAGIIGAQAPGFSSVGMMRIRPRFEPVSANARASGLWLERTDFTHTGRQINASPWISMFNVDGRIKLQLGFDTKFHEVEKMNQWLDRTVVWMRICAAAAATTSTSVSSTSVDATAPVFARL,Acyl-CoA-dependent acyltransferase MAC1 (EC 2.-.-.-) (Mannosylerythritol lipids (MELs) biosynthesis cluster protein MAC1),Free,Free,Linear,L,None,591,Biosurfactant,High Hemolytic,Sheep,Ustilago Maydis (Strain 521 / Fgsc 9021) (Corn Smut Fungus),NA,NA
14127,23933196,2018,MSSDIIMAGLGRPFTLGFLYDARREKLIPGFSLFGDETLQKYATSTPQHSSDFQIVASDSVESKSNVMDIEASLGVSFLGGLVEVGGSAKYLNNTKKYQNQSRVTLQYKVTTTFKQFKAPPGKVNVQQTAISDKNVATHVVTAILFGANAFFVFDSDKVEDSNLQDIQGKMEAVIKKIPSVSIEGSGSVQLTDEEKSLASNLSCKFHGDFLLESLPTTFEEAVMTYQKLPELVGEEASDGVPMKVWLVPLTRFYSKADLLVRDISQGLVRKVHSILEDLHKLKRRANDSLEDDTVKLFPLLEKKLKNFQKNYSDYMTTFRRTISQKLQSIRKGDEDETAMLQLFEDRLRSPFNIDSLNMWMEITEREINVLRSCIDIIEETKHKAVLSQSQMVKDLLDSEVMHAVCYVFTYVTDKDHYLDALRDYLKSPNSRPARVRPVVTWVASNTVLETMREKAHLFRSLAKDMENRCVHFLVASIVNLKVEGAAIHYYRESVLIEPNFKHPIISAVEKIVDRRDLLWYDCELTLDPNTSHPSLYLSEGNKKAVTGTLRAFDNNPERFGLWQQVLCNKGLSRRHYWEVEWNGYVIVGVTYSSIGRKNIDIQSFIGFSETSWTLMFIPKNGVAVKGARRSVSYYFISDLAFPPLGLYHDCHASTLSFYKVSDNVLNHFHTIEIKPKLSEPVYAIIRIGDEDRPYHGTVRLL,MSSDIIMAGLGRPFTLGFLYDARREKLIPGFSLFGDETLQKYATSTPQHSSDFQIVASDSVESKSNVMDIEASLGVSFLGGLVEVGGSAKYLNNTKKYQNQSRVTLQYKVTTTFKQFKAPPGKVNVQQTAISDKNVATHVVTAILFGANAFFVFDSDKVEDSNLQDIQGKMEAVIKKIPSVSIEGSGSVQLTDEEKSLASNLSCKFHGDFLLESLPTTFEEAVMTYQKLPELVGEEASDGVPMKVWLVPLTRFYSKADLLVRDISQGLVRKVHSILEDLHKLKRRANDSLEDDTVKLFPLLEKKLKNFQKNYSDYMTTFRRTISQKLQSIRKGDEDETAMLQLFEDRLRSPFNIDSLNMWMEITEREINVLRSCIDIIEETKHKAVLSQSQMVKDLLDSEVMHAVCYVFTYVTDKDHYLDALRDYLKSPNSRPARVRPVVTWVASNTVLETMREKAHLFRSLAKDMENRCVHFLVASIVNLKVEGAAIHYYRESVLIEPNFKHPIISAVEKIVDRRDLLWYDCELTLDPNTSHPSLYLSEGNKKAVTGTLRAFDNNPERFGLWQQVLCNKGLSRRHYWEVEWNGYVIVGVTYSSIGRKNIDIQSFIGFSETSWTLMFIPKNGVAVKGARRSVSYYFISDLAFPPLGLYHDCHASTLSFYKVSDNVLNHFHTIEIKPKLSEPVYAIIRIGDEDRPYHGTVRLL,Cytolytic toxin-alpha (Sp-CTx-alpha),Free,Free,Linear,L,None,702,Cytolytic,50 % Hemolytic at 25-56ng/mL,Rabbit,Scorpaena Plumieri (Spotted Scorpionfish),NA,NA
14148,30734396,2019,GLVSGLLNSVTGLLGNLAGGGL,GLVSGLLNSVTGLLGNLAGGGL,Plasticin-TR (PTC-TR),Free,Free,Linear,L,None,22,Anti-inflammatory,50 % Hemolytic at >500µM,Mouse,Phyllomedusa Trinitatis (Trinidad Leaf Frog),Helical,Non-hemolytic
14159,22342498,2012,FLKGIIDTVSNWL,FLKGIIDTVSNWL{ct:Amid},Amphipathic peptide CT1 (VsCT1) (Non-disulfide-bridged peptide 5.11) (NDBP-5.11),Amidation,Free,Linear,L,None,13,hemolytic,6 % Hemolytic at 50µM,Human,Mesomexovis Subcristatus (Scorpion) (Vaejovis Subcristatus),Alpha Helix,Low hemolytic
14160,22342498,2012,FLKGIIDTVSKLF,FLKGIIDTVSKLF{ct:Amid},Amphipathic peptide CT2 (VsCT2) (Non-disulfide-bridged peptide 5.12) (NDBP-5.12),Amidation,Free,Linear,L,None,13,hemolytic,2 % Hemolytic at 50µM,Human,Mesomexovis Subcristatus (Scorpion) (Vaejovis Subcristatus),Alpha Helix,Low hemolytic
14161,15274631,2004,MSSSTVMADGFEEIEVDVVSVWKEGYAYENRGNSSVQQKITMTKGMKNLNSETKTLTATHTLGRTLKVGDPFEIASVEVSYTFSHQKSQVSMTQTEVYSSQVIEHTVTIPPNKKFTRWKLNADVGGTGIEYMYLIDEVTAIGADLTIPEVNKSRAKILVGRQIHLGETEIRIKHAERKEYMTVISRKSWPAATLGNSNLFKFVLFEDSSGIRIKTLNTMYPGYEWAYSSDQGGIYFDESSDNPKQRWALSKAMPLRHGDVVTFRNNFFTNSGMCYDDGPATNVYCLEKREDKWILEVVNT,MSSSTVMADGFEEIEVDVVSVWKEGYAYENRGNSSVQQKITMTKGMKNLNSETKTLTATHTLGRTLKVGDPFEIASVEVSYTFSHQKSQVSMTQTEVYSSQVIEHTVTIPPNKKFTRWKLNADVGGTGIEYMYLIDEVTAIGADLTIPEVNKSRAKILVGRQIHLGETEIRIKHAERKEYMTVISRKSWPAATLGNSNLFKFVLFEDSSGIRIKTLNTMYPGYEWAYSSDQGGIYFDESSDNPKQRWALSKAMPLRHGDVVTFRNNFFTNSGMCYDDGPATNVYCLEKREDKWILEVVNT,Lysenin-related protein 1 (LRP-1) (Lysenin-2) (efL2),Free,Free,Linear,L,None,300,Cytolytic,Hemolytic,Sheep,Eisenia Fetida (Red Wiggler Worm),NA,NA
14165,15893660,2005,SLETKDVITRAAYENLVNSGAIQGITMTKTIISNPILEEALVSHFNRKLG,SLETKDVITRAAYENLVNSGAIQGITMTKTIISNPILEEALVSHFNRKLG{cyc:N-C},Tricyclon-A,Free,Free,Cyclic,L,None,50,Plant defense,2 % Hemolytic at 500µM,Human,Viola Arvensis (European Field Pansy) (Field Violet),Helix and Extended,NA
14170,20097251,2010,MMKQQFFLFLAVIVMISSVIEAGRGREFMSNLKEKLSGVKEKMKNSWNRLTSMSEYACPVIEKWCEDHCQAKNAIGRCENTECKCLSK,MMKQQFFLFLAVIVMISSVIEAGRGREFMSNLKEKLSGVKEKMKNSWNRLTSMSEYACPVIEKWCEDHCQAKNAIGRCENTECKCLSK,Potassium channel toxin MeuTXKbeta3-meucin-24 [Cleaved into: Meucin-24 (Non-disulfide-bridged peptide 5.1) (NDBP-5.1); Potassium channel toxin MeuTXKbeta3],Free,Free,Linear,L,None,88,Antiparasite,0 % Hemolytic at 100µM,Mouse,Mesobuthus Eupeus (Lesser Asian Scorpion) (Buthus Eupeus),NA,Non-hemolytic
14176,12236591,2002,NLFQFAEMIVKMTGKEAVH,NLFQFAEMIVKMTGKEAVH,Neutral phospholipase A2 RVV-PFIIc' (svPLA2) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase),Free,Free,Linear,L,None,19,"Hemolytic, Anticoagulant",31 % Hemolytic at 2µg,Rabbit,Daboia Russelii (Russel'S Viper) (Vipera Russelii),NA,NA
14184,34941722,2021,ISEALKSIIVG,ISEALKSIIVG{ct:Amid},Annulatin (Linear alpha-helical peptide),Amidation,Free,Linear,L,None,11,Histamine releasing activity from mast cells,15.4 % Hemolytic at 12.5µmol/l,Human,Campsomeriella Annulata (Wasp) (Campsomeris Annulata),Alpha Helix,Low hemolytic
14193,26456928,2016,LKCNKLIPLAYKTCPAGKDLCYKMYMVSNKTVPVKRGCIDVCPKNSLLVKYECCNTDRCN,LKCNKLIPLAYKTCPAGKDLCYKMYMVSNKTVPVKRGCIDVCPKNSLLVKYECCNTDRCN,Cytotoxin 7 (CTX7),Free,Free,Linear,L,None,60,Cytolytic,50 % Hemolytic at 0.096µM,Human,Naja Naja (Indian Cobra),NA,NA
14194,26456928,2016,LQCNKLVPIASKTCPPGKNLCYKMFMVSDLTIPVKRGCIDVCPKNSLLVKYECCNTDRCN,LQCNKLVPIASKTCPPGKNLCYKMFMVSDLTIPVKRGCIDVCPKNSLLVKYECCNTDRCN,Cytotoxin 2a (CTX2a) (Cytotoxin 2) (CTX2),Free,Free,Linear,L,None,60,Cytolytic,50 % Hemolytic at 1.024µM,Human,Naja Naja (Indian Cobra),NA,NA
14195,26456928,2016,LKCNKLIPLAYKTCPAGKDLCYKMYMVSDKTVPVKRGCIDVCPKNSLLVKYECCNTDRCN,LKCNKLIPLAYKTCPAGKDLCYKMYMVSDKTVPVKRGCIDVCPKNSLLVKYECCNTDRCN,Cytotoxin 8 (CTX8),Free,Free,Linear,L,None,60,Cytolytic,50 % Hemolytic at 0.074µM,Human,Naja Naja (Indian Cobra),NA,NA
14196,26456928,2016,LKCNKLVPLFYKTCPAGKDLCYKMYMVATPKVPVKRGCIDVCPKSSLLVKYVCCNTDRCN,LKCNKLVPLFYKTCPAGKDLCYKMYMVATPKVPVKRGCIDVCPKSSLLVKYVCCNTDRCN,Cytotoxin 10 (CTX10),Free,Free,Linear,L,None,60,Cytolytic,50 % Hemolytic at 0.162µM,Human,Naja Naja (Indian Cobra),NA,NA
14202,12657318,2003,GWPAYPGPNGIRSSVCQTKLGCGKKNLATKGVCKAFCLGRKRFWQKCGKNGSSGKGSRICNPVLAHAVEKAGKGLIKVTDMAVAAIVKYAGKK,GWPAYPGPNGIRSSVCQTKLGCGKKNLATKGVCKAFCLGRKRFWQKCGKNGSSGKGSRICNPVLAHAVEKAGKGLIKVTDMAVAAIVKYAGKK,Parbolysin P4 (Parbolysin 4),Free,Free,Linear,L,None,93,Cytolysis,50 % Hemolytic at 5.75μg/ml,Bovine,Parborlasia Corrugatus (Antarctic Nemertean Worm),NA,NA